<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10054333</article-id><article-id pub-id-type="pmid">36985733</article-id><article-id pub-id-type="doi">10.3390/molecules28062761</article-id><article-id pub-id-type="publisher-id">molecules-28-02761</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Rethinking Biosynthesis of Aclacinomycin A</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Ziling</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Pingfang</given-names></name><xref rid="c1-molecules-28-02761" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Rutledge</surname><given-names>Peter J.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-28-02761">Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China</aff><author-notes><corresp id="c1-molecules-28-02761"><label>*</label>Correspondence: <email>tianpf@mail.buct.edu.cn</email></corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>3</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2023</year></pub-date><volume>28</volume><issue>6</issue><elocation-id>2761</elocation-id><history><date date-type="received"><day>04</day><month>2</month><year>2023</year></date><date date-type="rev-recd"><day>01</day><month>3</month><year>2023</year></date><date date-type="accepted"><day>06</day><month>3</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 by the authors.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Aclacinomycin A (ACM-A) is an anthracycline antitumor agent widely used in clinical practice. The current industrial production of ACM-A relies primarily on chemical synthesis and microbial fermentation. However, chemical synthesis involves multiple reactions which give rise to high production costs and environmental pollution. Microbial fermentation is a sustainable strategy, yet the current fermentation yield is too low to satisfy market demand. Hence, strain improvement is highly desirable, and tremendous endeavors have been made to decipher biosynthesis pathways and modify key enzymes. In this review, we comprehensively describe the reported biosynthesis pathways, key enzymes, and, especially, catalytic mechanisms. In addition, we come up with strategies to uncover unknown enzymes and improve the activities of rate-limiting enzymes. Overall, this review aims to provide valuable insights for complete biosynthesis of ACM-A.</p></abstract><kwd-group><kwd>aclacinomycin A</kwd><kwd>antitumor agent</kwd><kwd>biosynthesis</kwd><kwd>glycosyltransferase</kwd><kwd>metabolic engineering</kwd></kwd-group><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>22278022</award-id></award-group><award-group><funding-source>National Key Research and Development Program of China</funding-source><award-id>2018YFA0901800</award-id></award-group><funding-statement>This study was funded by grants from the National Natural Science Foundation of China (22278022) and the National Key Research and Development Program of China (2018YFA0901800). The APC was funded by the both.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-28-02761"><title>1. Introduction</title><p>Cancer poses a severe threat to humans, and its resulting economic burden may increase in the future [<xref rid="B1-molecules-28-02761" ref-type="bibr">1</xref>,<xref rid="B2-molecules-28-02761" ref-type="bibr">2</xref>]. Although cancer incidence and fatality rates may recede due to early diagnosis, the treatment cost remains unaffordable for most patients [<xref rid="B3-molecules-28-02761" ref-type="bibr">3</xref>]. To address this issue, researchers are gearing up to develop efficient antitumor medicines, and impressive advancements have been achieved in this regard. Extant antitumor medicines are roughly divided into eight categories, including alkylating agents [<xref rid="B4-molecules-28-02761" ref-type="bibr">4</xref>], hormone antagonists [<xref rid="B5-molecules-28-02761" ref-type="bibr">5</xref>], antimetabolites, cytotoxic antibiotics [<xref rid="B6-molecules-28-02761" ref-type="bibr">6</xref>], plant alkaloids [<xref rid="B7-molecules-28-02761" ref-type="bibr">7</xref>], platinum compounds [<xref rid="B8-molecules-28-02761" ref-type="bibr">8</xref>], protein kinase inhibitors [<xref rid="B9-molecules-28-02761" ref-type="bibr">9</xref>], and monoclonal antibodies [<xref rid="B10-molecules-28-02761" ref-type="bibr">10</xref>]. Belonging to cytotoxic antibiotics, anthracycline antitumor agents have been widely used for the clinical treatment of cancer for half a century. Of the reported anthracycline antitumor agents, aclacinomycin (ACM), also known as aclarubicin (ACL), is actually the mixture of ACM-A, ACM-B, and ACM-Y, typically synthesized by <italic toggle="yes">Streptomyces galilaeus</italic> ATCC 31133 [<xref rid="B11-molecules-28-02761" ref-type="bibr">11</xref>,<xref rid="B12-molecules-28-02761" ref-type="bibr">12</xref>]. ACM-A manifests a long side-chain structure, in which three sugar residues, including L-rhodosamine, 2-deoxyfucose, and L-cinerulose A, are tethered to aklavinone. As an anticancer medicine used in Japan and China, ACM-A exhibits remarkable inhibitory activities against leukemias, gastric cancer, and lung cancer [<xref rid="B13-molecules-28-02761" ref-type="bibr">13</xref>,<xref rid="B14-molecules-28-02761" ref-type="bibr">14</xref>,<xref rid="B15-molecules-28-02761" ref-type="bibr">15</xref>,<xref rid="B16-molecules-28-02761" ref-type="bibr">16</xref>]. In principle, anthracyclines exhibit antitumor activity due to the targeting of the minor groove of DNA to form a stable complex [<xref rid="B17-molecules-28-02761" ref-type="bibr">17</xref>] (<xref rid="molecules-28-02761-f001" ref-type="fig">Figure 1</xref>). This reversible targeting can repress topoisomerase II and therefore hamper the transcription and replication of DNA in this complex. Consequently, double-stranded DNA unwinds and the accumulated DNA fragments, triggering programmed cell death [<xref rid="B18-molecules-28-02761" ref-type="bibr">18</xref>]. ACM-A was also found to evict histones and damage chromatin [<xref rid="B19-molecules-28-02761" ref-type="bibr">19</xref>,<xref rid="B20-molecules-28-02761" ref-type="bibr">20</xref>]. Compared to doxorubicin (DXR) and daunorubicin (DNR), the two anthracyclines isolated from <italic toggle="yes">Streptomyces peucetius</italic> ATCC 27952, ACM-A exhibits higher antitumor activity but much lower cardiotoxicity [<xref rid="B21-molecules-28-02761" ref-type="bibr">21</xref>].</p><p>The chemical synthesis of ACM-A is challenging due to its bulky and complex structure. Aklavinone is an important member of tetrahydronaphthol whose benzylic hydroxy group can be easily eliminated. In previously reported synthesis, Diels&#x02013;Alder reactions were found to be crucial for the synthesis of aklavinone, which raised the issue of regioselectivity [<xref rid="B22-molecules-28-02761" ref-type="bibr">22</xref>,<xref rid="B23-molecules-28-02761" ref-type="bibr">23</xref>]. It was reported that refinement led to only a 68% yield ratio of oligosaccharides in ACM-A [<xref rid="B24-molecules-28-02761" ref-type="bibr">24</xref>,<xref rid="B25-molecules-28-02761" ref-type="bibr">25</xref>]. Clearly, high stereoselectivity is desired, but the modulation of stereoselectivity is laborious and troublesome [<xref rid="B26-molecules-28-02761" ref-type="bibr">26</xref>]. Although strategies have been developed (e.g., donor-controlled stereoselectivity), the multi-step syntheses of ACM-A is tedious and seems to be inevitable [<xref rid="B27-molecules-28-02761" ref-type="bibr">27</xref>,<xref rid="B28-molecules-28-02761" ref-type="bibr">28</xref>]. In addition, the organic synthesis of ACM-A shows shortcomings such as the need for toxic catalysts, low yield, and severe pollution [<xref rid="B29-molecules-28-02761" ref-type="bibr">29</xref>]. In contrast, the bioproduction of ACM-A shows merits such as low cost, easy manipulation, and less environmental pollution. ACM-A is mainly obtained by the fermentation of <italic toggle="yes">Streptomyces</italic> sp.NO.MA144-MI ATCC 31133 or its mutants. Of reported <italic toggle="yes">Sreptomyces</italic> species, <italic toggle="yes">Streptomyces lavendofoliae</italic> is the most employed for the industrial production of ACM-A [<xref rid="B30-molecules-28-02761" ref-type="bibr">30</xref>]. Since ACM-A is a secondary metabolite and indirectly produced from the core metabolic pathways in <italic toggle="yes">Streptomyces</italic>, its production is therefore low and needs to be substantially enhanced. Synthetic biology and metabolic engineering raise the hope for the high-level production of ACM-A based on rational design and the subsequent construction of biological systems. In this review, we not only outline the reported biosynthetic pathways of ACM-A, but also discuss the catalytic mechanisms of key enzymes. Furthermore, we come up with protocols for the overproduction of this economically important medicine.</p></sec><sec id="sec2-molecules-28-02761"><title>2. Biosynthesis of ACM-A</title><p>The history of deciphering ACM-A biosynthesis dates back to the 1970s. In 1975, ACM-A and ACM-B were first isolated from the fermentation broth of <italic toggle="yes">S. galilaeus</italic> MA144-M1(ATCC 31133) [<xref rid="B11-molecules-28-02761" ref-type="bibr">11</xref>]. In 1979, ACM-A was extracted using organic solvents. After undergoing silicic acid column chromatography, the extracts from the fermentation broth were condensed into crystal or microcrystalline powder [<xref rid="B31-molecules-28-02761" ref-type="bibr">31</xref>]. In 1981, partial biosynthesis pathways of ACM-A were identified through the genetic loss of glycosylation and isotope labeling [<xref rid="B32-molecules-28-02761" ref-type="bibr">32</xref>]. Afterwards, the polyketide synthase (PKS) genes from <italic toggle="yes">S. galilaeus</italic> ATCC 31615 were cloned and sequenced [<xref rid="B33-molecules-28-02761" ref-type="bibr">33</xref>]. So far, a partial ACM-A pathway has been unraveled (Acc. NO. AF264025.1; Acc. NO. AF257324.2) (<xref rid="molecules-28-02761-f002" ref-type="fig">Figure 2</xref>). With one molecule of propionyl-CoA as a starter unit and nine molecules of malonyl-CoA as extender units, the type &#x02161; PKS catalyzes the formation of aklavinone through nine cycles of reactions, involving the incorporation of malonyl-CoA, cyclization, and oxidation. ACM-A is generated upon specific glycosylation and modification (<xref rid="molecules-28-02761-f003" ref-type="fig">Figure 3</xref>) [<xref rid="B34-molecules-28-02761" ref-type="bibr">34</xref>,<xref rid="B35-molecules-28-02761" ref-type="bibr">35</xref>,<xref rid="B36-molecules-28-02761" ref-type="bibr">36</xref>]. ACM-A can be converted to ACM-Y by oxidoreductase [<xref rid="B36-molecules-28-02761" ref-type="bibr">36</xref>]. The oxidoreductase located in cytoplasm catalyzes ACM-A to ACM-B, while the oxidoreductase in periplasm catalyzes ACM-B to ACM-A [<xref rid="B37-molecules-28-02761" ref-type="bibr">37</xref>,<xref rid="B38-molecules-28-02761" ref-type="bibr">38</xref>].</p><sec id="sec2dot1-molecules-28-02761"><title>2.1. Gene Cluster for Biosynthesis of Aklavinone in S. galilaeus</title><p>Although anthracyclines vary in structure, their biosynthesis pathways are similar. The iterative Claisen condensation reaction is accomplished by type &#x02161; PKSs which are encoded by a gene cluster in the <italic toggle="yes">Streptomyces</italic> genome. In this cluster, the polyketide assembly requires a minimal set of iteratively used enzymes. This minimal PKS (min PKS) consists of a ketosynthase (KS<sub>&#x003b1;</sub>), a chain length factor (CLF or KS<sub>&#x003b2;</sub>), and an acyl carrier protein (ACP) [<xref rid="B39-molecules-28-02761" ref-type="bibr">39</xref>]. In general, KS<sub>&#x003b1;</sub> shows high sequence similarity to KS<sub>&#x003b2;</sub> [<xref rid="B40-molecules-28-02761" ref-type="bibr">40</xref>]. However, KS<sub>&#x003b2;</sub> is catalytically inactive due to the lack of active-site cysteine. Instead, KS<sub>&#x003b2;</sub> carries a highly conserved glutamine [<xref rid="B41-molecules-28-02761" ref-type="bibr">41</xref>]. The malonyl-CoA: ACP acyltransferase (MAT) activity is usually crucial for PKS [<xref rid="B42-molecules-28-02761" ref-type="bibr">42</xref>]. The biosynthesis of polyketide starts with iterative action of the min PKS complex to form poly-&#x003b2;-ketone intermediates, which are subsequently folded into distinct aromatic compounds by ketoreductases (KR), cyclases (CYC), and aromatases (ARO) [<xref rid="B43-molecules-28-02761" ref-type="bibr">43</xref>].</p><p>Anthracyclines are assembled by tetracyclic aglycones, 7,8,9,10-tetrahydro-5,12-naphthacene-quinone, and various L-deoxysugar moieties. Aklavinone is the most common aglycones for the biosynthesis of anthracyclines. Sequence analysis reveals that a total of 12 genes participate in the biosynthesis of aklavinone in <italic toggle="yes">S. galilaeus</italic> ATCC 31615 (<xref rid="molecules-28-02761-t001" ref-type="table">Table 1</xref>). Briefly, one molecule of propionyl-CoA and nine molecules of malonyl-CoAs are catalyzed into one molecule of 21-carbon decaketide nascent chain (<bold>15</bold>) by min PKS which contains AknB (KS<sub>&#x003b1;</sub>, EC:2.3.1.-), AknC (KS<sub>&#x003b2;</sub>, EC:2.3.1.-), AknD (ACP), AknE2 (EC:4.2.1.-), and AknF (malonyl-CoA: ACP transacylase, MAT) [<xref rid="B33-molecules-28-02761" ref-type="bibr">33</xref>]. The growing polyketide chain accepts one 2-carbon unit from one molecule of malonyl-CoA. The interactions between AknD, AknE2, and AknF are essential for the choosing of the starter unit [<xref rid="B44-molecules-28-02761" ref-type="bibr">44</xref>]. Only when all aforementioned enzymes are available is propionyl-CoA then chosen as the starter unit. AknA (EC1.1.1-) and AknE1(EC:4.2.1.-) are NADPH-dependent reductase and aromatase, respectively, which jointly convert the linear skeleton to 12-deoxyaklanoate (<bold>17</bold>) [<xref rid="B45-molecules-28-02761" ref-type="bibr">45</xref>]. The cyclization of the second and third ring is catalyzed by AknW, leading to the formation of 12-deoxyalkalonic acid (<bold>18</bold>) [<xref rid="B33-molecules-28-02761" ref-type="bibr">33</xref>,<xref rid="B46-molecules-28-02761" ref-type="bibr">46</xref>]. This intermediate is subsequently converted to aklanonate (<bold>19</bold>) by mono-oyxgenase AknX-mediated oxidation. This mono-oyxgenase AknX (EC1.13.12.22) was successfully purified and biochemically verified [<xref rid="B47-molecules-28-02761" ref-type="bibr">47</xref>]. Native AknX was suggested to manifest homotrimeric subunit structure [<xref rid="B47-molecules-28-02761" ref-type="bibr">47</xref>]. Aklanonate (<bold>19</bold>) is then catalyzed into methyl aklanonate (<bold>20</bold>) by <italic toggle="yes">aknG</italic>-encoded (formerly <italic toggle="yes">acmA</italic>) acid methyltransferase (EC2.1.1.288) [<xref rid="B48-molecules-28-02761" ref-type="bibr">48</xref>,<xref rid="B49-molecules-28-02761" ref-type="bibr">49</xref>]. AknG is a SAM-dependent O-methyltransferase capable of transferring a methyl group from the donor to receptor using the ubiquitous methyl donor SAM as the cosubstrate. Aklaviketone (<bold>21</bold>) is formed by the closure of the fourth ring, which is catalyzed by cyclase AknH (EC5.5.1.23) [<xref rid="B50-molecules-28-02761" ref-type="bibr">50</xref>,<xref rid="B51-molecules-28-02761" ref-type="bibr">51</xref>]. This process is designated as intramolecular aldol condensation [<xref rid="B52-molecules-28-02761" ref-type="bibr">52</xref>]. Lastly, reductase AknU (EC1.1.1.362) converts the 7-oxo moiety of aklaviketone into a hydroxyl group to form aklavinone (<bold>22</bold>) [<xref rid="B48-molecules-28-02761" ref-type="bibr">48</xref>,<xref rid="B53-molecules-28-02761" ref-type="bibr">53</xref>,<xref rid="B54-molecules-28-02761" ref-type="bibr">54</xref>].</p><p>The structure analysis of PKSs not only reveals substrate specificity and protein interaction but also provides insights for combinatorial biosynthesis of derivatives based on tailored genes. However, it is challenging to determine crystal structures [<xref rid="B44-molecules-28-02761" ref-type="bibr">44</xref>]. Of the PKSs participating in ACM-A biosynthesis, only AknH has been investigated for its structure [<xref rid="B50-molecules-28-02761" ref-type="bibr">50</xref>]. AknH shares 61.91% identity with SnoaL, which catalyzes the ring closure in the biosynthesis of nogalamycin [<xref rid="B52-molecules-28-02761" ref-type="bibr">52</xref>]. In addition, AknH (PDB: 2F98) forms a tetramer with 222 symmetry, like SnoaL (PDB: 1SJW) (<xref rid="molecules-28-02761-f004" ref-type="fig">Figure 4</xref>A). Both AknH and SnoaL utilize the same substrate due to highly similar crystal structures, but their catalytic products are different due to the difference in stereoselectivity (<xref rid="molecules-28-02761-f004" ref-type="fig">Figure 4</xref>B). The stereoselectivity of AknH is mainly ascribed to amino acid residues Tyr15 and Asn51, whose counterparts in SnoaL are phenylalanine and leucine [<xref rid="B50-molecules-28-02761" ref-type="bibr">50</xref>].</p></sec><sec id="sec2dot2-molecules-28-02761"><title>2.2. Biosynthesis of TDP-Sugars</title><p>In the biosynthesis of antibiotics, sugar donors are tethered to aglycones, which are catalyzed by glycosyltransferases (GTs). This process is crucial for the pharmacological and pharmacokinetic properties of medicines [<xref rid="B55-molecules-28-02761" ref-type="bibr">55</xref>,<xref rid="B56-molecules-28-02761" ref-type="bibr">56</xref>]. By the introduction of amino groups, the modified sugars provide hydrogen bonds to the functional groups of protein or DNA targets [<xref rid="B57-molecules-28-02761" ref-type="bibr">57</xref>]. Dedicated glycosylation leads to the formation of products with diverse recognition elements, and sugar conjugation usually improves the solubility, chemical stability, and polarity of aglycone [<xref rid="B57-molecules-28-02761" ref-type="bibr">57</xref>].</p><p>The sugar moieties biosynthesis of ACM-A in <italic toggle="yes">S. galilaeus</italic> ATCC 31615 is mainly executed by a gene cluster consisting of <italic toggle="yes">aknY</italic>, <italic toggle="yes">aknR</italic>, <italic toggle="yes">aknN</italic>, <italic toggle="yes">aknQ</italic>, <italic toggle="yes">aknP</italic>, <italic toggle="yes">aknZ</italic>, <italic toggle="yes">aknL</italic>, <italic toggle="yes">aknM</italic>, and <italic toggle="yes">aknX2</italic> (<xref rid="molecules-28-02761-f003" ref-type="fig">Figure 3</xref>A) [<xref rid="B58-molecules-28-02761" ref-type="bibr">58</xref>]. In other <italic toggle="yes">Streptomyces</italic> species, the biosynthesis of dTDP-deoxyfucose (<bold>11</bold>) and dTDP-rhodinose (<bold>14</bold>) of ACM-A is accomplished by <italic toggle="yes">dnm</italic> or <italic toggle="yes">spn</italic> clusters (<xref rid="molecules-28-02761-t002" ref-type="table">Table 2</xref>) [<xref rid="B59-molecules-28-02761" ref-type="bibr">59</xref>,<xref rid="B60-molecules-28-02761" ref-type="bibr">60</xref>]. For sugar moieties biosynthesis in <italic toggle="yes">S</italic>. <italic toggle="yes">galilaeus</italic>, thymidylyltransferase converts glucose-1-phosphate (<bold>1</bold>) to TDP-D-glucose (<bold>2</bold>), which is subsequently converted to TDP-4-keto-6-deoxy-D-glucose (<bold>3</bold>) by TDP-D-glucose 4,6-dehydratase. The two steps are likely catalyzed by AknY (EC2.7.7.24) and AknR (EC4.2.1.46), respectively. AknN (EC4.2.1-) is a 2,3-dehydratase catalyzing the corresponding C-2 deoxygenation into TDP-3,4-diketo-2,6-dideoxy-D-glucose (<bold>4</bold>). AknZ is a putative 3-aminotransferase which transfers the amino group to the C-3 position, thereby generating TDP-3-amino-4-keto-2,3,6-trideoxy-D-glucose (<bold>5</bold>). AknL is proposed to show dTDP-4-dehydrorhamnose 3,5-epimerase activity and catalyze TDP-3-amino-4-keto-2,3,6-trideoxy-D-glucose into TDP-3-amino-4-keto-6-deoxy-L-glucose (<bold>6</bold>). AknM (EC4.2.1.164) may serve as an <italic toggle="yes">aknM</italic>-encoded 4-ketoreductase catalyzing C-4 ketone into TDP-L-daunosamine (<bold>7</bold>). AknX2 is an N-methyltransferase which transfers the methyl group at C-3 amine to TDP-rhodosamine (<bold>8</bold>) [<xref rid="B61-molecules-28-02761" ref-type="bibr">61</xref>]. AknQ (EC1.1.1.384) is a putative 3-ketoreductase catalyzing the C-2 deoxygenation of TDP-3,4-diketo-2,6-dideoxy-D-glucose and thereby the generation of TDP-4-keto-2,6-dideoxy-D-glucose (<bold>9</bold>), which is then converted into TDP-4-keto-2,3,6-trideoxy-D-glucose (<bold>12</bold>) by 3-dehydratase AknP (EC4.2.1.164) [<xref rid="B60-molecules-28-02761" ref-type="bibr">60</xref>]. d-TDP-rhodinose (<bold>14</bold>) is presumably synthesized from TDP-4-keto-2,3,6-trideoxy-D-glucose through two steps catalyzed by dTDP-4-dehydrorhamnose 3,5-epimerase and 4-keto reductase. TDP-4-keto-2,6-dideoxy-D-glucose is probably converted into dTDP-4-keto-2,6-dideoxy-beta-L-galactose by 3,5-epimerase. Unfortunately, the genes encoding these enzymes in <italic toggle="yes">S. galilaeus</italic> have not been completely elucidated.</p></sec><sec id="sec2dot3-molecules-28-02761"><title>2.3. Transfer of TDP-Sugars</title><p>GTs transfer glycosylated moieties from activated sugar donors to receptors. Such enzymes effectively mediate the formation of glycosidic linkage of natural oligosaccharides, glycoconjugates, and their analogues in a stereospecific and regiospecific way [<xref rid="B62-molecules-28-02761" ref-type="bibr">62</xref>]. In view of sequence similarity and conserved motifs, the reported GTs can be classified into a total of 114 families which are deposited in the Carbohydrate-Active enzyme database (CAZy) (<uri xlink:href="http://www.cazy.org/">http://www.cazy.org/</uri>, accessed on 22 October 2021). Of these GTs, the GT1 family is most common due to its excellent glycosylation capacity [<xref rid="B63-molecules-28-02761" ref-type="bibr">63</xref>].</p><p>In view of structures, the reported GTs can be divided into three superfamilies: GT-A, GT-B, and GT-C folds [<xref rid="B64-molecules-28-02761" ref-type="bibr">64</xref>]. In general, the GT1 family exhibits GT-B fold. GT-B glycosyltransferases harbor two distinct &#x003b2;/&#x003b1;/&#x003b2; Rossmann domains which are flexibly connected [<xref rid="B65-molecules-28-02761" ref-type="bibr">65</xref>]. The active site generally locates in the cleft between two domains [<xref rid="B66-molecules-28-02761" ref-type="bibr">66</xref>]. The C-terminal donor binding motif is relatively conserved, whereas the N-terminal domain shows high divergence and considerable topological plasticity [<xref rid="B67-molecules-28-02761" ref-type="bibr">67</xref>]. The binding sites mainly consist of hydrophobic amino acid residues, while the gateway to ligand entry and departure is generally rich in charged amino acid residues [<xref rid="B68-molecules-28-02761" ref-type="bibr">68</xref>,<xref rid="B69-molecules-28-02761" ref-type="bibr">69</xref>]. In glycosylation, GT-B proteins generally alter their conformation and shape of binding pocket when binding to the sugar donor, leading to a slight rotation of the N-terminal domain toward the C-terminal domain [<xref rid="B70-molecules-28-02761" ref-type="bibr">70</xref>].</p><p>GTs can be divided into two types: inverting GT and retaining GT, depending on whether the configuration of the transferred sugars in end-product is inverted or retained (<xref rid="molecules-28-02761-f005" ref-type="fig">Figure 5</xref>A) [<xref rid="B64-molecules-28-02761" ref-type="bibr">64</xref>,<xref rid="B71-molecules-28-02761" ref-type="bibr">71</xref>]. It was reported that the GT1 family undergoes an inversion of glycosylation and demonstrates a direct-displacement S<sub>N</sub>2-like mechanism: the acceptor nucleophilic hydroxyl attacks the anomeric carbon of the sugar donor and displaces the leaving nucleotide portion on the opposite face [<xref rid="B64-molecules-28-02761" ref-type="bibr">64</xref>,<xref rid="B72-molecules-28-02761" ref-type="bibr">72</xref>,<xref rid="B73-molecules-28-02761" ref-type="bibr">73</xref>]. Compared with standard glycosylation, the inverting GTs catalyze the formation of products with reversal anomeric configuration (<xref rid="molecules-28-02761-f004" ref-type="fig">Figure 4</xref>B).</p></sec><sec id="sec2dot4-molecules-28-02761"><title>2.4. Transfer of TDP-&#x003b2;-L-Rhodosamine</title><p>Once the polyketide stage is completed, the skeleton at the hydroxy group is glycosylated by specific GTs. In the presence of its auxiliary protein partner AknT, AknS (EC2.4.1.326) is an aklavinone 7-&#x003b2;-L-rhodosaminyltransferase which attaches TDP-&#x003b2;-L-rhodosamine to the C7-OH of aklavinone, resulting in the formation of rhodosaminyl-aklavinone (ACM-T). AknS promiscuously accepts diverse sugar donors and receptors. Consistent with this attribute, the recombinant <italic toggle="yes">S. venezuelae</italic> produces a range of DXR analogues which contain diverse deoxysugar moieties and AknS/AknT in complex with other enzymes [<xref rid="B74-molecules-28-02761" ref-type="bibr">74</xref>]. AknS/AknT can also efficiently transfer TDP-L-daunosamine to exogenous DXR aglycone &#x003b5;-rhodomycinone [<xref rid="B61-molecules-28-02761" ref-type="bibr">61</xref>]. The above studies indicate the wide substrate scope of AknS, which provides insights for the combinatorial biosynthesis of unnatural antibiotics. It is challenging to visualize the transient interaction between AknS and AknT, which jointly form a complex, and their crystallization as well as isolation methods remain poorly understood [<xref rid="B75-molecules-28-02761" ref-type="bibr">75</xref>]. Fortunately, AknS belongs to the GT1 family, whose comparable architectures allow for the characterization of congeneric proteins. Of the activator-dependent GTs, SpnP and EryCIII have been investigated for their crystal structures [<xref rid="B76-molecules-28-02761" ref-type="bibr">76</xref>,<xref rid="B77-molecules-28-02761" ref-type="bibr">77</xref>]. The above structural studies have uncovered key residues for their reactions, such as residue H13 deprotonating the corresponding hydroxy group in aglycone substrates, and residues D356 and E357 contributing to the formation of a two-residue motif (D/E-Q) which mediates the binding of sugar moieties [<xref rid="B78-molecules-28-02761" ref-type="bibr">78</xref>]. Interestingly, a three-helix motif was recognized as a common feature and used as an identification tag of GTs that require auxiliary proteins [<xref rid="B76-molecules-28-02761" ref-type="bibr">76</xref>]. Moreover, two amino acids (N230 and T335) were found to be crucial for the formation of a hydrogen bond with a TDP unit [<xref rid="B76-molecules-28-02761" ref-type="bibr">76</xref>]. AlphaFold is a protein structure prediction tool with high accuracy [<xref rid="B79-molecules-28-02761" ref-type="bibr">79</xref>], and the 3D structure of an AknS monomer predicted by the AlphaFold Monomer v2.0. Homologous analysis with other GTs reveals that AknS is arguably a homodimer. This AknS monomer contains a parallel &#x003b2;-sheet surrounded by &#x003b1;-helices, which is consistent with GT-B proteins (<xref rid="molecules-28-02761-f006" ref-type="fig">Figure 6</xref>A). The key residues H13 and D356 are labeled. The three-helix motif is found in the AknS sequence and comprises three helices (<xref rid="molecules-28-02761-f006" ref-type="fig">Figure 6</xref>B).</p><p>P450-like enzymes are fundamental for the functions of GTs. Located in the upstream of <italic toggle="yes">aknS</italic>, the gene <italic toggle="yes">aknT</italic> encodes an enzyme (AknT) which exhibits oxidoreductase activity. AknS exhibits low activity in the absence of AknT. When binding to AknS at a molar ratio of 3:1, AknT, as a regulator subunit, may optimize the fitness and productive orientation of akalvinone and thereby increase the catalytic constant of AknS by 40-fold [<xref rid="B34-molecules-28-02761" ref-type="bibr">34</xref>]. A BLAST search using AknT sequence as a query revealed a plethora of homologous proteins which are putative P450-derived enzymes from <italic toggle="yes">Streptomyces</italic>. The predicted structure of AknT is shown in <xref rid="molecules-28-02761-f007" ref-type="fig">Figure 7</xref>A. AknT shows a typical cytochrome P450 fold and the conserved amino acid sequence is only limited to the C-terminal [<xref rid="B77-molecules-28-02761" ref-type="bibr">77</xref>,<xref rid="B80-molecules-28-02761" ref-type="bibr">80</xref>]. Notably, AknT lacks the conserved cysteine binding to heme group, indicating its difference relative to the authentic cytochrome P450 family. Such a difference presumably makes the conformation of AknT more dynamic than typical P450 [<xref rid="B77-molecules-28-02761" ref-type="bibr">77</xref>]. Indeed, AknT transiently forms a ternary compound with AknS and substrate, which stimulates the conformational change in AknS and facilitates the transfer of sugar moieties [<xref rid="B81-molecules-28-02761" ref-type="bibr">81</xref>]. A previous study indicated that the complex of EryCIII with its auxiliary protein EryCII manifests an &#x003b1;2&#x003b2;2 heterodimer, which is an elongated quaternary organization when the auxiliary protein resides in the periphery of the GT homodimer (<xref rid="molecules-28-02761-f007" ref-type="fig">Figure 7</xref>B) [<xref rid="B77-molecules-28-02761" ref-type="bibr">77</xref>]. In this complex, EryCII may serve as a scaffold to provide an &#x003b1;-helix for linking EryCIII [<xref rid="B77-molecules-28-02761" ref-type="bibr">77</xref>]. These GT-auxiliary protein pairs may assemble in the same way. It is thus speculated that the interaction surface of the AknS/AknT heteromer is different from that of the AknS homomer.</p></sec><sec id="sec2dot5-molecules-28-02761"><title>2.5. Transfer of 2-Deoxy-&#x003b2;-L-Fucose and L-Rhodinose</title><p>There exist trisaccharide chains adhered to the skeleton of ACM-A. However, only AknS and AknK have been identified from the ACM-A-producing strain, meaning that one of the two GTs (AknS and AknK) accomplishes two glycosylation reactions [<xref rid="B34-molecules-28-02761" ref-type="bibr">34</xref>,<xref rid="B35-molecules-28-02761" ref-type="bibr">35</xref>,<xref rid="B81-molecules-28-02761" ref-type="bibr">81</xref>]. LanGT1 and LanGT4 are the first discovered iterative GTs [<xref rid="B82-molecules-28-02761" ref-type="bibr">82</xref>]. AknK (EC2.4.1.327) is an L-2-deoxyfucosyltransferase transferring two L-2-deoxysugars to the axial 4-OH of anthracycline monosaccharides. In the first reaction, AknK transfers 2-deoxy-&#x003b2;-L-fucose from the activated donor dTDP-2-deoxy-&#x003b2;-L-fucose to mono-glycosylated ACM-T, leading to the generation of di-glycosylated ACM-S [<xref rid="B35-molecules-28-02761" ref-type="bibr">35</xref>,<xref rid="B81-molecules-28-02761" ref-type="bibr">81</xref>]. L-rhodinose is considered a terminal sugar initially added to ACM-T. Next, L-rhodinose is converted to L-cinerulose (a 2,3,6-trideoxy-4-keto-L-hexose) to form ACM-N [<xref rid="B35-molecules-28-02761" ref-type="bibr">35</xref>]. AknK shows lower activity in catalyzing the second transfer reaction compared to the first, indicating the specificity of AknK to dTDP-rhodinose.</p><p>AknK exhibits substrate promiscuity and accepts various TDP-sugars as donors and different aglycones as receptors. In addition, its catalytic activity varies in different reactions [<xref rid="B35-molecules-28-02761" ref-type="bibr">35</xref>]. For instance, AknK shows the highest activity in the conversion of TDP-L-daunosamine to ACM-T, followed by the conversion of TDP-l-2-deoxyfocus. Most GTs function in a regio- and stereospecific manner. SpnG is a spinosyn rhamnosyltransferase which only accepts TDP substituent in an axial position to catalyze the nucleophilic displacement reaction [<xref rid="B78-molecules-28-02761" ref-type="bibr">78</xref>]. AknK requires a receptor with an axial hydroxyl at the nucleophilic attacking site [<xref rid="B35-molecules-28-02761" ref-type="bibr">35</xref>].</p><p>The TDP-binding active pockets are usually conserved, and the structural specificity of GTs relies on a receptor-binding region [<xref rid="B83-molecules-28-02761" ref-type="bibr">83</xref>]. ProteinsPlus (<uri xlink:href="https://proteins.plus">https://proteins.plus</uri>, accessed on 3 October 2022) can detect binding pockets for further protein&#x02013;ligand interaction analyses [<xref rid="B84-molecules-28-02761" ref-type="bibr">84</xref>,<xref rid="B85-molecules-28-02761" ref-type="bibr">85</xref>]. Based on the structure information given by the AlphaFold Monomer v2.0 pipeline, a binding pocket was recognized (<xref rid="molecules-28-02761-f008" ref-type="fig">Figure 8</xref>A). A docking analysis of AknK was carried out to elucidate the binding pockets of sugar donors by building a grid covering the deep pocket consisting of the aforementioned key residues and predicted pocket. A total of 100 dockings were performed by the genetic algorithm. Results show that two binding pockets of dTDP-2-deoxyfucose and dTDP-rhodinose are located in the cleft between the N-terminal and C-terminal domains. The energy of docking for dTDP-2-deoxyfucose is 4.74 kcal/mol, but that for dTDP-rhodinose is only 2.27 kcal/mol. The interaction residues in the binding pockets are labeled in <xref rid="molecules-28-02761-f008" ref-type="fig">Figure 8</xref>C,E.</p></sec><sec id="sec2dot6-molecules-28-02761"><title>2.6. Optimization of the Catalytic Activity of GTs</title><p>As a key enzyme for the biosynthesis of ACM-A, GT can be modified to show appropriate catalytic activity. However, its substrate specificity restricts applications. Although a one-pot multi-enzyme cascade system can yield natural or unnatural compounds, the natural GTs show drawbacks such as relatively low activity, cumbersome purification, and a short half-life [<xref rid="B86-molecules-28-02761" ref-type="bibr">86</xref>,<xref rid="B87-molecules-28-02761" ref-type="bibr">87</xref>,<xref rid="B88-molecules-28-02761" ref-type="bibr">88</xref>]. In addition, heterologous bacterial hosts may generate inclusion bodies [<xref rid="B89-molecules-28-02761" ref-type="bibr">89</xref>,<xref rid="B90-molecules-28-02761" ref-type="bibr">90</xref>]. To improve the solubility of GTs, a plethora of protein fusion partners and solubility tags have been successfully utilized [<xref rid="B89-molecules-28-02761" ref-type="bibr">89</xref>,<xref rid="B91-molecules-28-02761" ref-type="bibr">91</xref>,<xref rid="B92-molecules-28-02761" ref-type="bibr">92</xref>].</p><p>The GT-catalyzed glycosidic bond is formed in a high regio- and stereo-manner. That is, promiscuous GTs may fail to recognize nonnative receptors [<xref rid="B93-molecules-28-02761" ref-type="bibr">93</xref>]. The sugar donor versatility of GTs has been investigated and improved. For example, a study examined UrdGT1b and UrdGT1c, which involve in urdamycin A biosynthesis. Mutations of amino acids led to the altered substrate selectivity of GTs [<xref rid="B94-molecules-28-02761" ref-type="bibr">94</xref>]. Since members of the GT-B fold family are structurally modular, GT chimeras may be generated by domain swapping, leading to the alternation of sugar donor specificity, especially when parent templates are highly identical [<xref rid="B95-molecules-28-02761" ref-type="bibr">95</xref>]. Moreover, the domain exchange of AtUGT78D2 and AtUGT78D led to the generation of fusion proteins. Three of them demonstrated expanded sugar-donor range and enhanced catalytic activity [<xref rid="B96-molecules-28-02761" ref-type="bibr">96</xref>].</p><p>The rational modification of the GTs related to ACM-A biosynthesis is constrained by the lack of knowledge on crystal structure. To bypass this obstacle, high-throughput screening-dependent directed evolution could be implemented. For instance, a fluorescence-based high-throughput screening (HTS) together with error-prone PCR/saturation mutagenesis was conducted to modify GTs, leading to a 200&#x02013;300-fold increase in catalytic activity [<xref rid="B97-molecules-28-02761" ref-type="bibr">97</xref>]. A high-throughput colorimetric screen in conjunction with saturation mutagenesis was also conducted to generate GT variants, which showed enhanced catalytic activity [<xref rid="B98-molecules-28-02761" ref-type="bibr">98</xref>]. In general, rational design is a prerequisite for the molecular modification of enzymes [<xref rid="B99-molecules-28-02761" ref-type="bibr">99</xref>]. In this regard, SEARCHGTr is a web tool for GT analysis, which provides information on donor/receptor specificity and putative substrate-binding residues [<xref rid="B100-molecules-28-02761" ref-type="bibr">100</xref>]. The increasing crystal structures of GTs enable this web tool to accurately predict substrate-binding pockets and facilitate their redesigning. Indeed, relying on docking analysis and in silico mutagenesis, the candidate key residues in active sites can be genetically modified to improve substrate specificity and enzyme activity [<xref rid="B101-molecules-28-02761" ref-type="bibr">101</xref>,<xref rid="B102-molecules-28-02761" ref-type="bibr">102</xref>,<xref rid="B103-molecules-28-02761" ref-type="bibr">103</xref>]. The screening of novel enzymes from nature is an alternative to conventional chemical synthesis by which chemoselectivity, regioselectivity, and enantioselectivity are hard to control. Indeed, extensive studies on GTs and the burgeoning transcriptome data allow not only the mining of new GTs with substrate promiscuity but also the enriching of the glycosylation toolkit for diverse sugar molecules [<xref rid="B104-molecules-28-02761" ref-type="bibr">104</xref>,<xref rid="B105-molecules-28-02761" ref-type="bibr">105</xref>,<xref rid="B106-molecules-28-02761" ref-type="bibr">106</xref>]. No matter which strategies are adopted, the donor/receptor promiscuity of enzymes is required for the development of versatile biocatalysts.</p></sec><sec id="sec2dot7-molecules-28-02761"><title>2.7. Oxidation of Terminal Sugar Residue</title><p>Aclacinomycin oxidoreductase (AknOx) was first isolated from <italic toggle="yes">S. galilaeus</italic> ATCC 31133 [<xref rid="B107-molecules-28-02761" ref-type="bibr">107</xref>]. Later, the AknOx secreted from <italic toggle="yes">S. galilaeus</italic> ATCC 31615 was purified to determine its crystal structure [<xref rid="B36-molecules-28-02761" ref-type="bibr">36</xref>,<xref rid="B108-molecules-28-02761" ref-type="bibr">108</xref>]. AknOx catalyzes two steps of modifications of terminal sugar residue, namely the four-electron oxidation of rhodinose to L-aculose. The first step is the conversion of rhodinose to cinerulose A, i.e., oxidation of the hydroxyl at C4 to the keto group (EC1.1.3.45). The second step is the elimination of two hydrogen atoms, leading to a double bond between C2 and C3 (EC1.1.3.14) [<xref rid="B36-molecules-28-02761" ref-type="bibr">36</xref>]. That is, AknOx firstly serves as an oxidase to transfer hydride from rhodinose to FAD. In the second step, AknOx still acts on the terminal sugar as a proton/hydride redox catalyst. The cells lacking AknOx accumulate various ACM-A analogues [<xref rid="B107-molecules-28-02761" ref-type="bibr">107</xref>]. Unlike AknOx, which catalyzes the formation of cinerulose A, GcnQ is a flavin-dependent oxidoreductase catalyzing the formation of L-aculose. In the latter reaction, no intermediate cinerulose A was detected [<xref rid="B109-molecules-28-02761" ref-type="bibr">109</xref>].</p><p>AknOx is one member of vanillyl-alcohol oxidase/<italic toggle="yes">p</italic>-cresol methylhydroxylase (VAO/PCMH) flavoprotein family, whose catalytic motif consists of two tyrosine residues [<xref rid="B110-molecules-28-02761" ref-type="bibr">110</xref>]. The proton abstraction in the first step catalyzed by AknOx is usually executed by Tyr-493, and Tyr-421 mediates the second reaction to generate L-aculose [<xref rid="B36-molecules-28-02761" ref-type="bibr">36</xref>]. Clearly, AknOx is an unusual flavoenzyme, as it harnesses one active site but two different sets of catalytic residues. When tyrosine is mutated into phenylalanine, AknOx non-covalently binds to flavin and shows reduced activity [<xref rid="B111-molecules-28-02761" ref-type="bibr">111</xref>].</p><p>AknOx is an oxygen-dependent FAD-linked oxidoreductase. Cofactor reduction is implemented by the substrate. The subsequent regeneration of flavin by reacting with molecular oxygen leads to the formation of hydrogen peroxide and the reoxidation of FAD [<xref rid="B112-molecules-28-02761" ref-type="bibr">112</xref>]. BLASTp analysis reveals the high identity of AknOx amino acid sequences, and most of them come from the <italic toggle="yes">Streptomyces</italic> species. A large proportion of these proteins were annotated as FAD-dependent oxidoreductases or dehydrogenases containing the berberine bridge enzyme (BBE) sequence motif. In such enzymes, highly conserved His and Cys residues are characteristically linked to cofactor FAD via 8&#x003b1;-histidylation and 6-S-cysteinylation [<xref rid="B113-molecules-28-02761" ref-type="bibr">113</xref>]. Of the FAD-dependent enzymes, Dbv29 is a flavin mononucleotide-dependent hexose oxidase catalyzing a four-electron oxidation reaction [<xref rid="B114-molecules-28-02761" ref-type="bibr">114</xref>]. The isoalloxazine ring of flavin is covalently linked to the side-chains of His91 and Cys151. In AknOx, the two amino acid residues are replaced by His70 and Cys130, respectively (<xref rid="molecules-28-02761-f009" ref-type="fig">Figure 9</xref>C) [<xref rid="B36-molecules-28-02761" ref-type="bibr">36</xref>,<xref rid="B114-molecules-28-02761" ref-type="bibr">114</xref>]. This double-anchor allow enzymes showing an open active site to bind to bulky substrates and maintain architecture, thereby preventing the dissociation of the cofactor [<xref rid="B111-molecules-28-02761" ref-type="bibr">111</xref>]. In addition, covalent attachment enhances the oxidation capacity of cofactors and remarkably improves the reduction potential [<xref rid="B112-molecules-28-02761" ref-type="bibr">112</xref>]. AknOx harbors a Rossmann fold-binding motif (GXXGXXXG) that covalently binds to the BBE motif and adenosine moiety of FAD [<xref rid="B115-molecules-28-02761" ref-type="bibr">115</xref>]. The solution of purified enzymes containing a flavin-like cofactor was bright yellow. Conversely, when His and Cys were mutated, AknOx did not manifest bright yellow and therefore lost catalytic activity, while Dbv29 retained the original yellow color [<xref rid="B116-molecules-28-02761" ref-type="bibr">116</xref>].</p><p>Secretory expression is important for the large-scale production of proteins. The evolved Twin-Arginine Translocation (Tat) system can translocate fully-folded and cofactor-binding proteins across the cytoplasmic membrane [<xref rid="B117-molecules-28-02761" ref-type="bibr">117</xref>]. The endogenous Tat system in refined model organisms benefits the large-scale production of secreted proteins and enzymes [<xref rid="B118-molecules-28-02761" ref-type="bibr">118</xref>]. Bioinformatics analysis reveals that the N-terminal of AknOx carries a Tat signal peptide. This signal peptide benefits large-scale protein secretion in heterologous hosts.</p><p>AknOx is one of the few structurally identified enzymes participating in ACM-A biosynthesis. The crystal structure of AknOx was determined by multiwavelength anomalous diffraction [<xref rid="B108-molecules-28-02761" ref-type="bibr">108</xref>]. In addition, its crystal structure was reported by a group from the University of Turku [<xref rid="B36-molecules-28-02761" ref-type="bibr">36</xref>]. In its crystal, each stable unit contains four subunits of AknOx that constitute two dimers, and the AknOx harbors two domains: one is the F domain binding to FAD, the other is S domain carrying the majority of residues for interplay with the substrate (<xref rid="molecules-28-02761-f009" ref-type="fig">Figure 9</xref>A,B). FAD interacts with binding sites through several main- and side-chain hydrogen bonds [<xref rid="B36-molecules-28-02761" ref-type="bibr">36</xref>]. The side-chain of ACM-A inserts into the pocket of the S domain, resulting in van der Waals between the atoms of the ligand and several hydrophobic residues [<xref rid="B36-molecules-28-02761" ref-type="bibr">36</xref>].</p></sec><sec id="sec2dot8-molecules-28-02761"><title>2.8. Regulatory Genes for ACM-A Biosynthesis</title><p>In the genera of <italic toggle="yes">Streptomyces</italic>, the biosynthesis of secondary metabolites usually undergoes complicated hierarchical regulation [<xref rid="B119-molecules-28-02761" ref-type="bibr">119</xref>,<xref rid="B120-molecules-28-02761" ref-type="bibr">120</xref>]. First, signals are usually sensed by global and/or pleiotropic regulators. Next, signals are transferred to pathway-specific regulators of corresponding compounds and, in turn, activate biosynthesis. The <italic toggle="yes">Streptomyces</italic> Antibiotic Regulatory Protein (SARP) is a specific regulator influencing the gene clusters for the biosynthesis of secondary metabolites. SARP activates the ACM-A biosynthesis gene clusters, mainly by binding to DNA recognition sequences [<xref rid="B121-molecules-28-02761" ref-type="bibr">121</xref>]. AknI and AknO are homologous to the SARP family which regulates gene expression. The inactivation of AknO blocks the formation of ACM-A [<xref rid="B48-molecules-28-02761" ref-type="bibr">48</xref>]. Both AknO and AknI belong to the AfsR/DnrI/RedD regulatory family, which carries several highly conserved residues essential for DNA binding to the N-terminal [<xref rid="B122-molecules-28-02761" ref-type="bibr">122</xref>]. AntiSMASH analysis of biosynthetic gene clusters led to the identification of other regulators such as LuxR and TetR family regulators, which are adjacent to ACM-A biosynthetic genes in <italic toggle="yes">S. galilaeus</italic> [<xref rid="B123-molecules-28-02761" ref-type="bibr">123</xref>,<xref rid="B124-molecules-28-02761" ref-type="bibr">124</xref>]. The regulation of ACM-A biosynthesis requires in-depth study. In <italic toggle="yes">Streptomyces</italic>, two-component signal transduction systems (TCSs) serve as a primary mechanism influencing metabolite production, virulence factors, and quorum sensing (QS). The regulatory proteins in TCSs respond to the environmental cues captured by the sensor kinase in the cell membrane. Then, kinase phosphorylates itself to respond to the signal and transfers the phosphoryl group to a regulator [<xref rid="B125-molecules-28-02761" ref-type="bibr">125</xref>]. TCSs were mainly identified from the model strain <italic toggle="yes">S. coelicolor</italic> [<xref rid="B126-molecules-28-02761" ref-type="bibr">126</xref>]. However, the complicated regulatory network in <italic toggle="yes">S. galilaeus</italic> remains to be unraveled.</p></sec></sec><sec id="sec3-molecules-28-02761"><title>3. Strategies for Improving ACM-A Production</title><p>ACM-A and its analogues were originally isolated from <italic toggle="yes">S. galilaeus</italic> ATCC 31133 broth [<xref rid="B11-molecules-28-02761" ref-type="bibr">11</xref>]. It is challenging to separate ACM-A from its analogues due to similar structures. To increase ACM-A and accordingly reduce analogues, <italic toggle="yes">S. lavendofoliae</italic> ATCC 15872 was mutated, leading to <italic toggle="yes">S. lavendofoliae</italic> DKRS, which produced 125 mg/L ACM-A [<xref rid="B127-molecules-28-02761" ref-type="bibr">127</xref>]. Adjusting the pH value at the late stage of fermentation could also promote ACM-B conversion to ACM-A and thereby facilitate the purification of ACM-A [<xref rid="B128-molecules-28-02761" ref-type="bibr">128</xref>]. Interestingly, the mutants of <italic toggle="yes">S. galilaeus</italic> H026 caused by the treatment of N-methyl-N&#x02032;-nitro-N-nitrosoguanidine (NTG) could convert AcmB to AcmA, but could not catalyze AcmA to AcmB, which is conducive to the industrial production of AcmA [<xref rid="B129-molecules-28-02761" ref-type="bibr">129</xref>]. In an effort to advance aklavinone biosynthesis, a group from Stanford University leveraged bimodular PKSs to produce hexaketides and octaketides [<xref rid="B130-molecules-28-02761" ref-type="bibr">130</xref>]. Recently, by optimizing promoters, enzymes, and chassis cells, a recombinant <italic toggle="yes">Streptomyces</italic> strain was engineered, which produced 15&#x02013;20 mg/L aklavinone [<xref rid="B131-molecules-28-02761" ref-type="bibr">131</xref>]. More importantly, a total of 37 genomes were shown to harbor the gene clusters for the biosynthesis of aclacinomycin, indicating the feasibility of screening strains for the high-level production of ACM-A [<xref rid="B132-molecules-28-02761" ref-type="bibr">132</xref>,<xref rid="B133-molecules-28-02761" ref-type="bibr">133</xref>].</p><p>How to improve ACM-A production may also draw lessons from the biosynthesis of other antibiotics in <italic toggle="yes">Streptomyces</italic>. The biosynthesis pathway is strictly controlled by regulatory cascades mainly consisting of pleiotropic regulators, global regulators, and feedback regulation [<xref rid="B134-molecules-28-02761" ref-type="bibr">134</xref>]. Signal-transduction-mediated pleiotropic regulation works at the beginning of antibiotics biosynthesis. A previous study identified a &#x003b3;-butyrolactone (GBL) named autoregulatory factor (A-Factor) which could promote the production of streptomycin in <italic toggle="yes">S. griseus</italic> [<xref rid="B135-molecules-28-02761" ref-type="bibr">135</xref>]. Other GBLs can be categorized based on structure differences in their side-chain. The A-Factors bind to cytoplasmic receptors (e.g., TetR family regulators) and activate gene transcription [<xref rid="B136-molecules-28-02761" ref-type="bibr">136</xref>]. Relying on this principle, the levels of secondary metabolites in <italic toggle="yes">Streptomyces</italic> could be enhanced by the exogenous addition of A-Factor analogues or the manipulation of signal-molecule-related genes [<xref rid="B137-molecules-28-02761" ref-type="bibr">137</xref>,<xref rid="B138-molecules-28-02761" ref-type="bibr">138</xref>,<xref rid="B139-molecules-28-02761" ref-type="bibr">139</xref>]. Since SARP family proteins are pathway-specific regulators, the overexpression of SARP regulator DnrI and AfsR lead to improved production of DNR and DXR [<xref rid="B140-molecules-28-02761" ref-type="bibr">140</xref>,<xref rid="B141-molecules-28-02761" ref-type="bibr">141</xref>].</p><p>WblA and BldA are two highly homologous global regulators affecting antibiotic biosynthesis in <italic toggle="yes">Streptomyces</italic> [<xref rid="B142-molecules-28-02761" ref-type="bibr">142</xref>,<xref rid="B143-molecules-28-02761" ref-type="bibr">143</xref>]. While the deletion of the negative regulator WblA led to a 70% increase in DXR production in <italic toggle="yes">S. peucetius</italic>, the heterologous expression of <italic toggle="yes">bldA</italic> resulted in a 45.7% increase in DNR production in the same strain [<xref rid="B140-molecules-28-02761" ref-type="bibr">140</xref>,<xref rid="B144-molecules-28-02761" ref-type="bibr">144</xref>]. The <italic toggle="yes">Streptomyces</italic> TCSs participate in the global regulation of secondary metabolisms and presumably are related to QS [<xref rid="B145-molecules-28-02761" ref-type="bibr">145</xref>]. The discovery of QS inducers and related mechanisms suggests the essential roles of QS in metabolic regulation of <italic toggle="yes">Streptomyces</italic> [<xref rid="B146-molecules-28-02761" ref-type="bibr">146</xref>,<xref rid="B147-molecules-28-02761" ref-type="bibr">147</xref>,<xref rid="B148-molecules-28-02761" ref-type="bibr">148</xref>,<xref rid="B149-molecules-28-02761" ref-type="bibr">149</xref>]. When an endogenous QS system was combined with CRISPR interference, the resulting circuits precisely regulated gene expression and resulted in a 560% increase in rapamycin production in <italic toggle="yes">S. rapamycinicus</italic> [<xref rid="B150-molecules-28-02761" ref-type="bibr">150</xref>]. A Gram-negative bacterial QS system was also engineered in <italic toggle="yes">Streptomyces</italic>, leading to the improved production of oxazolomycin [<xref rid="B151-molecules-28-02761" ref-type="bibr">151</xref>]. In particular, gene expression was regulated by DNA methylation, which hampered the binding of RNA polymerases to promoters or transcription factors to their recognization sites at a pretranscriptional level in bacteria [<xref rid="B152-molecules-28-02761" ref-type="bibr">152</xref>,<xref rid="B153-molecules-28-02761" ref-type="bibr">153</xref>]. Unlike DNA methylation, small regulatory RNAs (sRNAs) control gene expression at posttranscriptional level [<xref rid="B154-molecules-28-02761" ref-type="bibr">154</xref>]. It was reported that paired-termini antisense RNAs were used to inhibit DoxR and overproduce doxorubicin [<xref rid="B155-molecules-28-02761" ref-type="bibr">155</xref>]. Compared to sRNAs, DNA methylation seems to be more attractive in strain improvement, as it is heritable. Unfortunately, so far, DNA methylation in <italic toggle="yes">Streptomyces</italic> remains poorly understood, and in-depth study is needed to determine the epigenetic variation loci affecting metabolite formation. We believe epigenome research will offer valuable insights into the high-level production of ACM-A and beyond.</p><p>The biosynthesis of antibiotics leads to feedback inhibition, which halts cell growth and constrains their further accumulation due to toxicity and the presence of pathway-specific negative regulators [<xref rid="B156-molecules-28-02761" ref-type="bibr">156</xref>,<xref rid="B157-molecules-28-02761" ref-type="bibr">157</xref>]. Negative feedback can be minimized by the overexpression of resistance genes [<xref rid="B157-molecules-28-02761" ref-type="bibr">157</xref>,<xref rid="B158-molecules-28-02761" ref-type="bibr">158</xref>], transporters [<xref rid="B159-molecules-28-02761" ref-type="bibr">159</xref>], and efflux-pump-coding genes [<xref rid="B160-molecules-28-02761" ref-type="bibr">160</xref>,<xref rid="B161-molecules-28-02761" ref-type="bibr">161</xref>]. Ribosome engineering is also effective to improve cell resistance to metabolites, especially when in conjunction with conventional mutagenesis or genome shuffling [<xref rid="B162-molecules-28-02761" ref-type="bibr">162</xref>,<xref rid="B163-molecules-28-02761" ref-type="bibr">163</xref>,<xref rid="B164-molecules-28-02761" ref-type="bibr">164</xref>,<xref rid="B165-molecules-28-02761" ref-type="bibr">165</xref>,<xref rid="B166-molecules-28-02761" ref-type="bibr">166</xref>]. Compared with genetic modification strategies for screening secondary metabolites, small-molecule perturbation seems to be more applicable to generate mutants. For example, a group identified four molecules designated as ACR2 (antibiotic remodeling compound) which were able to inhibit the enoyl reductase activity of FabI. The inhibition of FabI blocked fatty acid biosynthesis, as it catalyzes the final and rate-limiting step [<xref rid="B167-molecules-28-02761" ref-type="bibr">167</xref>]. While this inhibition reduced the precursors toward fatty acid biosynthesis, it increased those toward secondary metabolites, especially for CoA-dependent metabolite formation. In fact, this inhibition led to the improved production of doxorubicin, baumycin, and desferrioxamine B and E [<xref rid="B168-molecules-28-02761" ref-type="bibr">168</xref>].</p><p>Apart from aforementioned strategies, ACM-A could also be overproduced by the overexpression of rate-limiting enzymes [<xref rid="B169-molecules-28-02761" ref-type="bibr">169</xref>] or the genes for the glycosylation and biosynthesis of sugar moieties [<xref rid="B170-molecules-28-02761" ref-type="bibr">170</xref>]. Incorporating a heterologous metabolic pathway into host cells may lead to the increased production of desired metabolites if the host cells provide sufficient precursors and energy and show genetic tractability [<xref rid="B171-molecules-28-02761" ref-type="bibr">171</xref>,<xref rid="B172-molecules-28-02761" ref-type="bibr">172</xref>]. Synthetic biology provides feasible strategies to create efficient chassis cells for heterologous protein expression [<xref rid="B173-molecules-28-02761" ref-type="bibr">173</xref>,<xref rid="B174-molecules-28-02761" ref-type="bibr">174</xref>]. For the overproduction of ACM-A, one challenge is how to express a functional min PKS which is insoluble in some prokaryotes [<xref rid="B175-molecules-28-02761" ref-type="bibr">175</xref>]. The solution to this challenge may be the employment of a molecular chaperon [<xref rid="B176-molecules-28-02761" ref-type="bibr">176</xref>] or an appropriate promoter, because the former helps proper protein folding and the latter controls transcription speed. Another issue is the perturbation of the host metabolism. The sigma factor (&#x003c3;s) could be leveraged to stimulate the production of the desired metabolites, as &#x003c3;s can allocate metabolic fluxes [<xref rid="B177-molecules-28-02761" ref-type="bibr">177</xref>,<xref rid="B178-molecules-28-02761" ref-type="bibr">178</xref>]. Indeed, &#x003c3;-based regulation has been utilized to intensify gene expression [<xref rid="B179-molecules-28-02761" ref-type="bibr">179</xref>,<xref rid="B180-molecules-28-02761" ref-type="bibr">180</xref>]. In recent years, orthogonal gene circuits and modular devices are considered effective to coordinate product formation and cell growth [<xref rid="B177-molecules-28-02761" ref-type="bibr">177</xref>,<xref rid="B181-molecules-28-02761" ref-type="bibr">181</xref>].</p><p>One notable challenge for overproducing ACM-A is how to efficiently drive the long biosynthesis pathway. Solutions to this challenge include the coupling of the ACM-A pathway to a core pathway, the timely alleviation of feedback inhibition, the adequate utilization of metabolism [<xref rid="B182-molecules-28-02761" ref-type="bibr">182</xref>], and the augmentation of precursor supply [<xref rid="B183-molecules-28-02761" ref-type="bibr">183</xref>,<xref rid="B184-molecules-28-02761" ref-type="bibr">184</xref>,<xref rid="B185-molecules-28-02761" ref-type="bibr">185</xref>,<xref rid="B186-molecules-28-02761" ref-type="bibr">186</xref>]. In addition, cluster-free hosts can divert the precursor to the desired chemicals [<xref rid="B187-molecules-28-02761" ref-type="bibr">187</xref>]. Although the overexpression of key enzymes is, in most cases, feasible to overproduce desired chemicals, it exerts a metabolic burden on the host cells [<xref rid="B188-molecules-28-02761" ref-type="bibr">188</xref>]. Apart from molecular biology approaches, the timely in situ removal of metabolites is actually feasible to minimize metabolic stress and simplify downstream purification [<xref rid="B189-molecules-28-02761" ref-type="bibr">189</xref>,<xref rid="B190-molecules-28-02761" ref-type="bibr">190</xref>]. Recently, a tRNA from <italic toggle="yes">Streptomyces</italic> was shown to benefit antibiotic production by circumventing inefficient wobble base-pairing, which is insightful for product formation [<xref rid="B191-molecules-28-02761" ref-type="bibr">191</xref>]. <xref rid="molecules-28-02761-t003" ref-type="table">Table 3</xref> shows the reported strategies for improving the production of ACM-A and other secondary metabolites in <italic toggle="yes">Streptomyces</italic>.</p><p>Anthracyclines are important anticancer agents; however, their cardiotoxicity limits doses in clinical practice. Hence, it is desirable to seek new anthracycline analogues with high antitumor activity and low cardiotoxicity. 11-hydroxyaclacinomycin A is an analog showing higher in vitro cytotoxicity against melanoma and leukemia compared to ACM-A. 11-hydroxyaclacinomycin A could be produced by transforming <italic toggle="yes">S. galilaeus</italic> ATCC 31133 with doxorubicin resistance genes <italic toggle="yes">drrA</italic> and <italic toggle="yes">drrB</italic>, as well as the aklavinone 11-hydroxylase-coding gene <italic toggle="yes">dnrF</italic> from the doxorubicin producer [<xref rid="B192-molecules-28-02761" ref-type="bibr">192</xref>]. Moreover, the isomerization of the ACM-A hydroxyl region in <italic toggle="yes">S. galilaeus</italic> mutants led to the production of iso-aclacinomycins, which showed enhanced (1~5 folds) anticancer activity relative to ACM-A [<xref rid="B193-molecules-28-02761" ref-type="bibr">193</xref>]. Overall, a lot of approaches could be developed to overproduce ACM-A and its analogues.</p></sec><sec sec-type="conclusions" id="sec4-molecules-28-02761"><title>4. Conclusions</title><p>The antitumor activity of ACM-A has brought a glimmer of hope for cancer patients. This review comprehensively describes the pathways and key enzymes for the biosynthesis of ACM-A. Although the enzymes for the biosynthesis of ACM-A have not been completely unraveled, genome sequencing and bioinformatics analysis hold promise to fasten its annotation and identification. Although current low production constrains its clinical application, a set of strategies have been developed. For instance, constraint-based modeling techniques have been developed for the accurate analysis of metabolic networks [<xref rid="B194-molecules-28-02761" ref-type="bibr">194</xref>], and cell systems can be modified at DNA, RNA, and protein levels. For DNA modification, the genome and gene cluster can be reshaped by DNA editing tools such as Multiplex Automated Genome Engineering (MAGE), Multiplexed Site-specific Genome Engineering (MSGE) [<xref rid="B195-molecules-28-02761" ref-type="bibr">195</xref>,<xref rid="B196-molecules-28-02761" ref-type="bibr">196</xref>], CRISPR/Cas9, base editing [<xref rid="B197-molecules-28-02761" ref-type="bibr">197</xref>,<xref rid="B198-molecules-28-02761" ref-type="bibr">198</xref>], and prime editing [<xref rid="B199-molecules-28-02761" ref-type="bibr">199</xref>]. CRISPR-Cas9 holds the potential to rewire the metabolic pathways and regulatory networks in <italic toggle="yes">Streptomyces</italic> [<xref rid="B200-molecules-28-02761" ref-type="bibr">200</xref>,<xref rid="B201-molecules-28-02761" ref-type="bibr">201</xref>]. Transcription can be modulated by RNA interference, anti-sense technology, and CRISPR-Cas13 technology, especially in eucaryotic host cells [<xref rid="B202-molecules-28-02761" ref-type="bibr">202</xref>]. Notably, the combination of CRISPR-dCas9 with DNA methylation seems to be a promising strategy for targeted gene knockdown [<xref rid="B203-molecules-28-02761" ref-type="bibr">203</xref>]. Apart from the modifications to DNA and RNA, protein engineering is ushering in a new era, as structure prediction tools, especially AlphaFold, help the directed evolution of the enzymes that catalyze the formation of desired metabolites [<xref rid="B79-molecules-28-02761" ref-type="bibr">79</xref>]. We envision that the aforementioned strategies and tools will substantially advance the bioproduction of ACM-A and beyond.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>P.T. designed the manuscript. Z.X. wrote the first draft. P.T. polished the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors have no conflicts of interest to declare.</p></notes><ref-list><title>References</title><ref id="B1-molecules-28-02761"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bray</surname><given-names>F.</given-names></name>
<name><surname>Ferlay</surname><given-names>J.</given-names></name>
<name><surname>Soerjomataram</surname><given-names>I.</given-names></name>
<name><surname>Siegel</surname><given-names>R.L.</given-names></name>
<name><surname>Torre</surname><given-names>L.A.</given-names></name>
<name><surname>Jemal</surname><given-names>A.</given-names></name>
</person-group><article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J. Clin.</source><year>2018</year><volume>68</volume><fpage>394</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.3322/caac.21492</pub-id><?supplied-pmid 30207593?><pub-id pub-id-type="pmid">30207593</pub-id></element-citation></ref><ref id="B2-molecules-28-02761"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sung</surname><given-names>H.</given-names></name>
<name><surname>Ferlay</surname><given-names>J.</given-names></name>
<name><surname>Siegel</surname><given-names>R.L.</given-names></name>
<name><surname>Laversanne</surname><given-names>M.</given-names></name>
<name><surname>Soerjomataram</surname><given-names>I.</given-names></name>
<name><surname>Jemal</surname><given-names>A.</given-names></name>
<name><surname>Bray</surname><given-names>F.</given-names></name>
</person-group><article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J. Clin.</source><year>2021</year><volume>71</volume><fpage>209</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.3322/caac.21660</pub-id><pub-id pub-id-type="pmid">33538338</pub-id></element-citation></ref><ref id="B3-molecules-28-02761"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Siegel</surname><given-names>R.L.</given-names></name>
<name><surname>Miller</surname><given-names>K.D.</given-names></name>
<name><surname>Jemal</surname><given-names>A.</given-names></name>
</person-group><article-title>Cancer statistics, 2020</article-title><source>CA Cancer J. Clin.</source><year>2020</year><volume>70</volume><fpage>7</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.3322/caac.21590</pub-id><?supplied-pmid 31912902?><pub-id pub-id-type="pmid">31912902</pub-id></element-citation></ref><ref id="B4-molecules-28-02761"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Puyo</surname><given-names>S.</given-names></name>
<name><surname>Montaudon</surname><given-names>D.</given-names></name>
<name><surname>Pourquier</surname><given-names>P.</given-names></name>
</person-group><article-title>From old alkylating agents to new minor groove binders</article-title><source>Crit. Rev. Oncol. Hematol.</source><year>2014</year><volume>89</volume><fpage>43</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.critrevonc.2013.07.006</pub-id><?supplied-pmid 23972663?><pub-id pub-id-type="pmid">23972663</pub-id></element-citation></ref><ref id="B5-molecules-28-02761"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parczyk</surname><given-names>K.</given-names></name>
<name><surname>Schneider</surname><given-names>M.R.</given-names></name>
</person-group><article-title>The future of antihormone therapy: Innovations based on an established principle</article-title><source>J. Cancer Res. Clin. Oncol.</source><year>1996</year><volume>122</volume><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1007/BF01212877</pub-id><?supplied-pmid 8690748?><pub-id pub-id-type="pmid">8690748</pub-id></element-citation></ref><ref id="B6-molecules-28-02761"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silvis</surname><given-names>N.G.</given-names></name>
</person-group><article-title>Antimetabolites and cytotoxic drugs</article-title><source>Dermatol. Clin.</source><year>2001</year><volume>19</volume><fpage>105</fpage><lpage>118</lpage><comment>viii&#x02013;ix</comment><pub-id pub-id-type="doi">10.1016/S0733-8635(05)70233-3</pub-id><?supplied-pmid 11155576?><pub-id pub-id-type="pmid">11155576</pub-id></element-citation></ref><ref id="B7-molecules-28-02761"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schlager</surname><given-names>S.</given-names></name>
<name><surname>Drager</surname><given-names>B.</given-names></name>
</person-group><article-title>Exploiting plant alkaloids</article-title><source>Curr. Opin. Biotechnol.</source><year>2016</year><volume>37</volume><fpage>155</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2015.12.003</pub-id><pub-id pub-id-type="pmid">26748036</pub-id></element-citation></ref><ref id="B8-molecules-28-02761"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kelland</surname><given-names>L.</given-names></name>
</person-group><article-title>The resurgence of platinum-based cancer chemotherapy</article-title><source>Nat. Rev. Cancer</source><year>2007</year><volume>7</volume><fpage>573</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1038/nrc2167</pub-id><pub-id pub-id-type="pmid">17625587</pub-id></element-citation></ref><ref id="B9-molecules-28-02761"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>L.N.</given-names></name>
</person-group><article-title>Protein kinase inhibitors: Contributions from structure to clinical compounds</article-title><source>Q. Rev. Biophys.</source><year>2009</year><volume>42</volume><fpage>1</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1017/S0033583508004745</pub-id><pub-id pub-id-type="pmid">19296866</pub-id></element-citation></ref><ref id="B10-molecules-28-02761"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nelson</surname><given-names>P.N.</given-names></name>
<name><surname>Reynolds</surname><given-names>G.M.</given-names></name>
<name><surname>Waldron</surname><given-names>E.E.</given-names></name>
<name><surname>Ward</surname><given-names>E.</given-names></name>
<name><surname>Giannopoulos</surname><given-names>K.</given-names></name>
<name><surname>Murray</surname><given-names>P.G.</given-names></name>
</person-group><article-title>Monoclonal antibodies</article-title><source>Mol. Pathol.</source><year>2000</year><volume>53</volume><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1136/mp.53.3.111</pub-id><pub-id pub-id-type="pmid">10897328</pub-id></element-citation></ref><ref id="B11-molecules-28-02761"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oki</surname><given-names>T.</given-names></name>
<name><surname>Matsuzawa</surname><given-names>Y.</given-names></name>
<name><surname>Yoshimoto</surname><given-names>A.</given-names></name>
<name><surname>Numata</surname><given-names>K.</given-names></name>
<name><surname>Kitamura</surname><given-names>I.</given-names></name>
</person-group><article-title>New antitumor antibiotics aclacinomycins A and B</article-title><source>J. Antibiot.</source><year>1975</year><volume>28</volume><fpage>830</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.28.830</pub-id><?supplied-pmid 1184473?><pub-id pub-id-type="pmid">1184473</pub-id></element-citation></ref><ref id="B12-molecules-28-02761"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.S.</given-names></name>
<name><surname>Kim</surname><given-names>Y.H.</given-names></name>
<name><surname>Yoo</surname><given-names>O.J.</given-names></name>
<name><surname>Lee</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Aclacinomycin X, a novel anthracycline antibiotic produced by <italic toggle="yes">Streptomyces galilaeus</italic> ATCC 31133</article-title><source>Biosci. Biotechnol. Biochem.</source><year>1996</year><volume>60</volume><fpage>906</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1271/bbb.60.906</pub-id><?supplied-pmid 8704322?><pub-id pub-id-type="pmid">8704322</pub-id></element-citation></ref><ref id="B13-molecules-28-02761"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>J.Y.</given-names></name>
<name><surname>Shen</surname><given-names>X.Z.</given-names></name>
<name><surname>Deng</surname><given-names>Y.H.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
</person-group><article-title>Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumor</article-title><source>World J. Gastroenterol.</source><year>2004</year><volume>10</volume><fpage>2010</fpage><lpage>2013</lpage><pub-id pub-id-type="doi">10.3748/wjg.v10.i14.2010</pub-id><pub-id pub-id-type="pmid">15237424</pub-id></element-citation></ref><ref id="B14-molecules-28-02761"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>Y.L.</given-names></name>
<name><surname>Chen</surname><given-names>C.W.</given-names></name>
<name><surname>Liu</surname><given-names>F.H.</given-names></name>
<name><surname>Huang</surname><given-names>Y.W.</given-names></name>
<name><surname>Huang</surname><given-names>H.M.</given-names></name>
</person-group><article-title>Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e61939</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0061939</pub-id><pub-id pub-id-type="pmid">23613979</pub-id></element-citation></ref><ref id="B15-molecules-28-02761"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feng</surname><given-names>C.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Dong</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
</person-group><article-title>RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: Evaluation of their effect in lung cancer</article-title><source>Drug Des. Devel. Ther.</source><year>2015</year><volume>9</volume><fpage>4613</fpage><lpage>4620</lpage><?supplied-pmid 26316700?><pub-id pub-id-type="pmid">26316700</pub-id></element-citation></ref><ref id="B16-molecules-28-02761"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>F.</given-names></name>
<name><surname>Xie</surname><given-names>M.</given-names></name>
<name><surname>Chen</surname><given-names>P.</given-names></name>
<name><surname>Wang</surname><given-names>D.</given-names></name>
<name><surname>Yang</surname><given-names>M.</given-names></name>
</person-group><article-title>Homoharringtonine combined with cladribine and aclarubicin (HCA) in acute myeloid leukemia: A new regimen of conventional drugs and its mechanism</article-title><source>Oxid. Med. Cell. Longev.</source><year>2022</year><volume>2022</volume><fpage>8212286</fpage><pub-id pub-id-type="doi">10.1155/2022/8212286</pub-id><pub-id pub-id-type="pmid">35873796</pub-id></element-citation></ref><ref id="B17-molecules-28-02761"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moore</surname><given-names>M.H.</given-names></name>
<name><surname>Hunter</surname><given-names>W.N.</given-names></name>
<name><surname>d&#x02019;Estaintot</surname><given-names>B.L.</given-names></name>
<name><surname>Kennard</surname><given-names>O.</given-names></name>
</person-group><article-title>DNA-drug interactions. The crystal structure of d(CGATCG) complexed with daunomycin</article-title><source>J. Mol. Biol.</source><year>1989</year><volume>206</volume><fpage>693</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/0022-2836(89)90577-9</pub-id><pub-id pub-id-type="pmid">2738914</pub-id></element-citation></ref><ref id="B18-molecules-28-02761"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Capranico</surname><given-names>G.</given-names></name>
<name><surname>Binaschi</surname><given-names>M.</given-names></name>
<name><surname>Borgnetto</surname><given-names>M.E.</given-names></name>
<name><surname>Zunino</surname><given-names>F.</given-names></name>
<name><surname>Palumbo</surname><given-names>M.</given-names></name>
</person-group><article-title>A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons</article-title><source>Trends Pharmacol. Sci.</source><year>1997</year><volume>18</volume><fpage>323</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/S0165-6147(97)90658-1</pub-id><pub-id pub-id-type="pmid">9345851</pub-id></element-citation></ref><ref id="B19-molecules-28-02761"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pang</surname><given-names>B.</given-names></name>
<name><surname>Qiao</surname><given-names>X.</given-names></name>
<name><surname>Janssen</surname><given-names>L.</given-names></name>
<name><surname>Velds</surname><given-names>A.</given-names></name>
<name><surname>Groothuis</surname><given-names>T.</given-names></name>
<name><surname>Kerkhoven</surname><given-names>R.</given-names></name>
<name><surname>Nieuwland</surname><given-names>M.</given-names></name>
<name><surname>Ovaa</surname><given-names>H.</given-names></name>
<name><surname>Rottenberg</surname><given-names>S.</given-names></name>
<name><surname>van Tellingen</surname><given-names>O.</given-names></name>
<etal/>
</person-group><article-title>Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin</article-title><source>Nat. Commun.</source><year>2013</year><volume>4</volume><fpage>1908</fpage><pub-id pub-id-type="doi">10.1038/ncomms2921</pub-id><pub-id pub-id-type="pmid">23715267</pub-id></element-citation></ref><ref id="B20-molecules-28-02761"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qiao</surname><given-names>X.</given-names></name>
<name><surname>van der Zanden</surname><given-names>S.Y.</given-names></name>
<name><surname>Wander</surname><given-names>D.P.A.</given-names></name>
<name><surname>Borras</surname><given-names>D.M.</given-names></name>
<name><surname>Song</surname><given-names>J.Y.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>van Duikeren</surname><given-names>S.</given-names></name>
<name><surname>van Gils</surname><given-names>N.</given-names></name>
<name><surname>Rutten</surname><given-names>A.</given-names></name>
<name><surname>van Herwaarden</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Uncoupling DNA damage from chromatin damage to detoxify doxorubicin</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2020</year><volume>117</volume><fpage>15182</fpage><lpage>15192</lpage><pub-id pub-id-type="doi">10.1073/pnas.1922072117</pub-id><pub-id pub-id-type="pmid">32554494</pub-id></element-citation></ref><ref id="B21-molecules-28-02761"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hori</surname><given-names>S.</given-names></name>
<name><surname>Shirai</surname><given-names>M.</given-names></name>
<name><surname>Hirano</surname><given-names>S.</given-names></name>
<name><surname>Oki</surname><given-names>T.</given-names></name>
<name><surname>Inui</surname><given-names>T.</given-names></name>
<name><surname>Tsukagoshi</surname><given-names>S.</given-names></name>
<name><surname>Ishizuka</surname><given-names>M.</given-names></name>
<name><surname>Takeuchi</surname><given-names>T.</given-names></name>
<name><surname>Umezawa</surname><given-names>H.</given-names></name>
</person-group><article-title>Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity</article-title><source>Gan</source><year>1977</year><volume>68</volume><fpage>685</fpage><lpage>690</lpage><?supplied-pmid 579346?><pub-id pub-id-type="pmid">579346</pub-id></element-citation></ref><ref id="B22-molecules-28-02761"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jung</surname><given-names>M.E.</given-names></name>
<name><surname>Lowe</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Synthetic approaches to aclacinomycin and pyrromycin antitumour antibiotics via Diels&#x02013;Alder reactions of 6-alkoxy-2-pyrones: Total synthesis of chrysophanol, helminthosporin and pachybasin</article-title><source>J. Chem. Soc. Chem. Commun.</source><year>1978</year><volume>3</volume><fpage>95</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1039/C39780000095</pub-id></element-citation></ref><ref id="B23-molecules-28-02761"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krohn</surname><given-names>K.</given-names></name>
</person-group><article-title>Total Synthesis of Anthracyclinone</article-title><source>Angew. Chem. Int. Ed.</source><year>1986</year><volume>25</volume><fpage>790</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1002/anie.198607901</pub-id></element-citation></ref><ref id="B24-molecules-28-02761"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Monneret</surname><given-names>C.</given-names></name>
<name><surname>Martin</surname><given-names>A.</given-names></name>
<name><surname>Pais</surname><given-names>M.</given-names></name>
</person-group><article-title>Synthesis of the Oligosaccharide moieties of musettamycin, marcellomycin and aclacinomycin A, Antitumor antibiotics</article-title><source>J. Carbohydr. Chem.</source><year>1988</year><volume>7</volume><fpage>417</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1080/07328308808058934</pub-id></element-citation></ref><ref id="B25-molecules-28-02761"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martin</surname><given-names>A.</given-names></name>
<name><surname>Pais</surname><given-names>M.</given-names></name>
<name><surname>Monneret</surname><given-names>C.</given-names></name>
</person-group><article-title>Synthesis of a trisaccharide related to the antitumour antibiotic, aclacinomycin A</article-title><source>J. Chem. Soc. Chem. Commun.</source><year>1983</year><volume>6</volume><fpage>305</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1039/c39830000305</pub-id></element-citation></ref><ref id="B26-molecules-28-02761"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>S.</given-names></name>
<name><surname>Liang</surname><given-names>R.</given-names></name>
<name><surname>Jiang</surname><given-names>H.</given-names></name>
<name><surname>Wu</surname><given-names>W.</given-names></name>
</person-group><article-title>An efficient route to polysubstituted tetrahydronaphthols: Silver-catalyzed [4+2] cyclization of 2-alkylbenzaldehydes and alkenes</article-title><source>Angew. Chem. Int. Ed. Engl.</source><year>2012</year><volume>51</volume><fpage>10861</fpage><lpage>10865</lpage><pub-id pub-id-type="doi">10.1002/anie.201204798</pub-id><pub-id pub-id-type="pmid">23011915</pub-id></element-citation></ref><ref id="B27-molecules-28-02761"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yao</surname><given-names>H.</given-names></name>
<name><surname>Vu</surname><given-names>M.D.</given-names></name>
<name><surname>Liu</surname><given-names>X.W.</given-names></name>
</person-group><article-title>Recent advances in reagent-controlled stereoselective/stereospecific glycosylation</article-title><source>Carbohydr. Res.</source><year>2019</year><volume>473</volume><fpage>72</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.carres.2018.10.006</pub-id><pub-id pub-id-type="pmid">30641292</pub-id></element-citation></ref><ref id="B28-molecules-28-02761"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bennett</surname><given-names>C.S.</given-names></name>
<name><surname>Galan</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Methods for 2-Deoxyglycoside Synthesis</article-title><source>Chem. Rev.</source><year>2018</year><volume>118</volume><fpage>7931</fpage><lpage>7985</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.7b00731</pub-id><pub-id pub-id-type="pmid">29953219</pub-id></element-citation></ref><ref id="B29-molecules-28-02761"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wander</surname><given-names>D.P.A.</given-names></name>
<name><surname>van der Zanden</surname><given-names>S.Y.</given-names></name>
<name><surname>van der Marel</surname><given-names>G.A.</given-names></name>
<name><surname>Overkleeft</surname><given-names>H.S.</given-names></name>
<name><surname>Neefjes</surname><given-names>J.</given-names></name>
<name><surname>Codee</surname><given-names>J.D.C.</given-names></name>
</person-group><article-title>Doxorubicin and aclarubicin: Shuffling anthracycline glycans for improved anticancer agents</article-title><source>J. Med. Chem.</source><year>2020</year><volume>63</volume><fpage>12814</fpage><lpage>12829</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c01191</pub-id><pub-id pub-id-type="pmid">33064004</pub-id></element-citation></ref><ref id="B30-molecules-28-02761"><label>30.</label><element-citation publication-type="patent"><person-group person-group-type="author">
<name><surname>Cho</surname><given-names>W.T.</given-names></name>
<name><surname>Kim</surname><given-names>W.S.</given-names></name>
<name><surname>Kim</surname><given-names>M.K.</given-names></name>
<name><surname>Park</surname><given-names>J.K.</given-names></name>
<name><surname>Kim</surname><given-names>H.R.</given-names></name>
<name><surname>Rhee</surname><given-names>S.K.</given-names></name>
<name><surname>Domracheva</surname><given-names>A.G.</given-names></name>
<name><surname>Panichkina</surname><given-names>T.B.</given-names></name>
<name><surname>Saburoba</surname><given-names>L.A.</given-names></name>
<name><surname>Nobikoba</surname><given-names>L.M.</given-names></name>
<etal/>
</person-group><article-title>Method for producing aclacinomycins A, B, Y using <italic toggle="yes">Strepomyces lavendofoliae</italic> DKRS</article-title><patent>US5484712</patent><day>16</day><month>January</month><year>1996</year></element-citation></ref><ref id="B31-molecules-28-02761"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oki</surname><given-names>T.</given-names></name>
<name><surname>Kitamura</surname><given-names>I.</given-names></name>
<name><surname>Yoshimoto</surname><given-names>A.</given-names></name>
<name><surname>Matsuzawa</surname><given-names>Y.</given-names></name>
<name><surname>Shibamoto</surname><given-names>N.</given-names></name>
<name><surname>Ogasawara</surname><given-names>T.</given-names></name>
<name><surname>Inui</surname><given-names>T.</given-names></name>
<name><surname>Takamatsu</surname><given-names>A.</given-names></name>
<name><surname>Takeuchi</surname><given-names>T.</given-names></name>
<name><surname>Masuda</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties</article-title><source>J. Antibiot.</source><year>1979</year><volume>32</volume><fpage>791</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.32.791</pub-id></element-citation></ref><ref id="B32-molecules-28-02761"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kitamura</surname><given-names>I.</given-names></name>
<name><surname>Tobe</surname><given-names>H.</given-names></name>
<name><surname>Yoshimoto</surname><given-names>A.</given-names></name>
<name><surname>Oki</surname><given-names>T.</given-names></name>
<name><surname>Naganawa</surname><given-names>H.</given-names></name>
<name><surname>Takeuchi</surname><given-names>T.</given-names></name>
<name><surname>Umezawa</surname><given-names>H.</given-names></name>
</person-group><article-title>Biosynthesis of aklavinone and aclacinomycins</article-title><source>J. Antibiot.</source><year>1981</year><volume>34</volume><fpage>1498</fpage><lpage>1500</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.34.1498</pub-id><?supplied-pmid 7319911?><pub-id pub-id-type="pmid">7319911</pub-id></element-citation></ref><ref id="B33-molecules-28-02761"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>R&#x000e4;ty</surname><given-names>K.</given-names></name>
<name><surname>Kantola</surname><given-names>J.</given-names></name>
<name><surname>Hautala</surname><given-names>A.</given-names></name>
<name><surname>Hakala</surname><given-names>J.</given-names></name>
<name><surname>Ylihonko</surname><given-names>K.</given-names></name>
<name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname><given-names>P.</given-names></name>
</person-group><article-title>Cloning and characterization of <italic toggle="yes">Streptomyces galilaeus</italic> aclacinomycins polyketide synthase (PKS) cluster</article-title><source>Gene</source><year>2002</year><volume>293</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/S0378-1119(02)00699-6</pub-id><?supplied-pmid 12137949?><pub-id pub-id-type="pmid">12137949</pub-id></element-citation></ref><ref id="B34-molecules-28-02761"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>W.</given-names></name>
<name><surname>Leimkuhler</surname><given-names>C.</given-names></name>
<name><surname>Gatto</surname><given-names>G.J.</given-names><suffix>Jr.</suffix></name>
<name><surname>Kruger</surname><given-names>R.G.</given-names></name>
<name><surname>Oberthur</surname><given-names>M.</given-names></name>
<name><surname>Kahne</surname><given-names>D.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>AknT is an activating protein for the glycosyltransferase AknS in L-aminodeoxysugar transfer to the aglycone of aclacinomycin A</article-title><source>Chem. Biol.</source><year>2005</year><volume>12</volume><fpage>527</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2005.02.016</pub-id><?supplied-pmid 15911373?><pub-id pub-id-type="pmid">15911373</pub-id></element-citation></ref><ref id="B35-molecules-28-02761"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>W.</given-names></name>
<name><surname>Leimkuhler</surname><given-names>C.</given-names></name>
<name><surname>Oberthur</surname><given-names>M.</given-names></name>
<name><surname>Kahne</surname><given-names>D.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>AknK is an L-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A</article-title><source>Biochemistry</source><year>2004</year><volume>43</volume><fpage>4548</fpage><lpage>4558</lpage><pub-id pub-id-type="doi">10.1021/bi035945i</pub-id><pub-id pub-id-type="pmid">15078101</pub-id></element-citation></ref><ref id="B36-molecules-28-02761"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alexeev</surname><given-names>I.</given-names></name>
<name><surname>Sultana</surname><given-names>A.</given-names></name>
<name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname><given-names>P.</given-names></name>
<name><surname>Niemi</surname><given-names>J.</given-names></name>
<name><surname>Schneider</surname><given-names>G.</given-names></name>
</person-group><article-title>Aclacinomycin oxidoreductase (AknOx) from the biosynthetic pathway of the antibiotic aclacinomycin is an unusual flavoenzyme with a dual active site</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>6170</fpage><lpage>6175</lpage><pub-id pub-id-type="doi">10.1073/pnas.0700579104</pub-id><pub-id pub-id-type="pmid">17395717</pub-id></element-citation></ref><ref id="B37-molecules-28-02761"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoshino</surname><given-names>T.</given-names></name>
<name><surname>Sekine</surname><given-names>Y.</given-names></name>
<name><surname>Fujiwara</surname><given-names>A.</given-names></name>
</person-group><article-title>Microbial conversion of anthracycline antibiotics. I. Microbial conversion of aclacinomycin B to aclacinomycin A</article-title><source>J. Antibiot.</source><year>1983</year><volume>36</volume><fpage>1458</fpage><lpage>1462</lpage></element-citation></ref><ref id="B38-molecules-28-02761"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gr&#x000e4;fe</surname><given-names>U.</given-names></name>
<name><surname>Dornberger</surname><given-names>K.</given-names></name>
<name><surname>Fleck</surname><given-names>W.F.</given-names></name>
<name><surname>Bormann</surname><given-names>E.J.</given-names></name>
<name><surname>Ihn</surname><given-names>W.</given-names></name>
</person-group><article-title>Bioconversion of aclacinomycin A to Y and B by an intracellular enzyme of <italic toggle="yes">Streptomyces</italic> spec. AM 33352</article-title><source>Biotechnol. Lett.</source><year>1988</year><volume>10</volume><fpage>167</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1007/BF01134820</pub-id></element-citation></ref><ref id="B39-molecules-28-02761"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ridley</surname><given-names>C.P.</given-names></name>
<name><surname>Lee</surname><given-names>H.Y.</given-names></name>
<name><surname>Khosla</surname><given-names>C.</given-names></name>
</person-group><article-title>Evolution of polyketide synthases in bacteria</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>4595</fpage><lpage>4600</lpage><pub-id pub-id-type="doi">10.1073/pnas.0710107105</pub-id><?supplied-pmid 18250311?><pub-id pub-id-type="pmid">18250311</pub-id></element-citation></ref><ref id="B40-molecules-28-02761"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>R.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Yan</surname><given-names>Y.</given-names></name>
<name><surname>Shen</surname><given-names>X.</given-names></name>
<name><surname>Yuan</surname><given-names>Q.</given-names></name>
</person-group><article-title>Biosynthesis of aromatic polyketides in microorganisms using type II polyketide synthases</article-title><source>Microb. Cell Fact.</source><year>2020</year><volume>19</volume><fpage>110</fpage><pub-id pub-id-type="doi">10.1186/s12934-020-01367-4</pub-id><pub-id pub-id-type="pmid">32448179</pub-id></element-citation></ref><ref id="B41-molecules-28-02761"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bisang</surname><given-names>C.</given-names></name>
<name><surname>Long</surname><given-names>P.F.</given-names></name>
<name><surname>Cortes</surname><given-names>J.</given-names></name>
<name><surname>Westcott</surname><given-names>J.</given-names></name>
<name><surname>Crosby</surname><given-names>J.</given-names></name>
<name><surname>Matharu</surname><given-names>A.L.</given-names></name>
<name><surname>Cox</surname><given-names>R.J.</given-names></name>
<name><surname>Simpson</surname><given-names>T.J.</given-names></name>
<name><surname>Staunton</surname><given-names>J.</given-names></name>
<name><surname>Leadlay</surname><given-names>P.F.</given-names></name>
</person-group><article-title>A chain initiation factor common to both modular and aromatic polyketide synthases</article-title><source>Nature</source><year>1999</year><volume>401</volume><fpage>502</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1038/46829</pub-id><?supplied-pmid 10519556?><pub-id pub-id-type="pmid">10519556</pub-id></element-citation></ref><ref id="B42-molecules-28-02761"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujii</surname><given-names>I.</given-names></name>
</person-group><article-title>Heterologous expression systems for polyketide synthases</article-title><source>Nat. Prod. Rep.</source><year>2009</year><volume>26</volume><fpage>155</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1039/B817092B</pub-id><?supplied-pmid 19177221?><pub-id pub-id-type="pmid">19177221</pub-id></element-citation></ref><ref id="B43-molecules-28-02761"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mets&#x000e4;-Ketel&#x000e4;</surname><given-names>M.</given-names></name>
<name><surname>Palmu</surname><given-names>K.</given-names></name>
<name><surname>Kunnari</surname><given-names>T.</given-names></name>
<name><surname>Ylihonko</surname><given-names>K.</given-names></name>
<name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname><given-names>P.</given-names></name>
</person-group><article-title>Engineering anthracycline biosynthesis toward angucyclines</article-title><source>Antimicrob. Agents Chemother.</source><year>2003</year><volume>47</volume><fpage>1291</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1128/AAC.47.4.1291-1296.2003</pub-id><?supplied-pmid 12654660?><pub-id pub-id-type="pmid">12654660</pub-id></element-citation></ref><ref id="B44-molecules-28-02761"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsai</surname><given-names>S.C.</given-names></name>
</person-group><article-title>The structural enzymology of iterative aromatic polyketide synthases: A critical comparison with fatty acid synthases</article-title><source>Annu. Rev. Biochem.</source><year>2018</year><volume>87</volume><fpage>503</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-063011-164509</pub-id><?supplied-pmid 29925265?><pub-id pub-id-type="pmid">29925265</pub-id></element-citation></ref><ref id="B45-molecules-28-02761"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsukamoto</surname><given-names>N.</given-names></name>
<name><surname>Fujii</surname><given-names>I.</given-names></name>
<name><surname>Ebizuka</surname><given-names>Y.</given-names></name>
<name><surname>Sankawa</surname><given-names>U.</given-names></name>
</person-group><article-title>Nucleotide sequence of the <italic toggle="yes">aknA</italic> region of the aklavinone biosynthetic gene cluster of <italic toggle="yes">Streptomyces galilaeus</italic></article-title><source>J. Bacteriol.</source><year>1994</year><volume>176</volume><fpage>2473</fpage><lpage>2475</lpage><pub-id pub-id-type="doi">10.1128/jb.176.8.2473-2475.1994</pub-id><?supplied-pmid 8157619?><pub-id pub-id-type="pmid">8157619</pub-id></element-citation></ref><ref id="B46-molecules-28-02761"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prado</surname><given-names>L.</given-names></name>
<name><surname>Lombo</surname><given-names>F.</given-names></name>
<name><surname>Brana</surname><given-names>A.F.</given-names></name>
<name><surname>Mendez</surname><given-names>C.</given-names></name>
<name><surname>Rohr</surname><given-names>J.</given-names></name>
<name><surname>Salas</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Analysis of two chromosomal regions adjacent to genes for a type II polyketide synthase involved in the biosynthesis of the antitumor polyketide mithramycin in <italic toggle="yes">Streptomyces argillaceus</italic></article-title><source>Mol. Gen. Genet.</source><year>1999</year><volume>261</volume><fpage>216</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1007/s004380050960</pub-id><pub-id pub-id-type="pmid">10102355</pub-id></element-citation></ref><ref id="B47-molecules-28-02761"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chung</surname><given-names>J.Y.</given-names></name>
<name><surname>Fujii</surname><given-names>I.</given-names></name>
<name><surname>Harada</surname><given-names>S.</given-names></name>
<name><surname>Sankawa</surname><given-names>U.</given-names></name>
<name><surname>Ebizuka</surname><given-names>Y.</given-names></name>
</person-group><article-title>Expression, purification, and characterization of AknX anthrone oxygenase, which is involved in aklavinone biosynthesis in <italic toggle="yes">Streptomyces galilaeus</italic></article-title><source>J. Bacteriol.</source><year>2002</year><volume>184</volume><fpage>6115</fpage><lpage>6122</lpage><pub-id pub-id-type="doi">10.1128/JB.184.22.6115-6122.2002</pub-id><pub-id pub-id-type="pmid">12399480</pub-id></element-citation></ref><ref id="B48-molecules-28-02761"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>R&#x000e4;ty</surname><given-names>K.</given-names></name>
<name><surname>Kunnari</surname><given-names>T.</given-names></name>
<name><surname>Hakala</surname><given-names>J.</given-names></name>
<name><surname>Mantsala</surname><given-names>P.</given-names></name>
<name><surname>Ylihonko</surname><given-names>K.</given-names></name>
</person-group><article-title>A gene cluster from <italic toggle="yes">Streptomyces galilaeus</italic> involved in glycosylation of aclarubicin</article-title><source>Mol. Gen. Genet.</source><year>2000</year><volume>264</volume><fpage>164</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1007/s004380000306</pub-id><pub-id pub-id-type="pmid">11016846</pub-id></element-citation></ref><ref id="B49-molecules-28-02761"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kantola</surname><given-names>J.</given-names></name>
<name><surname>Kunnari</surname><given-names>T.</given-names></name>
<name><surname>Hautala</surname><given-names>A.</given-names></name>
<name><surname>Hakala</surname><given-names>J.</given-names></name>
<name><surname>Ylihonko</surname><given-names>K.</given-names></name>
<name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname><given-names>P.</given-names></name>
</person-group><article-title>Elucidation of anthracyclinone biosynthesis by stepwise cloning of genes for anthracyclines from three different <italic toggle="yes">Streptomyces</italic> spp.</article-title><source>Microbiology</source><year>2000</year><volume>146</volume><fpage>155</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1099/00221287-146-1-155</pub-id><pub-id pub-id-type="pmid">10658662</pub-id></element-citation></ref><ref id="B50-molecules-28-02761"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kallio</surname><given-names>P.</given-names></name>
<name><surname>Sultana</surname><given-names>A.</given-names></name>
<name><surname>Niemi</surname><given-names>J.</given-names></name>
<name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname><given-names>P.</given-names></name>
<name><surname>Schneider</surname><given-names>G.</given-names></name>
</person-group><article-title>Crystal structure of the polyketide cyclase AknH with bound substrate and product analogue: Implications for catalytic mechanism and product stereoselectivity</article-title><source>J. Mol. Biol.</source><year>2006</year><volume>357</volume><fpage>210</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2005.12.064</pub-id><pub-id pub-id-type="pmid">16414075</pub-id></element-citation></ref><ref id="B51-molecules-28-02761"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kendrew</surname><given-names>S.G.</given-names></name>
<name><surname>Katayama</surname><given-names>K.</given-names></name>
<name><surname>Deutsch</surname><given-names>E.</given-names></name>
<name><surname>Madduri</surname><given-names>K.</given-names></name>
<name><surname>Hutchinson</surname><given-names>C.R.</given-names></name>
</person-group><article-title>DnrD cyclase involved in the biosynthesis of doxorubicin: Purification and characterization of the recombinant enzyme</article-title><source>Biochemistry</source><year>1999</year><volume>38</volume><fpage>4794</fpage><lpage>4799</lpage><pub-id pub-id-type="doi">10.1021/bi9827924</pub-id><pub-id pub-id-type="pmid">10200167</pub-id></element-citation></ref><ref id="B52-molecules-28-02761"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sultana</surname><given-names>A.</given-names></name>
<name><surname>Kallio</surname><given-names>P.</given-names></name>
<name><surname>Jansson</surname><given-names>A.</given-names></name>
<name><surname>Wang</surname><given-names>J.S.</given-names></name>
<name><surname>Niemi</surname><given-names>J.</given-names></name>
<name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname><given-names>P.</given-names></name>
<name><surname>Schneider</surname><given-names>G.</given-names></name>
</person-group><article-title>Structure of the polyketide cyclase SnoaL reveals a novel mechanism for enzymatic aldol condensation</article-title><source>EMBO J.</source><year>2004</year><volume>23</volume><fpage>1911</fpage><lpage>1921</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600201</pub-id><?supplied-pmid 15071504?><pub-id pub-id-type="pmid">15071504</pub-id></element-citation></ref><ref id="B53-molecules-28-02761"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dickens</surname><given-names>M.L.</given-names></name>
<name><surname>Ye</surname><given-names>J.</given-names></name>
<name><surname>Strohl</surname><given-names>W.R.</given-names></name>
</person-group><article-title>Cloning, sequencing, and analysis of aklaviketone reductase from <italic toggle="yes">Streptomyces</italic> sp. strain C5</article-title><source>J. Bacteriol.</source><year>1996</year><volume>178</volume><fpage>3384</fpage><lpage>3388</lpage><pub-id pub-id-type="doi">10.1128/jb.178.11.3384-3388.1996</pub-id><pub-id pub-id-type="pmid">8655529</pub-id></element-citation></ref><ref id="B54-molecules-28-02761"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Torkkell</surname><given-names>S.</given-names></name>
<name><surname>Kunnari</surname><given-names>T.</given-names></name>
<name><surname>Palmu</surname><given-names>K.</given-names></name>
<name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname><given-names>P.</given-names></name>
<name><surname>Hakala</surname><given-names>J.</given-names></name>
<name><surname>Ylihonko</surname><given-names>K.</given-names></name>
</person-group><article-title>The entire nogalamycin biosynthetic gene cluster of <italic toggle="yes">Streptomyces nogalater</italic>: Characterization of a 20-kb DNA region and generation of hybrid structures</article-title><source>Mol. Genet. Genomics</source><year>2001</year><volume>266</volume><fpage>276</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1007/s004380100554</pub-id><?supplied-pmid 11683270?><pub-id pub-id-type="pmid">11683270</pub-id></element-citation></ref><ref id="B55-molecules-28-02761"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thibodeaux</surname><given-names>C.J.</given-names></name>
<name><surname>Melancon</surname><given-names>C.E.</given-names><suffix>3rd</suffix></name>
<name><surname>Liu</surname><given-names>H.W.</given-names></name>
</person-group><article-title>Natural-product sugar biosynthesis and enzymatic glycodiversification</article-title><source>Angew. Chem. Int. Ed. Engl.</source><year>2008</year><volume>47</volume><fpage>9814</fpage><lpage>9859</lpage><pub-id pub-id-type="doi">10.1002/anie.200801204</pub-id><pub-id pub-id-type="pmid">19058170</pub-id></element-citation></ref><ref id="B56-molecules-28-02761"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salcedo</surname><given-names>R.G.</given-names></name>
<name><surname>Olano</surname><given-names>C.</given-names></name>
<name><surname>Fernandez</surname><given-names>R.</given-names></name>
<name><surname>Brana</surname><given-names>A.F.</given-names></name>
<name><surname>Mendez</surname><given-names>C.</given-names></name>
<name><surname>de la Calle</surname><given-names>F.</given-names></name>
<name><surname>Salas</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Elucidation of the glycosylation steps during biosynthesis of antitumor macrolides PM100117 and PM100118 and engineering for novel derivatives</article-title><source>Microb. Cell Fact.</source><year>2016</year><volume>15</volume><fpage>187</fpage><pub-id pub-id-type="doi">10.1186/s12934-016-0591-7</pub-id><?supplied-pmid 27829451?><pub-id pub-id-type="pmid">27829451</pub-id></element-citation></ref><ref id="B57-molecules-28-02761"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
<name><surname>Losey</surname><given-names>H.C.</given-names></name>
<name><surname>Freel Meyers</surname><given-names>C.L.</given-names></name>
</person-group><article-title>Antibiotic glycosyltransferases</article-title><source>Biochem. Soc. Trans.</source><year>2003</year><volume>31</volume><fpage>487</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1042/bst0310487</pub-id><pub-id pub-id-type="pmid">12773141</pub-id></element-citation></ref><ref id="B58-molecules-28-02761"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>R&#x000e4;ty</surname><given-names>K.</given-names></name>
<name><surname>Hautala</surname><given-names>A.</given-names></name>
<name><surname>Torkkell</surname><given-names>S.</given-names></name>
<name><surname>Kantola</surname><given-names>J.</given-names></name>
<name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname><given-names>P.</given-names></name>
<name><surname>Hakala</surname><given-names>J.</given-names></name>
<name><surname>Ylihonko</surname><given-names>K.</given-names></name>
</person-group><article-title>Characterization of mutations in aclacinomycin A-non-producing <italic toggle="yes">Streptomyces galilaeus</italic> strains with altered glycosylation patterns</article-title><source>Microbiology</source><year>2002</year><volume>148</volume><fpage>3375</fpage><lpage>3384</lpage><pub-id pub-id-type="doi">10.1099/00221287-148-11-3375</pub-id><pub-id pub-id-type="pmid">12427929</pub-id></element-citation></ref><ref id="B59-molecules-28-02761"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Otten</surname><given-names>S.L.</given-names></name>
<name><surname>Gallo</surname><given-names>M.A.</given-names></name>
<name><surname>Madduri</surname><given-names>K.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Hutchinson</surname><given-names>C.R.</given-names></name>
</person-group><article-title>Cloning and characterization of the <italic toggle="yes">Streptomyces peucetius dnmZUV</italic> genes encoding three enzymes required for biosynthesis of the daunorubicin precursor thymidine diphospho-L-daunosamine</article-title><source>J. Bacteriol.</source><year>1997</year><volume>179</volume><fpage>4446</fpage><lpage>4450</lpage><pub-id pub-id-type="doi">10.1128/jb.179.13.4446-4450.1997</pub-id><pub-id pub-id-type="pmid">9209071</pub-id></element-citation></ref><ref id="B60-molecules-28-02761"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hong</surname><given-names>L.</given-names></name>
<name><surname>Zhao</surname><given-names>Z.</given-names></name>
<name><surname>Melancon</surname><given-names>C.E.</given-names><suffix>3rd</suffix></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Liu</surname><given-names>H.W.</given-names></name>
</person-group><article-title>In vitro characterization of the enzymes involved in TDP-D-forosamine biosynthesis in the spinosyn pathway of <italic toggle="yes">Saccharopolyspora spinosa</italic></article-title><source>J. Am. Chem. Soc.</source><year>2008</year><volume>130</volume><fpage>4954</fpage><lpage>4967</lpage><pub-id pub-id-type="doi">10.1021/ja0771383</pub-id><pub-id pub-id-type="pmid">18345667</pub-id></element-citation></ref><ref id="B61-molecules-28-02761"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Han</surname><given-names>A.R.</given-names></name>
<name><surname>Park</surname><given-names>J.W.</given-names></name>
<name><surname>Lee</surname><given-names>M.K.</given-names></name>
<name><surname>Ban</surname><given-names>Y.H.</given-names></name>
<name><surname>Yoo</surname><given-names>Y.J.</given-names></name>
<name><surname>Kim</surname><given-names>E.J.</given-names></name>
<name><surname>Kim</surname><given-names>E.</given-names></name>
<name><surname>Kim</surname><given-names>B.G.</given-names></name>
<name><surname>Sohng</surname><given-names>J.K.</given-names></name>
<name><surname>Yoon</surname><given-names>Y.J.</given-names></name>
</person-group><article-title>Development of a <italic toggle="yes">Streptomyces venezuelae</italic>-based combinatorial biosynthetic system for the production of glycosylated derivatives of doxorubicin and its biosynthetic intermediates</article-title><source>Appl. Environ. Microbiol.</source><year>2011</year><volume>77</volume><fpage>4912</fpage><lpage>4923</lpage><pub-id pub-id-type="doi">10.1128/AEM.02527-10</pub-id><pub-id pub-id-type="pmid">21602397</pub-id></element-citation></ref><ref id="B62-molecules-28-02761"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palcic</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Glycosyltransferases as biocatalysts</article-title><source>Curr. Opin. Chem. Biol.</source><year>2011</year><volume>15</volume><fpage>226</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2010.11.022</pub-id><?supplied-pmid 21334964?><pub-id pub-id-type="pmid">21334964</pub-id></element-citation></ref><ref id="B63-molecules-28-02761"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>P.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Wu</surname><given-names>C.</given-names></name>
</person-group><article-title>Glycosyltransferase GT1 family: Phylogenetic distribution, substrates coverage, and representative structural features</article-title><source>Comput. Struct. Biotechnol. J.</source><year>2020</year><volume>18</volume><fpage>1383</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2020.06.003</pub-id><?supplied-pmid 32637037?><pub-id pub-id-type="pmid">32637037</pub-id></element-citation></ref><ref id="B64-molecules-28-02761"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lairson</surname><given-names>L.L.</given-names></name>
<name><surname>Henrissat</surname><given-names>B.</given-names></name>
<name><surname>Davies</surname><given-names>G.J.</given-names></name>
<name><surname>Withers</surname><given-names>S.G.</given-names></name>
</person-group><article-title>Glycosyltransferases: Structures, functions, and mechanisms</article-title><source>Annu. Rev. Biochem.</source><year>2008</year><volume>77</volume><fpage>521</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.76.061005.092322</pub-id><?supplied-pmid 18518825?><pub-id pub-id-type="pmid">18518825</pub-id></element-citation></ref><ref id="B65-molecules-28-02761"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Coutinho</surname><given-names>P.M.</given-names></name>
<name><surname>Deleury</surname><given-names>E.</given-names></name>
<name><surname>Davies</surname><given-names>G.J.</given-names></name>
<name><surname>Henrissat</surname><given-names>B.</given-names></name>
</person-group><article-title>An evolving hierarchical family classification for glycosyltransferases</article-title><source>J. Mol. Biol.</source><year>2003</year><volume>328</volume><fpage>307</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(03)00307-3</pub-id><pub-id pub-id-type="pmid">12691742</pub-id></element-citation></ref><ref id="B66-molecules-28-02761"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gloster</surname><given-names>T.M.</given-names></name>
</person-group><article-title>Advances in understanding glycosyltransferases from a structural perspective</article-title><source>Curr. Opin. Struct. Biol.</source><year>2014</year><volume>28</volume><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2014.08.012</pub-id><pub-id pub-id-type="pmid">25240227</pub-id></element-citation></ref><ref id="B67-molecules-28-02761"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>A.</given-names></name>
<name><surname>Singh</surname><given-names>S.</given-names></name>
<name><surname>Phillips</surname><given-names>G.N.</given-names><suffix>Jr.</suffix></name>
<name><surname>Thorson</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Glycosyltransferase structural biology and its role in the design of catalysts for glycosylation</article-title><source>Curr. Opin. Biotechnol.</source><year>2011</year><volume>22</volume><fpage>800</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2011.04.013</pub-id><pub-id pub-id-type="pmid">21592771</pub-id></element-citation></ref><ref id="B68-molecules-28-02761"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brazier-Hicks</surname><given-names>M.</given-names></name>
<name><surname>Offen</surname><given-names>W.A.</given-names></name>
<name><surname>Gershater</surname><given-names>M.C.</given-names></name>
<name><surname>Revett</surname><given-names>T.J.</given-names></name>
<name><surname>Lim</surname><given-names>E.K.</given-names></name>
<name><surname>Bowles</surname><given-names>D.J.</given-names></name>
<name><surname>Davies</surname><given-names>G.J.</given-names></name>
<name><surname>Edwards</surname><given-names>R.</given-names></name>
</person-group><article-title>Characterization and engineering of the bifunctional N- and O-glucosyltransferase involved in xenobiotic metabolism in plants</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>20238</fpage><lpage>20243</lpage><pub-id pub-id-type="doi">10.1073/pnas.0706421104</pub-id><pub-id pub-id-type="pmid">18077347</pub-id></element-citation></ref><ref id="B69-molecules-28-02761"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Offen</surname><given-names>W.</given-names></name>
<name><surname>Martinez-Fleites</surname><given-names>C.</given-names></name>
<name><surname>Yang</surname><given-names>M.</given-names></name>
<name><surname>Kiat-Lim</surname><given-names>E.</given-names></name>
<name><surname>Davis</surname><given-names>B.G.</given-names></name>
<name><surname>Tarling</surname><given-names>C.A.</given-names></name>
<name><surname>Ford</surname><given-names>C.M.</given-names></name>
<name><surname>Bowles</surname><given-names>D.J.</given-names></name>
<name><surname>Davies</surname><given-names>G.J.</given-names></name>
</person-group><article-title>Structure of a flavonoid glucosyltransferase reveals the basis for plant natural product modification</article-title><source>EMBO J.</source><year>2006</year><volume>25</volume><fpage>1396</fpage><lpage>1405</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600970</pub-id><pub-id pub-id-type="pmid">16482224</pub-id></element-citation></ref><ref id="B70-molecules-28-02761"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>D.M.</given-names></name>
<name><surname>Liu</surname><given-names>J.H.</given-names></name>
<name><surname>Wu</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>B.B.</given-names></name>
<name><surname>Zhu</surname><given-names>H.J.</given-names></name>
<name><surname>Qiao</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Glycosyltransferases: Mechanisms and applications in natural product development</article-title><source>Chem. Soc. Rev.</source><year>2015</year><volume>44</volume><fpage>8350</fpage><lpage>8374</lpage><pub-id pub-id-type="doi">10.1039/C5CS00600G</pub-id><pub-id pub-id-type="pmid">26330279</pub-id></element-citation></ref><ref id="B71-molecules-28-02761"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Breton</surname><given-names>C.</given-names></name>
<name><surname>Fournel-Gigleux</surname><given-names>S.</given-names></name>
<name><surname>Palcic</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Recent structures, evolution and mechanisms of glycosyltransferases</article-title><source>Curr. Opin. Struct. Biol.</source><year>2012</year><volume>22</volume><fpage>540</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2012.06.007</pub-id><pub-id pub-id-type="pmid">22819665</pub-id></element-citation></ref><ref id="B72-molecules-28-02761"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tvaro&#x00161;ka</surname><given-names>I.</given-names></name>
<name><surname>Kozmon</surname><given-names>S.</given-names></name>
<name><surname>Wimmerova</surname><given-names>M.</given-names></name>
<name><surname>Koca</surname><given-names>J.</given-names></name>
</person-group><article-title>Substrate-assisted catalytic mechanism of O-GlcNAc transferase discovered by quantum mechanics/molecular mechanics investigation</article-title><source>J. Am. Chem. Soc.</source><year>2012</year><volume>134</volume><fpage>15563</fpage><lpage>15571</lpage><pub-id pub-id-type="doi">10.1021/ja307040m</pub-id><pub-id pub-id-type="pmid">22928765</pub-id></element-citation></ref><ref id="B73-molecules-28-02761"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tvaro&#x00161;ka</surname><given-names>I.</given-names></name>
<name><surname>Kozmon</surname><given-names>S.</given-names></name>
<name><surname>Wimmerova</surname><given-names>M.</given-names></name>
<name><surname>Koca</surname><given-names>J.</given-names></name>
</person-group><article-title>A QM/MM investigation of the catalytic mechanism of metal-ion-independent core 2 beta1,6-N-acetylglucosaminyltransferase</article-title><source>Chemistry</source><year>2013</year><volume>19</volume><fpage>8153</fpage><lpage>8162</lpage><pub-id pub-id-type="doi">10.1002/chem.201300383</pub-id><?supplied-pmid 23616464?><pub-id pub-id-type="pmid">23616464</pub-id></element-citation></ref><ref id="B74-molecules-28-02761"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>E.</given-names></name>
<name><surname>Song</surname><given-names>M.C.</given-names></name>
<name><surname>Kim</surname><given-names>M.S.</given-names></name>
<name><surname>Beom</surname><given-names>J.Y.</given-names></name>
<name><surname>Jung</surname><given-names>J.A.</given-names></name>
<name><surname>Cho</surname><given-names>H.S.</given-names></name>
<name><surname>Yoon</surname><given-names>Y.J.</given-names></name>
</person-group><article-title>One-Pot combinatorial biosynthesis of glycosylated anthracyclines by cocultivation of <italic toggle="yes">Streptomyces</italic> strains producing aglycones and nucleotide deoxysugars</article-title><source>ACS. Comb. Sci.</source><year>2017</year><volume>19</volume><fpage>262</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1021/acscombsci.6b00194</pub-id><?supplied-pmid 28191923?><pub-id pub-id-type="pmid">28191923</pub-id></element-citation></ref><ref id="B75-molecules-28-02761"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harrus</surname><given-names>D.</given-names></name>
<name><surname>Kellokumpu</surname><given-names>S.</given-names></name>
<name><surname>Glumoff</surname><given-names>T.</given-names></name>
</person-group><article-title>Crystal structures of eukaryote glycosyltransferases reveal biologically relevant enzyme homooligomers</article-title><source>Cell. Mol. Life Sci.</source><year>2018</year><volume>75</volume><fpage>833</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1007/s00018-017-2659-x</pub-id><pub-id pub-id-type="pmid">28932871</pub-id></element-citation></ref><ref id="B76-molecules-28-02761"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Isiorho</surname><given-names>E.A.</given-names></name>
<name><surname>Jeon</surname><given-names>B.S.</given-names></name>
<name><surname>Kim</surname><given-names>N.H.</given-names></name>
<name><surname>Liu</surname><given-names>H.W.</given-names></name>
<name><surname>Keatinge-Clay</surname><given-names>A.T.</given-names></name>
</person-group><article-title>Structural studies of the spinosyn forosaminyltransferase, SpnP</article-title><source>Biochemistry</source><year>2014</year><volume>53</volume><fpage>4292</fpage><lpage>4301</lpage><pub-id pub-id-type="doi">10.1021/bi5003629</pub-id><?supplied-pmid 24945604?><pub-id pub-id-type="pmid">24945604</pub-id></element-citation></ref><ref id="B77-molecules-28-02761"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moncrieffe</surname><given-names>M.C.</given-names></name>
<name><surname>Fernandez</surname><given-names>M.J.</given-names></name>
<name><surname>Spiteller</surname><given-names>D.</given-names></name>
<name><surname>Matsumura</surname><given-names>H.</given-names></name>
<name><surname>Gay</surname><given-names>N.J.</given-names></name>
<name><surname>Luisi</surname><given-names>B.F.</given-names></name>
<name><surname>Leadlay</surname><given-names>P.F.</given-names></name>
</person-group><article-title>Structure of the glycosyltransferase EryCIII in complex with its activating P450 homologue EryCII</article-title><source>J. Mol. Biol.</source><year>2012</year><volume>415</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2011.10.036</pub-id><?supplied-pmid 22056329?><pub-id pub-id-type="pmid">22056329</pub-id></element-citation></ref><ref id="B78-molecules-28-02761"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Isiorho</surname><given-names>E.A.</given-names></name>
<name><surname>Liu</surname><given-names>H.W.</given-names></name>
<name><surname>Keatinge-Clay</surname><given-names>A.T.</given-names></name>
</person-group><article-title>Structural studies of the spinosyn rhamnosyltransferase, SpnG</article-title><source>Biochemistry</source><year>2012</year><volume>51</volume><fpage>1213</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1021/bi201860q</pub-id><?supplied-pmid 22283226?><pub-id pub-id-type="pmid">22283226</pub-id></element-citation></ref><ref id="B79-molecules-28-02761"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jumper</surname><given-names>J.</given-names></name>
<name><surname>Evans</surname><given-names>R.</given-names></name>
<name><surname>Pritzel</surname><given-names>A.</given-names></name>
<name><surname>Green</surname><given-names>T.</given-names></name>
<name><surname>Figurnov</surname><given-names>M.</given-names></name>
<name><surname>Ronneberger</surname><given-names>O.</given-names></name>
<name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></name>
<name><surname>Bates</surname><given-names>R.</given-names></name>
<name><surname>Zidek</surname><given-names>A.</given-names></name>
<name><surname>Potapenko</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="B80-molecules-28-02761"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Otten</surname><given-names>S.L.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Ferguson</surname><given-names>J.</given-names></name>
<name><surname>Hutchinson</surname><given-names>C.R.</given-names></name>
</person-group><article-title>Cloning and characterization of the <italic toggle="yes">Streptomyces peucetius dnrQS</italic> genes encoding a daunosamine biosynthesis enzyme and a glycosyl transferase involved in daunorubicin biosynthesis</article-title><source>J. Bacteriol.</source><year>1995</year><volume>177</volume><fpage>6688</fpage><lpage>6692</lpage><pub-id pub-id-type="doi">10.1128/jb.177.22.6688-6692.1995</pub-id><pub-id pub-id-type="pmid">7592454</pub-id></element-citation></ref><ref id="B81-molecules-28-02761"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leimkuhler</surname><given-names>C.</given-names></name>
<name><surname>Fridman</surname><given-names>M.</given-names></name>
<name><surname>Lupoli</surname><given-names>T.</given-names></name>
<name><surname>Walker</surname><given-names>S.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
<name><surname>Kahne</surname><given-names>D.</given-names></name>
</person-group><article-title>Characterization of rhodosaminyl transfer by the AknS/AknT glycosylation complex and its use in reconstituting the biosynthetic pathway of aclacinomycin A</article-title><source>J. Am. Chem. Soc.</source><year>2007</year><volume>129</volume><fpage>10546</fpage><lpage>10550</lpage><pub-id pub-id-type="doi">10.1021/ja072909o</pub-id><pub-id pub-id-type="pmid">17685523</pub-id></element-citation></ref><ref id="B82-molecules-28-02761"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
<name><surname>Fedoryshyn</surname><given-names>M.</given-names></name>
<name><surname>Durr</surname><given-names>C.</given-names></name>
<name><surname>Taguchi</surname><given-names>T.</given-names></name>
<name><surname>Novikov</surname><given-names>V.</given-names></name>
<name><surname>Bechthold</surname><given-names>A.</given-names></name>
</person-group><article-title>Iteratively acting glycosyltransferases involved in the hexasaccharide biosynthesis of landomycin A</article-title><source>Chem. Biol.</source><year>2005</year><volume>12</volume><fpage>725</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2005.05.008</pub-id><?supplied-pmid 16039521?><pub-id pub-id-type="pmid">16039521</pub-id></element-citation></ref><ref id="B83-molecules-28-02761"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>A.</given-names></name>
<name><surname>Singh</surname><given-names>S.</given-names></name>
<name><surname>Helmich</surname><given-names>K.E.</given-names></name>
<name><surname>Goff</surname><given-names>R.D.</given-names></name>
<name><surname>Bingman</surname><given-names>C.A.</given-names></name>
<name><surname>Thorson</surname><given-names>J.S.</given-names></name>
<name><surname>Phillips</surname><given-names>G.N.</given-names><suffix>Jr.</suffix></name>
</person-group><article-title>Complete set of glycosyltransferase structures in the calicheamicin biosynthetic pathway reveals the origin of regiospecificity</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>17649</fpage><lpage>17654</lpage><pub-id pub-id-type="doi">10.1073/pnas.1108484108</pub-id><?supplied-pmid 21987796?><pub-id pub-id-type="pmid">21987796</pub-id></element-citation></ref><ref id="B84-molecules-28-02761"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Diedrich</surname><given-names>K.</given-names></name>
<name><surname>Graef</surname><given-names>J.</given-names></name>
<name><surname>Schoning-Stierand</surname><given-names>K.</given-names></name>
<name><surname>Rarey</surname><given-names>M.</given-names></name>
</person-group><article-title>GeoMine: Interactive pattern mining of protein-ligand interfaces in the Protein Data Bank</article-title><source>Bioinformatics</source><year>2021</year><volume>37</volume><fpage>424</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btaa693</pub-id><pub-id pub-id-type="pmid">32735322</pub-id></element-citation></ref><ref id="B85-molecules-28-02761"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schoning-Stierand</surname><given-names>K.</given-names></name>
<name><surname>Diedrich</surname><given-names>K.</given-names></name>
<name><surname>Fahrrolfes</surname><given-names>R.</given-names></name>
<name><surname>Flachsenberg</surname><given-names>F.</given-names></name>
<name><surname>Meyder</surname><given-names>A.</given-names></name>
<name><surname>Nittinger</surname><given-names>E.</given-names></name>
<name><surname>Steinegger</surname><given-names>R.</given-names></name>
<name><surname>Rarey</surname><given-names>M.</given-names></name>
</person-group><article-title>ProteinsPlus: Interactive analysis of protein-ligand binding interfaces</article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>W48</fpage><lpage>W53</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa235</pub-id><pub-id pub-id-type="pmid">32297936</pub-id></element-citation></ref><ref id="B86-molecules-28-02761"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>E.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
<name><surname>Yoon</surname><given-names>Y.J.</given-names></name>
</person-group><article-title>Reinvigorating natural product combinatorial biosynthesis with synthetic biology</article-title><source>Nat. Chem. Biol.</source><year>2015</year><volume>11</volume><fpage>649</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1893</pub-id><?supplied-pmid 26284672?><pub-id pub-id-type="pmid">26284672</pub-id></element-citation></ref><ref id="B87-molecules-28-02761"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schm&#x000f6;lzer</surname><given-names>K.</given-names></name>
<name><surname>Lemmerer</surname><given-names>M.</given-names></name>
<name><surname>Nidetzky</surname><given-names>B.</given-names></name>
</person-group><article-title>Glycosyltransferase cascades made fit for chemical production: Integrated biocatalytic process for the natural polyphenol C-glucoside nothofagin</article-title><source>Biotechnol. Bioeng.</source><year>2018</year><volume>115</volume><fpage>545</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1002/bit.26491</pub-id><pub-id pub-id-type="pmid">29131308</pub-id></element-citation></ref><ref id="B88-molecules-28-02761"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schm&#x000f6;lzer</surname><given-names>K.</given-names></name>
<name><surname>Gutmann</surname><given-names>A.</given-names></name>
<name><surname>Diricks</surname><given-names>M.</given-names></name>
<name><surname>Desmet</surname><given-names>T.</given-names></name>
<name><surname>Nidetzky</surname><given-names>B.</given-names></name>
</person-group><article-title>Sucrose synthase: A unique glycosyltransferase for biocatalytic glycosylation process development</article-title><source>Biotechnol. Adv.</source><year>2016</year><volume>34</volume><fpage>88</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2015.11.003</pub-id><pub-id pub-id-type="pmid">26657050</pub-id></element-citation></ref><ref id="B89-molecules-28-02761"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mestrom</surname><given-names>L.</given-names></name>
<name><surname>Marsden</surname><given-names>S.R.</given-names></name>
<name><surname>Dieters</surname><given-names>M.</given-names></name>
<name><surname>Achterberg</surname><given-names>P.</given-names></name>
<name><surname>Stolk</surname><given-names>L.</given-names></name>
<name><surname>Bento</surname><given-names>I.</given-names></name>
<name><surname>Hanefeld</surname><given-names>U.</given-names></name>
<name><surname>Hagedoorn</surname><given-names>P.L.</given-names></name>
</person-group><article-title>Artificial Fusion of mCherry enhances trehalose transferase solubility and stability</article-title><source>Appl. Environ. Microbiol.</source><year>2019</year><volume>85</volume><elocation-id>e03084-18</elocation-id><pub-id pub-id-type="doi">10.1128/AEM.03084-18</pub-id><pub-id pub-id-type="pmid">30737350</pub-id></element-citation></ref><ref id="B90-molecules-28-02761"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>T.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Lu</surname><given-names>X.</given-names></name>
<name><surname>Lan</surname><given-names>W.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Wu</surname><given-names>H.</given-names></name>
<name><surname>Cao</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Highly efficient production of soluble proteins from insoluble inclusion bodies by a two-step-denaturing and refolding method</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e22981</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0022981</pub-id><pub-id pub-id-type="pmid">21829569</pub-id></element-citation></ref><ref id="B91-molecules-28-02761"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shu</surname><given-names>W.</given-names></name>
<name><surname>Zheng</surname><given-names>H.</given-names></name>
<name><surname>Fu</surname><given-names>X.</given-names></name>
<name><surname>Zhen</surname><given-names>J.</given-names></name>
<name><surname>Tan</surname><given-names>M.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Zhao</surname><given-names>X.</given-names></name>
<name><surname>Yang</surname><given-names>S.</given-names></name>
<name><surname>Song</surname><given-names>H.</given-names></name>
<name><surname>Ma</surname><given-names>Y.</given-names></name>
</person-group><article-title>Enhanced heterologous production of glycosyltransferase UGT76G1 by co-expression of endogenous <italic toggle="yes">prpD</italic> and <italic toggle="yes">malK</italic> in <italic toggle="yes">Escherichia coli</italic> and its transglycosylation application in production of rebaudioside</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>5752</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21165752</pub-id><pub-id pub-id-type="pmid">32796599</pub-id></element-citation></ref><ref id="B92-molecules-28-02761"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moremen</surname><given-names>K.W.</given-names></name>
<name><surname>Ramiah</surname><given-names>A.</given-names></name>
<name><surname>Stuart</surname><given-names>M.</given-names></name>
<name><surname>Steel</surname><given-names>J.</given-names></name>
<name><surname>Meng</surname><given-names>L.</given-names></name>
<name><surname>Forouhar</surname><given-names>F.</given-names></name>
<name><surname>Moniz</surname><given-names>H.A.</given-names></name>
<name><surname>Gahlay</surname><given-names>G.</given-names></name>
<name><surname>Gao</surname><given-names>Z.</given-names></name>
<name><surname>Chapla</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Expression system for structural and functional studies of human glycosylation enzymes</article-title><source>Nat. Chem. Biol.</source><year>2018</year><volume>14</volume><fpage>156</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2539</pub-id><?supplied-pmid 29251719?><pub-id pub-id-type="pmid">29251719</pub-id></element-citation></ref><ref id="B93-molecules-28-02761"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yoon</surname><given-names>J.A.</given-names></name>
<name><surname>Kim</surname><given-names>B.G.</given-names></name>
<name><surname>Lee</surname><given-names>W.J.</given-names></name>
<name><surname>Lim</surname><given-names>Y.</given-names></name>
<name><surname>Chong</surname><given-names>Y.</given-names></name>
<name><surname>Ahn</surname><given-names>J.H.</given-names></name>
</person-group><article-title>Production of a novel quercetin glycoside through metabolic engineering of <italic toggle="yes">Escherichia coli</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2012</year><volume>78</volume><fpage>4256</fpage><lpage>4262</lpage><pub-id pub-id-type="doi">10.1128/AEM.00275-12</pub-id><pub-id pub-id-type="pmid">22492444</pub-id></element-citation></ref><ref id="B94-molecules-28-02761"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoffmeister</surname><given-names>D.</given-names></name>
<name><surname>Wilkinson</surname><given-names>B.</given-names></name>
<name><surname>Foster</surname><given-names>G.</given-names></name>
<name><surname>Sidebottom</surname><given-names>P.J.</given-names></name>
<name><surname>Ichinose</surname><given-names>K.</given-names></name>
<name><surname>Bechthold</surname><given-names>A.</given-names></name>
</person-group><article-title>Engineered urdamycin glycosyltransferases are broadened and altered in substrate specificity</article-title><source>Chem. Biol.</source><year>2002</year><volume>9</volume><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(02)00114-X</pub-id><pub-id pub-id-type="pmid">11927254</pub-id></element-citation></ref><ref id="B95-molecules-28-02761"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.L.</given-names></name>
<name><surname>Kim</surname><given-names>A.H.</given-names></name>
<name><surname>Park</surname><given-names>M.B.</given-names></name>
<name><surname>Lee</surname><given-names>S.W.</given-names></name>
<name><surname>Park</surname><given-names>Y.S.</given-names></name>
</person-group><article-title>Altered sugar donor specificity and catalytic activity of pteridine glycosyltransferases by domain swapping or site-directed mutagenesis</article-title><source>BMB Rep.</source><year>2013</year><volume>46</volume><fpage>37</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.5483/BMBRep.2013.46.1.147</pub-id><pub-id pub-id-type="pmid">23351382</pub-id></element-citation></ref><ref id="B96-molecules-28-02761"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>H.S.</given-names></name>
<name><surname>Kim</surname><given-names>B.G.</given-names></name>
<name><surname>Sung</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>M.</given-names></name>
<name><surname>Mok</surname><given-names>H.</given-names></name>
<name><surname>Chong</surname><given-names>Y.</given-names></name>
<name><surname>Ahn</surname><given-names>J.H.</given-names></name>
</person-group><article-title>Engineering flavonoid glycosyltransferases for enhanced catalytic efficiency and extended sugar-donor selectivity</article-title><source>Planta</source><year>2013</year><volume>238</volume><fpage>683</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1007/s00425-013-1922-0</pub-id><?supplied-pmid 23801300?><pub-id pub-id-type="pmid">23801300</pub-id></element-citation></ref><ref id="B97-molecules-28-02761"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>G.J.</given-names></name>
<name><surname>Thorson</surname><given-names>J.S.</given-names></name>
</person-group><article-title>A high-throughput fluorescence-based glycosyltransferase screen and its application in directed evolution</article-title><source>Nat. Protoc.</source><year>2008</year><volume>3</volume><fpage>357</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.538</pub-id><?supplied-pmid 18323806?><pub-id pub-id-type="pmid">18323806</pub-id></element-citation></ref><ref id="B98-molecules-28-02761"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gantt</surname><given-names>R.W.</given-names></name>
<name><surname>Peltier-Pain</surname><given-names>P.</given-names></name>
<name><surname>Singh</surname><given-names>S.</given-names></name>
<name><surname>Zhou</surname><given-names>M.</given-names></name>
<name><surname>Thorson</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Broadening the scope of glycosyltransferase-catalyzed sugar nucleotide synthesis</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2013</year><volume>110</volume><fpage>7648</fpage><lpage>7653</lpage><pub-id pub-id-type="doi">10.1073/pnas.1220220110</pub-id><pub-id pub-id-type="pmid">23610417</pub-id></element-citation></ref><ref id="B99-molecules-28-02761"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>R.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Wilson</surname><given-names>L.M.</given-names></name>
<name><surname>Yan</surname><given-names>Y.</given-names></name>
</person-group><article-title>Protein engineering for improving and diversifying natural product biosynthesis</article-title><source>Trends Biotechnol.</source><year>2020</year><volume>38</volume><fpage>729</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2019.12.008</pub-id><pub-id pub-id-type="pmid">31954530</pub-id></element-citation></ref><ref id="B100-molecules-28-02761"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kamra</surname><given-names>P.</given-names></name>
<name><surname>Gokhale</surname><given-names>R.S.</given-names></name>
<name><surname>Mohanty</surname><given-names>D.</given-names></name>
</person-group><article-title>SEARCHGTr: A program for analysis of glycosyltransferases involved in glycosylation of secondary metabolites</article-title><source>Nucleic Acids Res.</source><year>2005</year><volume>33</volume><fpage>W220</fpage><lpage>W225</lpage><pub-id pub-id-type="doi">10.1093/nar/gki449</pub-id><pub-id pub-id-type="pmid">15980457</pub-id></element-citation></ref><ref id="B101-molecules-28-02761"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Akere</surname><given-names>A.</given-names></name>
<name><surname>Chen</surname><given-names>S.H.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Dantu</surname><given-names>S.C.</given-names></name>
<name><surname>Pandini</surname><given-names>A.</given-names></name>
<name><surname>Bhowmik</surname><given-names>D.</given-names></name>
<name><surname>Haider</surname><given-names>S.</given-names></name>
</person-group><article-title>Structure-based enzyme engineering improves donor-substrate recognition of <italic toggle="yes">Arabidopsis thaliana</italic> glycosyltransferases</article-title><source>Biochem. J.</source><year>2020</year><volume>477</volume><fpage>2791</fpage><lpage>2805</lpage><pub-id pub-id-type="doi">10.1042/BCJ20200477</pub-id><pub-id pub-id-type="pmid">32657326</pub-id></element-citation></ref><ref id="B102-molecules-28-02761"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Joshi</surname><given-names>R.</given-names></name>
<name><surname>Trinkl</surname><given-names>J.</given-names></name>
<name><surname>Haugeneder</surname><given-names>A.</given-names></name>
<name><surname>Hartl</surname><given-names>K.</given-names></name>
<name><surname>Franz-Oberdorf</surname><given-names>K.</given-names></name>
<name><surname>Giri</surname><given-names>A.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.</given-names></name>
<name><surname>Schwab</surname><given-names>W.</given-names></name>
</person-group><article-title>Semirational design and engineering of grapevine glucosyltransferases for enhanced activity and modified product selectivity</article-title><source>Glycobiology</source><year>2019</year><volume>29</volume><fpage>765</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwz056</pub-id><?supplied-pmid 31361022?><pub-id pub-id-type="pmid">31361022</pub-id></element-citation></ref><ref id="B103-molecules-28-02761"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schm&#x000f6;lzer</surname><given-names>K.</given-names></name>
<name><surname>Czabany</surname><given-names>T.</given-names></name>
<name><surname>Luley-Goedl</surname><given-names>C.</given-names></name>
<name><surname>Pavkov-Keller</surname><given-names>T.</given-names></name>
<name><surname>Ribitsch</surname><given-names>D.</given-names></name>
<name><surname>Schwab</surname><given-names>H.</given-names></name>
<name><surname>Gruber</surname><given-names>K.</given-names></name>
<name><surname>Weber</surname><given-names>H.</given-names></name>
<name><surname>Nidetzky</surname><given-names>B.</given-names></name>
</person-group><article-title>Complete switch from alpha-2,3- to alpha-2,6-regioselectivity in <italic toggle="yes">Pasteurella dagmatis</italic> beta-D-galactoside sialyltransferase by active-site redesign</article-title><source>Chem. Commun.</source><year>2015</year><volume>51</volume><fpage>3083</fpage><lpage>3086</lpage><pub-id pub-id-type="doi">10.1039/C4CC09772F</pub-id><?supplied-pmid 25619424?><pub-id pub-id-type="pmid">25619424</pub-id></element-citation></ref><ref id="B104-molecules-28-02761"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pandey</surname><given-names>R.P.</given-names></name>
<name><surname>Bashyal</surname><given-names>P.</given-names></name>
<name><surname>Parajuli</surname><given-names>P.</given-names></name>
<name><surname>Yamaguchi</surname><given-names>T.</given-names></name>
<name><surname>Sohng</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Two Trifunctional leloir glycosyltransferases as biocatalysts for natural products glycodiversification</article-title><source>Org. Lett.</source><year>2019</year><volume>21</volume><fpage>8058</fpage><lpage>8064</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.9b03040</pub-id><pub-id pub-id-type="pmid">31550168</pub-id></element-citation></ref><ref id="B105-molecules-28-02761"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
</person-group><article-title>Structural dissection of sterol glycosyltransferase UGT51 from <italic toggle="yes">Saccharomyces cerevisiae</italic> for substrate specificity</article-title><source>J. Struct. Biol.</source><year>2018</year><volume>204</volume><fpage>371</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2018.11.001</pub-id><?supplied-pmid 30395931?><pub-id pub-id-type="pmid">30395931</pub-id></element-citation></ref><ref id="B106-molecules-28-02761"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ding</surname><given-names>F.</given-names></name>
<name><surname>Liu</surname><given-names>F.</given-names></name>
<name><surname>Shao</surname><given-names>W.</given-names></name>
<name><surname>Chu</surname><given-names>J.</given-names></name>
<name><surname>Wu</surname><given-names>B.</given-names></name>
<name><surname>He</surname><given-names>B.</given-names></name>
</person-group><article-title>Efficient synthesis of crocins from crocetin by a microbial glycosyltransferase from Bacillus subtilis 168</article-title><source>J. Agric. Food Chem.</source><year>2018</year><volume>66</volume><fpage>11701</fpage><lpage>11708</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.8b04274</pub-id><?supplied-pmid 30350978?><pub-id pub-id-type="pmid">30350978</pub-id></element-citation></ref><ref id="B107-molecules-28-02761"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yoshimoto</surname><given-names>A.</given-names></name>
<name><surname>Ogasawara</surname><given-names>T.</given-names></name>
<name><surname>Kitamura</surname><given-names>I.</given-names></name>
<name><surname>Oki</surname><given-names>T.</given-names></name>
<name><surname>Inui</surname><given-names>T.</given-names></name>
<name><surname>Takeuchi</surname><given-names>T.</given-names></name>
<name><surname>Umezawa</surname><given-names>H.</given-names></name>
</person-group><article-title>Enzymatic conversion of aclacinomycin A to Y by a specific oxidoreductase in <italic toggle="yes">Streptomyces</italic></article-title><source>J. Antibiot.</source><year>1979</year><volume>32</volume><fpage>472</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.32.472</pub-id></element-citation></ref><ref id="B108-molecules-28-02761"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sultana</surname><given-names>A.</given-names></name>
<name><surname>Alexeev</surname><given-names>I.</given-names></name>
<name><surname>Kursula</surname><given-names>I.</given-names></name>
<name><surname>Mantsala</surname><given-names>P.</given-names></name>
<name><surname>Niemi</surname><given-names>J.</given-names></name>
<name><surname>Schneider</surname><given-names>G.</given-names></name>
</person-group><article-title>Structure determination by multiwavelength anomalous diffraction of aclacinomycin oxidoreductase: Indications of multidomain pseudomerohedral twinning</article-title><source>Acta Crystallogr. D Biol. Crystallogr.</source><year>2007</year><volume>63</volume><fpage>149</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1107/S0907444906044271</pub-id><pub-id pub-id-type="pmid">17242508</pub-id></element-citation></ref><ref id="B109-molecules-28-02761"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>Q.</given-names></name>
<name><surname>Luo</surname><given-names>M.</given-names></name>
<name><surname>Sun</surname><given-names>A.</given-names></name>
<name><surname>Song</surname><given-names>Y.</given-names></name>
<name><surname>Ma</surname><given-names>J.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
</person-group><article-title>Identification of the grincamycin gene cluster unveils divergent roles for GcnQ in different hosts, tailoring the L-rhodinose moiety</article-title><source>Org. Lett.</source><year>2013</year><volume>15</volume><fpage>3254</fpage><lpage>3257</lpage><pub-id pub-id-type="doi">10.1021/ol401253p</pub-id><pub-id pub-id-type="pmid">23782455</pub-id></element-citation></ref><ref id="B110-molecules-28-02761"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leferink</surname><given-names>N.G.</given-names></name>
<name><surname>Heuts</surname><given-names>D.P.</given-names></name>
<name><surname>Fraaije</surname><given-names>M.W.</given-names></name>
<name><surname>van Berkel</surname><given-names>W.J.</given-names></name>
</person-group><article-title>The growing VAO flavoprotein family</article-title><source>Arch. Biochem. Biophys.</source><year>2008</year><volume>474</volume><fpage>292</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2008.01.027</pub-id><pub-id pub-id-type="pmid">18280246</pub-id></element-citation></ref><ref id="B111-molecules-28-02761"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heuts</surname><given-names>D.P.</given-names></name>
<name><surname>Scrutton</surname><given-names>N.S.</given-names></name>
<name><surname>McIntire</surname><given-names>W.S.</given-names></name>
<name><surname>Fraaije</surname><given-names>M.W.</given-names></name>
</person-group><article-title>What&#x02019;s in a covalent bond? On the role and formation of covalently bound flavin cofactors</article-title><source>FEBS J.</source><year>2009</year><volume>276</volume><fpage>3405</fpage><lpage>3427</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07053.x</pub-id><pub-id pub-id-type="pmid">19438712</pub-id></element-citation></ref><ref id="B112-molecules-28-02761"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Winkler</surname><given-names>A.</given-names></name>
<name><surname>Kutchan</surname><given-names>T.M.</given-names></name>
<name><surname>Macheroux</surname><given-names>P.</given-names></name>
</person-group><article-title>6-S-cysteinylation of bi-covalently attached FAD in berberine bridge enzyme tunes the redox potential for optimal activity</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>24437</fpage><lpage>24443</lpage><pub-id pub-id-type="doi">10.1074/jbc.M703642200</pub-id><?supplied-pmid 17573342?><pub-id pub-id-type="pmid">17573342</pub-id></element-citation></ref><ref id="B113-molecules-28-02761"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Winkler</surname><given-names>A.</given-names></name>
<name><surname>Motz</surname><given-names>K.</given-names></name>
<name><surname>Riedl</surname><given-names>S.</given-names></name>
<name><surname>Puhl</surname><given-names>M.</given-names></name>
<name><surname>Macheroux</surname><given-names>P.</given-names></name>
<name><surname>Gruber</surname><given-names>K.</given-names></name>
</person-group><article-title>Structural and mechanistic studies reveal the functional role of bicovalent flavinylation in berberine bridge enzyme</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>19993</fpage><lpage>20001</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.015727</pub-id><?supplied-pmid 19457868?><pub-id pub-id-type="pmid">19457868</pub-id></element-citation></ref><ref id="B114-molecules-28-02761"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y.S.</given-names></name>
<name><surname>Ho</surname><given-names>J.Y.</given-names></name>
<name><surname>Huang</surname><given-names>C.C.</given-names></name>
<name><surname>Lyu</surname><given-names>S.Y.</given-names></name>
<name><surname>Lee</surname><given-names>C.Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.T.</given-names></name>
<name><surname>Wu</surname><given-names>C.J.</given-names></name>
<name><surname>Chan</surname><given-names>H.C.</given-names></name>
<name><surname>Huang</surname><given-names>C.J.</given-names></name>
<name><surname>Hsu</surname><given-names>N.S.</given-names></name>
<etal/>
</person-group><article-title>A unique flavin mononucleotide-linked primary alcohol oxidase for glycopeptide A40926 maturation</article-title><source>J. Am. Chem. Soc.</source><year>2007</year><volume>129</volume><fpage>13384</fpage><lpage>13385</lpage><pub-id pub-id-type="doi">10.1021/ja075748x</pub-id><pub-id pub-id-type="pmid">17935335</pub-id></element-citation></ref><ref id="B115-molecules-28-02761"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mo</surname><given-names>X.</given-names></name>
<name><surname>Huang</surname><given-names>H.</given-names></name>
<name><surname>Ma</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
</person-group><article-title>Characterization of TrdL as a 10-hydroxy dehydrogenase and generation of new analogues from a tirandamycin biosynthetic pathway</article-title><source>Org. Lett.</source><year>2011</year><volume>13</volume><fpage>2212</fpage><lpage>2215</lpage><pub-id pub-id-type="doi">10.1021/ol200447h</pub-id><?supplied-pmid 21456513?><pub-id pub-id-type="pmid">21456513</pub-id></element-citation></ref><ref id="B116-molecules-28-02761"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y.C.</given-names></name>
<name><surname>Li</surname><given-names>Y.S.</given-names></name>
<name><surname>Lyu</surname><given-names>S.Y.</given-names></name>
<name><surname>Hsu</surname><given-names>L.J.</given-names></name>
<name><surname>Chen</surname><given-names>Y.H.</given-names></name>
<name><surname>Huang</surname><given-names>Y.T.</given-names></name>
<name><surname>Chan</surname><given-names>H.C.</given-names></name>
<name><surname>Huang</surname><given-names>C.J.</given-names></name>
<name><surname>Chen</surname><given-names>G.H.</given-names></name>
<name><surname>Chou</surname><given-names>C.C.</given-names></name>
<etal/>
</person-group><article-title>Interception of teicoplanin oxidation intermediates yields new antimicrobial scaffolds</article-title><source>Nat. Chem. Biol.</source><year>2011</year><volume>7</volume><fpage>304</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1038/nchembio.556</pub-id><?supplied-pmid 21478878?><pub-id pub-id-type="pmid">21478878</pub-id></element-citation></ref><ref id="B117-molecules-28-02761"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berks</surname><given-names>B.C.</given-names></name>
<name><surname>Sargent</surname><given-names>F.</given-names></name>
<name><surname>Palmer</surname><given-names>T.</given-names></name>
</person-group><article-title>The Tat protein export pathway</article-title><source>Mol. Microbiol.</source><year>2000</year><volume>35</volume><fpage>260</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.01719.x</pub-id><?supplied-pmid 10652088?><pub-id pub-id-type="pmid">10652088</pub-id></element-citation></ref><ref id="B118-molecules-28-02761"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valverde</surname><given-names>J.R.</given-names></name>
<name><surname>Gullon</surname><given-names>S.</given-names></name>
<name><surname>Mellado</surname><given-names>R.P.</given-names></name>
</person-group><article-title>Modelling the metabolism of protein secretion through the Tat route in <italic toggle="yes">Streptomyces lividans</italic></article-title><source>BMC Microbiol.</source><year>2018</year><volume>18</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.1186/s12866-018-1199-3</pub-id><pub-id pub-id-type="pmid">29898665</pub-id></element-citation></ref><ref id="B119-molecules-28-02761"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>G.</given-names></name>
<name><surname>Chater</surname><given-names>K.F.</given-names></name>
<name><surname>Chandra</surname><given-names>G.</given-names></name>
<name><surname>Niu</surname><given-names>G.</given-names></name>
<name><surname>Tan</surname><given-names>H.</given-names></name>
</person-group><article-title>Molecular regulation of antibiotic biosynthesis in <italic toggle="yes">streptomyces</italic></article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2013</year><volume>77</volume><fpage>112</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00054-12</pub-id><pub-id pub-id-type="pmid">23471619</pub-id></element-citation></ref><ref id="B120-molecules-28-02761"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wei</surname><given-names>J.</given-names></name>
<name><surname>He</surname><given-names>L.</given-names></name>
<name><surname>Niu</surname><given-names>G.</given-names></name>
</person-group><article-title>Regulation of antibiotic biosynthesis in actinomycetes: Perspectives and challenges</article-title><source>Synth. Syst. Biotechnol.</source><year>2018</year><volume>3</volume><fpage>229</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.synbio.2018.10.005</pub-id><pub-id pub-id-type="pmid">30417136</pub-id></element-citation></ref><ref id="B121-molecules-28-02761"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krause</surname><given-names>J.</given-names></name>
<name><surname>Handayani</surname><given-names>I.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Kulik</surname><given-names>A.</given-names></name>
<name><surname>Mast</surname><given-names>Y.</given-names></name>
</person-group><article-title>Disclosing the potential of the SARP-type regulator papr2 for the activation of antibiotic gene clusters in <italic toggle="yes">Streptomycetes</italic></article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><fpage>225</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.00225</pub-id><pub-id pub-id-type="pmid">32132989</pub-id></element-citation></ref><ref id="B122-molecules-28-02761"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sheldon</surname><given-names>P.J.</given-names></name>
<name><surname>Busarow</surname><given-names>S.B.</given-names></name>
<name><surname>Hutchinson</surname><given-names>C.R.</given-names></name>
</person-group><article-title>Mapping the DNA-binding domain and target sequences of the <italic toggle="yes">Streptomyces peucetius</italic> daunorubicin biosynthesis regulatory protein, DnrI</article-title><source>Mol. Microbiol.</source><year>2002</year><volume>44</volume><fpage>449</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.02886.x</pub-id><?supplied-pmid 11972782?><pub-id pub-id-type="pmid">11972782</pub-id></element-citation></ref><ref id="B123-molecules-28-02761"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Ke</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>N.</given-names></name>
<name><surname>Tan</surname><given-names>G.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>R.</given-names></name>
<name><surname>Bai</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>TetR-Type regulator SLCG_2919 is a negative regulator of lincomycin biosynthesis in <italic toggle="yes">Streptomyces lincolnensis</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2019</year><volume>85</volume><elocation-id>e02091-18</elocation-id><pub-id pub-id-type="doi">10.1128/AEM.02091-18</pub-id><?supplied-pmid 30341075?><pub-id pub-id-type="pmid">30341075</pub-id></element-citation></ref><ref id="B124-molecules-28-02761"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brotherton</surname><given-names>C.A.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Greenberg</surname><given-names>E.P.</given-names></name>
</person-group><article-title>LuxR homolog-linked biosynthetic gene clusters in proteobacteria</article-title><source>mSystems</source><year>2018</year><volume>3</volume><elocation-id>e00208-17</elocation-id><pub-id pub-id-type="doi">10.1128/mSystems.00208-17</pub-id><?supplied-pmid 29600287?><pub-id pub-id-type="pmid">29600287</pub-id></element-citation></ref><ref id="B125-molecules-28-02761"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>R.</given-names></name>
<name><surname>Stock</surname><given-names>A.M.</given-names></name>
</person-group><article-title>Biological insights from structures of two-component proteins</article-title><source>Annu. Rev. Microbiol.</source><year>2009</year><volume>63</volume><fpage>133</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.091208.073214</pub-id><?supplied-pmid 19575571?><pub-id pub-id-type="pmid">19575571</pub-id></element-citation></ref><ref id="B126-molecules-28-02761"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>S&#x000e1;nchez de la Nieta</surname><given-names>R.</given-names></name>
<name><surname>Santamar&#x000ed;a</surname><given-names>R.I.</given-names></name>
<name><surname>D&#x000ed;az</surname><given-names>M.</given-names></name>
</person-group><article-title>Two-Component Systems of <italic toggle="yes">Streptomyces coelicolor</italic>: An intricate network to be unraveled</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>15085</elocation-id><pub-id pub-id-type="doi">10.3390/ijms232315085</pub-id><pub-id pub-id-type="pmid">36499414</pub-id></element-citation></ref><ref id="B127-molecules-28-02761"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>W.-S.</given-names></name>
<name><surname>Youn</surname><given-names>D.J.</given-names></name>
<name><surname>Cho</surname><given-names>W.</given-names></name>
<name><surname>Kim</surname><given-names>M.-K.</given-names></name>
<name><surname>Kim</surname><given-names>H.R.</given-names></name>
<name><surname>Rhee</surname><given-names>S.K.</given-names></name>
<name><surname>Choi</surname><given-names>E.-S.</given-names></name>
</person-group><article-title>Improved production, and purification of aclacinomycin A from <italic toggle="yes">Streptomyces lavendofoliae</italic> DKRS</article-title><source>J. Microbiol. Biotechnol.</source><year>1995</year><volume>5</volume><fpage>297</fpage><lpage>301</lpage></element-citation></ref><ref id="B128-molecules-28-02761"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>W.S.</given-names></name>
<name><surname>Youn</surname><given-names>D.J.</given-names></name>
<name><surname>Kim</surname><given-names>H.R.</given-names></name>
<name><surname>Rhee</surname><given-names>S.K.</given-names></name>
<name><surname>Choi</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Metabolic conversion of aclacinomycins B and Y to A by pH shift during fermentation with <italic toggle="yes">Streptomyces lavendofoliae</italic> DKRS</article-title><source>Biotechnol. Tech.</source><year>1995</year><volume>9</volume><fpage>671</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1007/BF00156354</pub-id></element-citation></ref><ref id="B129-molecules-28-02761"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ylihonko</surname><given-names>K.</given-names></name>
<name><surname>Hakala</surname><given-names>J.</given-names></name>
<name><surname>Niemi</surname><given-names>J.</given-names></name>
<name><surname>Lundell</surname><given-names>J.</given-names></name>
<name><surname>Mantsala</surname><given-names>P.</given-names></name>
</person-group><article-title>Isolation and characterization of aclacinomycin A-non-producing <italic toggle="yes">Streptomyces galilaeus</italic> (ATCC 31615) mutants</article-title><source>Microbiology</source><year>1994</year><volume>140</volume><fpage>1359</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1099/00221287-140-6-1359</pub-id><pub-id pub-id-type="pmid">8081501</pub-id></element-citation></ref><ref id="B130-molecules-28-02761"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>T.S.</given-names></name>
<name><surname>Khosla</surname><given-names>C.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Engineered biosynthesis of aklanonic acid analogues</article-title><source>J. Am. Chem. Soc.</source><year>2005</year><volume>127</volume><fpage>12254</fpage><lpage>12262</lpage><pub-id pub-id-type="doi">10.1021/ja051429z</pub-id><pub-id pub-id-type="pmid">16131203</pub-id></element-citation></ref><ref id="B131-molecules-28-02761"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>R.</given-names></name>
<name><surname>Nguyen</surname><given-names>J.</given-names></name>
<name><surname>Hecht</surname><given-names>J.</given-names></name>
<name><surname>Schwartz</surname><given-names>N.</given-names></name>
<name><surname>Brown</surname><given-names>K.V.</given-names></name>
<name><surname>Ponomareva</surname><given-names>L.V.</given-names></name>
<name><surname>Niemczura</surname><given-names>M.</given-names></name>
<name><surname>van Dissel</surname><given-names>D.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
<name><surname>Thorson</surname><given-names>J.S.</given-names></name>
<etal/>
</person-group><article-title>A biobricks metabolic engineering platform for the biosynthesis of anthracyclinones in <italic toggle="yes">Streptomyces coelicolor</italic></article-title><source>ACS Synth. Biol.</source><year>2022</year><volume>11</volume><fpage>4193</fpage><lpage>4209</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.2c00498</pub-id><pub-id pub-id-type="pmid">36378506</pub-id></element-citation></ref><ref id="B132-molecules-28-02761"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Belknap</surname><given-names>K.C.</given-names></name>
<name><surname>Park</surname><given-names>C.J.</given-names></name>
<name><surname>Barth</surname><given-names>B.M.</given-names></name>
<name><surname>Andam</surname><given-names>C.P.</given-names></name>
</person-group><article-title>Genome mining of biosynthetic and chemotherapeutic gene clusters in <italic toggle="yes">Streptomyces</italic> bacteria</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>2003</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-58904-9</pub-id><?supplied-pmid 32029878?><pub-id pub-id-type="pmid">32029878</pub-id></element-citation></ref><ref id="B133-molecules-28-02761"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bundale</surname><given-names>S.</given-names></name>
<name><surname>Begde</surname><given-names>D.</given-names></name>
<name><surname>Pillai</surname><given-names>D.</given-names></name>
<name><surname>Gangwani</surname><given-names>K.</given-names></name>
<name><surname>Nashikkar</surname><given-names>N.</given-names></name>
<name><surname>Kadam</surname><given-names>T.</given-names></name>
<name><surname>Upadhyay</surname><given-names>A.</given-names></name>
</person-group><article-title>Novel aromatic polyketides from soil <italic toggle="yes">Streptomyces</italic> spp.: Purification, characterization and bioactivity studies</article-title><source>World J. Microbiol. Biotechnol.</source><year>2018</year><volume>34</volume><fpage>67</fpage><pub-id pub-id-type="doi">10.1007/s11274-018-2448-1</pub-id><?supplied-pmid 29691661?><pub-id pub-id-type="pmid">29691661</pub-id></element-citation></ref><ref id="B134-molecules-28-02761"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xia</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Zhan</surname><given-names>X.</given-names></name>
<name><surname>Mao</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
</person-group><article-title>The application of regulatory cascades in Streptomyces: Yield enhancement and metabolite mining</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><fpage>406</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.00406</pub-id><?supplied-pmid 32265866?><pub-id pub-id-type="pmid">32265866</pub-id></element-citation></ref><ref id="B135-molecules-28-02761"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khokhlov</surname><given-names>A.S.</given-names></name>
<name><surname>Tovarova</surname><given-names>I.I.</given-names></name>
<name><surname>Borisova</surname><given-names>L.N.</given-names></name>
<name><surname>Pliner</surname><given-names>S.A.</given-names></name>
<name><surname>Shevchenko</surname><given-names>L.</given-names></name>
<name><surname>Kornitskaia</surname><given-names>E.I.</given-names></name>
<name><surname>Ivkina</surname><given-names>N.S.</given-names></name>
<name><surname>Rapoport</surname><given-names>I.A.</given-names></name>
</person-group><article-title>The A-factor, responsible for streptomycin biosynthesis by mutant strains of Actinomyces streptomycini</article-title><source>Dok. Akad. Nauk SSSR</source><year>1967</year><volume>177</volume><fpage>232</fpage><lpage>325</lpage></element-citation></ref><ref id="B136-molecules-28-02761"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Horinouchi</surname><given-names>S.</given-names></name>
<name><surname>Beppu</surname><given-names>T.</given-names></name>
</person-group><article-title>Hormonal control by A-factor of morphological development and secondary metabolism in <italic toggle="yes">Streptomyces</italic></article-title><source>Proc. Jpn. Acad. Ser. B Phys. Biol. Sci.</source><year>2007</year><volume>83</volume><fpage>277</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.2183/pjab.83.277</pub-id></element-citation></ref><ref id="B137-molecules-28-02761"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>G.Y.</given-names></name>
<name><surname>Bai</surname><given-names>L.</given-names></name>
<name><surname>Zhong</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Exogenous 1,4-butyrolactone stimulates A-factor-like cascade and validamycin biosynthesis in <italic toggle="yes">Streptomyces hygroscopicus</italic> 5008</article-title><source>Biotechnol. Bioeng.</source><year>2013</year><volume>110</volume><fpage>2984</fpage><lpage>2993</lpage><pub-id pub-id-type="doi">10.1002/bit.24965</pub-id><pub-id pub-id-type="pmid">23703669</pub-id></element-citation></ref><ref id="B138-molecules-28-02761"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Misaki</surname><given-names>Y.</given-names></name>
<name><surname>Yamamoto</surname><given-names>S.</given-names></name>
<name><surname>Suzuki</surname><given-names>T.</given-names></name>
<name><surname>Iwakuni</surname><given-names>M.</given-names></name>
<name><surname>Sasaki</surname><given-names>H.</given-names></name>
<name><surname>Takahashi</surname><given-names>Y.</given-names></name>
<name><surname>Inada</surname><given-names>K.</given-names></name>
<name><surname>Kinashi</surname><given-names>H.</given-names></name>
<name><surname>Arakawa</surname><given-names>K.</given-names></name>
</person-group><article-title>SrrB, a pseudo-receptor protein, acts as a negative regulator for lankacidin and lankamycin production in <italic toggle="yes">Streptomyces rochei</italic></article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><fpage>1089</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.01089</pub-id><pub-id pub-id-type="pmid">32582072</pub-id></element-citation></ref><ref id="B139-molecules-28-02761"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Wen</surname><given-names>J.</given-names></name>
</person-group><article-title>Manipulating the expression of SARP family regulator BulZ and its target gene product to increase tacrolimus production</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2018</year><volume>102</volume><fpage>4887</fpage><lpage>4900</lpage><pub-id pub-id-type="doi">10.1007/s00253-018-8979-4</pub-id><pub-id pub-id-type="pmid">29666890</pub-id></element-citation></ref><ref id="B140-molecules-28-02761"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pokhrel</surname><given-names>A.R.</given-names></name>
<name><surname>Chaudhary</surname><given-names>A.K.</given-names></name>
<name><surname>Nguyen</surname><given-names>H.T.</given-names></name>
<name><surname>Dhakal</surname><given-names>D.</given-names></name>
<name><surname>Le</surname><given-names>T.T.</given-names></name>
<name><surname>Shrestha</surname><given-names>A.</given-names></name>
<name><surname>Liou</surname><given-names>K.</given-names></name>
<name><surname>Sohng</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Overexpression of a pathway specific negative regulator enhances production of daunorubicin in <italic toggle="yes">bldA</italic> deficient <italic toggle="yes">Streptomyces peucetius</italic> ATCC 27952</article-title><source>Microbiol. Res.</source><year>2016</year><volume>192</volume><fpage>96</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2016.06.009</pub-id><pub-id pub-id-type="pmid">27664727</pub-id></element-citation></ref><ref id="B141-molecules-28-02761"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malla</surname><given-names>S.</given-names></name>
<name><surname>Niraula</surname><given-names>N.P.</given-names></name>
<name><surname>Liou</surname><given-names>K.</given-names></name>
<name><surname>Sohng</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Improvement in doxorubicin productivity by overexpression of regulatory genes in <italic toggle="yes">Streptomyces peucetius</italic></article-title><source>Res. Microbiol.</source><year>2010</year><volume>161</volume><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.resmic.2009.12.003</pub-id><pub-id pub-id-type="pmid">20045726</pub-id></element-citation></ref><ref id="B142-molecules-28-02761"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nah</surname><given-names>H.J.</given-names></name>
<name><surname>Park</surname><given-names>J.</given-names></name>
<name><surname>Choi</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>E.S.</given-names></name>
</person-group><article-title>WblA, a global regulator of antibiotic biosynthesis in <italic toggle="yes">Streptomyces</italic></article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2021</year><volume>48</volume><fpage>kuab007</fpage><pub-id pub-id-type="doi">10.1093/jimb/kuab007</pub-id><?supplied-pmid 33928363?><pub-id pub-id-type="pmid">33928363</pub-id></element-citation></ref><ref id="B143-molecules-28-02761"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Merrick</surname><given-names>M.J.</given-names></name>
</person-group><article-title>A morphological and genetic mapping study of bald colony mutants of <italic toggle="yes">Streptomyces coelicolor</italic></article-title><source>J. Gen. Microbiol.</source><year>1976</year><volume>96</volume><fpage>299</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1099/00221287-96-2-299</pub-id><pub-id pub-id-type="pmid">186556</pub-id></element-citation></ref><ref id="B144-molecules-28-02761"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Noh</surname><given-names>J.H.</given-names></name>
<name><surname>Kim</surname><given-names>S.H.</given-names></name>
<name><surname>Lee</surname><given-names>H.N.</given-names></name>
<name><surname>Lee</surname><given-names>S.Y.</given-names></name>
<name><surname>Kim</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Isolation and genetic manipulation of the antibiotic down-regulatory gene, <italic toggle="yes">wblA</italic> ortholog for doxorubicin-producing <italic toggle="yes">Streptomyces</italic> strain improvement</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2010</year><volume>86</volume><fpage>1145</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1007/s00253-009-2391-z</pub-id><?supplied-pmid 20020285?><pub-id pub-id-type="pmid">20020285</pub-id></element-citation></ref><ref id="B145-molecules-28-02761"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zschiedrich</surname><given-names>C.P.</given-names></name>
<name><surname>Keidel</surname><given-names>V.</given-names></name>
<name><surname>Szurmant</surname><given-names>H.</given-names></name>
</person-group><article-title>Molecular mechanisms of two-component signal transduction</article-title><source>J. Mol. Biol.</source><year>2016</year><volume>428</volume><fpage>3752</fpage><lpage>3775</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2016.08.003</pub-id><?supplied-pmid 27519796?><pub-id pub-id-type="pmid">27519796</pub-id></element-citation></ref><ref id="B146-molecules-28-02761"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Recio</surname><given-names>E.</given-names></name>
<name><surname>Colinas</surname><given-names>A.</given-names></name>
<name><surname>Rumbero</surname><given-names>A.</given-names></name>
<name><surname>Aparicio</surname><given-names>J.F.</given-names></name>
<name><surname>Martin</surname><given-names>J.F.</given-names></name>
</person-group><article-title>PI factor, a novel type quorum-sensing inducer elicits pimaricin production in <italic toggle="yes">Streptomyces natalensis</italic></article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>41586</fpage><lpage>41593</lpage><pub-id pub-id-type="doi">10.1074/jbc.M402340200</pub-id><?supplied-pmid 15231842?><pub-id pub-id-type="pmid">15231842</pub-id></element-citation></ref><ref id="B147-molecules-28-02761"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kitani</surname><given-names>S.</given-names></name>
<name><surname>Miyamoto</surname><given-names>K.T.</given-names></name>
<name><surname>Takamatsu</surname><given-names>S.</given-names></name>
<name><surname>Herawati</surname><given-names>E.</given-names></name>
<name><surname>Iguchi</surname><given-names>H.</given-names></name>
<name><surname>Nishitomi</surname><given-names>K.</given-names></name>
<name><surname>Uchida</surname><given-names>M.</given-names></name>
<name><surname>Nagamitsu</surname><given-names>T.</given-names></name>
<name><surname>Omura</surname><given-names>S.</given-names></name>
<name><surname>Ikeda</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Avenolide, a <italic toggle="yes">Streptomyces</italic> hormone controlling antibiotic production in <italic toggle="yes">Streptomyces avermitilis</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>16410</fpage><lpage>16415</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113908108</pub-id><pub-id pub-id-type="pmid">21930904</pub-id></element-citation></ref><ref id="B148-molecules-28-02761"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matselyukh</surname><given-names>B.</given-names></name>
<name><surname>Mohammadipanah</surname><given-names>F.</given-names></name>
<name><surname>Laatsch</surname><given-names>H.</given-names></name>
<name><surname>Rohr</surname><given-names>J.</given-names></name>
<name><surname>Efremenkova</surname><given-names>O.</given-names></name>
<name><surname>Khilya</surname><given-names>V.</given-names></name>
</person-group><article-title>N-methylphenylalanyl-dehydrobutyrine diketopiperazine, an A-factor mimic that restores antibiotic biosynthesis and morphogenesis in <italic toggle="yes">Streptomyces globisporus</italic> 1912-B2 and <italic toggle="yes">Streptomyces griseus</italic> 1439</article-title><source>J. Antibiot.</source><year>2015</year><volume>68</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/ja.2014.86</pub-id></element-citation></ref><ref id="B149-molecules-28-02761"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takano</surname><given-names>E.</given-names></name>
</person-group><article-title>Gamma-butyrolactones: <italic toggle="yes">Streptomyces</italic> signalling molecules regulating antibiotic production and differentiation</article-title><source>Curr. Opin. Microbiol.</source><year>2006</year><volume>9</volume><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2006.04.003</pub-id><pub-id pub-id-type="pmid">16675291</pub-id></element-citation></ref><ref id="B150-molecules-28-02761"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tian</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>G.</given-names></name>
<name><surname>Gu</surname><given-names>Y.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Lu</surname><given-names>Y.</given-names></name>
<name><surname>Jiang</surname><given-names>W.</given-names></name>
</person-group><article-title>Developing an endogenous quorum-sensing based CRISPRi circuit for autonomous and tunable dynamic regulation of multiple targets in <italic toggle="yes">Streptomyces</italic></article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>8188</fpage><lpage>8202</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa602</pub-id><pub-id pub-id-type="pmid">32672817</pub-id></element-citation></ref><ref id="B151-molecules-28-02761"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Sun</surname><given-names>H.</given-names></name>
<name><surname>Zheng</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Tan</surname><given-names>H.</given-names></name>
</person-group><article-title>A visualization reporter system for characterizing antibiotic biosynthetic gene clusters expression with high-sensitivity</article-title><source>Commun. Biol.</source><year>2022</year><volume>5</volume><fpage>901</fpage><pub-id pub-id-type="doi">10.1038/s42003-022-03832-9</pub-id><pub-id pub-id-type="pmid">36056143</pub-id></element-citation></ref><ref id="B152-molecules-28-02761"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adhikari</surname><given-names>S.</given-names></name>
<name><surname>Curtis</surname><given-names>P.D.</given-names></name>
</person-group><article-title>DNA methyltransferases and epigenetic regulation in bacteria</article-title><source>FEMS Microbiol. Rev.</source><year>2016</year><volume>40</volume><fpage>575</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuw023</pub-id><?supplied-pmid 27476077?><pub-id pub-id-type="pmid">27476077</pub-id></element-citation></ref><ref id="B153-molecules-28-02761"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghosh</surname><given-names>D.</given-names></name>
<name><surname>Veeraraghavan</surname><given-names>B.</given-names></name>
<name><surname>Elangovan</surname><given-names>R.</given-names></name>
<name><surname>Vivekanandan</surname><given-names>P.</given-names></name>
</person-group><article-title>Antibiotic resistance and epigenetics: More to it than meets the eye</article-title><source>Antimicrob. Agents Chemother.</source><year>2020</year><volume>64</volume><elocation-id>e02225-19</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.02225-19</pub-id><?supplied-pmid 31740560?><pub-id pub-id-type="pmid">31740560</pub-id></element-citation></ref><ref id="B154-molecules-28-02761"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Na</surname><given-names>D.</given-names></name>
<name><surname>Yoo</surname><given-names>S.M.</given-names></name>
<name><surname>Chung</surname><given-names>H.</given-names></name>
<name><surname>Park</surname><given-names>H.</given-names></name>
<name><surname>Park</surname><given-names>J.H.</given-names></name>
<name><surname>Lee</surname><given-names>S.Y.</given-names></name>
</person-group><article-title>Metabolic engineering of <italic toggle="yes">Escherichia coli</italic> using synthetic small regulatory RNAs</article-title><source>Nat. Biotechnol.</source><year>2013</year><volume>31</volume><fpage>170</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1038/nbt.2461</pub-id><pub-id pub-id-type="pmid">23334451</pub-id></element-citation></ref><ref id="B155-molecules-28-02761"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chaudhary</surname><given-names>A.K.</given-names></name>
<name><surname>Pokhrel</surname><given-names>A.R.</given-names></name>
<name><surname>Hue</surname><given-names>N.T.</given-names></name>
<name><surname>Yoo</surname><given-names>J.C.</given-names></name>
<name><surname>Sohng</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Paired-termini antisense RNA mediated inhibition of DoxR in <italic toggle="yes">Streptomyces peucetius</italic> ATCC 27952</article-title><source>Biotechnol. Bioprocess Eng.</source><year>2015</year><volume>20</volume><fpage>381</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1007/s12257-014-0810-1</pub-id></element-citation></ref><ref id="B156-molecules-28-02761"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Galm</surname><given-names>U.</given-names></name>
<name><surname>Hager</surname><given-names>M.H.</given-names></name>
<name><surname>Van Lanen</surname><given-names>S.G.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
<name><surname>Thorson</surname><given-names>J.S.</given-names></name>
<name><surname>Shen</surname><given-names>B.</given-names></name>
</person-group><article-title>Antitumor antibiotics: Bleomycin, enediynes, and mitomycin</article-title><source>Chem. Rev.</source><year>2005</year><volume>105</volume><fpage>739</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1021/cr030117g</pub-id><?supplied-pmid 15700963?><pub-id pub-id-type="pmid">15700963</pub-id></element-citation></ref><ref id="B157-molecules-28-02761"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malla</surname><given-names>S.</given-names></name>
<name><surname>Niraula</surname><given-names>N.P.</given-names></name>
<name><surname>Liou</surname><given-names>K.</given-names></name>
<name><surname>Sohng</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Self-resistance mechanism in <italic toggle="yes">Streptomyces peucetius</italic>: Overexpression of <italic toggle="yes">drrA</italic>, <italic toggle="yes">drrB</italic> and <italic toggle="yes">drrC</italic> for doxorubicin enhancement</article-title><source>Microbiol. Res.</source><year>2010</year><volume>165</volume><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2009.04.002</pub-id><pub-id pub-id-type="pmid">19651502</pub-id></element-citation></ref><ref id="B158-molecules-28-02761"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yin</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Shi</surname><given-names>M.</given-names></name>
<name><surname>Yuan</surname><given-names>F.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Jia</surname><given-names>X.</given-names></name>
<name><surname>Yuan</surname><given-names>F.</given-names></name>
<name><surname>Sun</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>T.</given-names></name>
<name><surname>Yang</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Improvement of oxytetracycline production mediated via cooperation of resistance genes in <italic toggle="yes">Streptomyces rimosus</italic></article-title><source>Sci. China Life Sci.</source><year>2017</year><volume>60</volume><fpage>992</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1007/s11427-017-9121-4</pub-id><pub-id pub-id-type="pmid">28755296</pub-id></element-citation></ref><ref id="B159-molecules-28-02761"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>L.</given-names></name>
<name><surname>Yan</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Chu</surname><given-names>J.</given-names></name>
<name><surname>Zhuang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Guo</surname><given-names>M.</given-names></name>
</person-group><article-title>Molecular cloning and functional characterization of an ATP-binding cassette transporter OtrC from <italic toggle="yes">Streptomyces rimosus</italic></article-title><source>BMC Biotechnol.</source><year>2012</year><volume>12</volume><elocation-id>52</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6750-12-52</pub-id><pub-id pub-id-type="pmid">22906146</pub-id></element-citation></ref><ref id="B160-molecules-28-02761"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yao</surname><given-names>H.</given-names></name>
<name><surname>Shen</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Deng</surname><given-names>F.</given-names></name>
<name><surname>Liu</surname><given-names>D.</given-names></name>
<name><surname>Naren</surname><given-names>G.</given-names></name>
<name><surname>Dai</surname><given-names>L.</given-names></name>
<name><surname>Su</surname><given-names>C.C.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Emergence of a potent multidrug efflux pump variant that enhances campylobacter resistance to multiple antibiotics</article-title><source>mBio</source><year>2016</year><volume>7</volume><elocation-id>e01543-16</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01543-16</pub-id><pub-id pub-id-type="pmid">27651364</pub-id></element-citation></ref><ref id="B161-molecules-28-02761"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nag</surname><given-names>A.</given-names></name>
<name><surname>Mehra</surname><given-names>S.</given-names></name>
</person-group><article-title>A major facilitator superfamily (MFS) efflux pump, SCO4121, from <italic toggle="yes">Streptomyces coelicolor</italic> with roles in multidrug resistance and oxidative stress tolerance and its regulation by a MarR regulator</article-title><source>Appl. Environ. Microbiol.</source><year>2021</year><volume>87</volume><elocation-id>e02238-20</elocation-id><pub-id pub-id-type="doi">10.1128/AEM.02238-20</pub-id><pub-id pub-id-type="pmid">33483304</pub-id></element-citation></ref><ref id="B162-molecules-28-02761"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ochi</surname><given-names>K.</given-names></name>
<name><surname>Okamoto</surname><given-names>S.</given-names></name>
<name><surname>Tozawa</surname><given-names>Y.</given-names></name>
<name><surname>Inaoka</surname><given-names>T.</given-names></name>
<name><surname>Hosaka</surname><given-names>T.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Kurosawa</surname><given-names>K.</given-names></name>
</person-group><article-title>Ribosome engineering and secondary metabolite production</article-title><source>Adv. Appl. Microbiol.</source><year>2004</year><volume>56</volume><fpage>155</fpage><lpage>184</lpage><?supplied-pmid 15566979?><pub-id pub-id-type="pmid">15566979</pub-id></element-citation></ref><ref id="B163-molecules-28-02761"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hosoya</surname><given-names>Y.</given-names></name>
<name><surname>Okamoto</surname><given-names>S.</given-names></name>
<name><surname>Muramatsu</surname><given-names>H.</given-names></name>
<name><surname>Ochi</surname><given-names>K.</given-names></name>
</person-group><article-title>Acquisition of certain streptomycin-resistant (str) mutations enhances antibiotic production in bacteria</article-title><source>Antimicrob. Agents Chemother.</source><year>1998</year><volume>42</volume><fpage>2041</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1128/AAC.42.8.2041</pub-id><?supplied-pmid 9687404?><pub-id pub-id-type="pmid">9687404</pub-id></element-citation></ref><ref id="B164-molecules-28-02761"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shentu</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>N.</given-names></name>
<name><surname>Tang</surname><given-names>G.</given-names></name>
<name><surname>Tanaka</surname><given-names>Y.</given-names></name>
<name><surname>Ochi</surname><given-names>K.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Yu</surname><given-names>X.</given-names></name>
</person-group><article-title>Improved antibiotic production and silent gene activation in <italic toggle="yes">Streptomyces diastatochromogenes</italic> by ribosome engineering</article-title><source>J. Antibiot.</source><year>2016</year><volume>69</volume><fpage>406</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/ja.2015.123</pub-id><?supplied-pmid 26648118?><pub-id pub-id-type="pmid">26648118</pub-id></element-citation></ref><ref id="B165-molecules-28-02761"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Tian</surname><given-names>Y.</given-names></name>
<name><surname>Tan</surname><given-names>H.</given-names></name>
</person-group><article-title>Enhancement of salinomycin production by ribosome engineering in <italic toggle="yes">Streptomyces albus</italic></article-title><source>Sci. China Life Sci.</source><year>2019</year><volume>62</volume><fpage>276</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1007/s11427-018-9474-7</pub-id><pub-id pub-id-type="pmid">30659450</pub-id></element-citation></ref><ref id="B166-molecules-28-02761"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lv</surname><given-names>X.A.</given-names></name>
<name><surname>Jin</surname><given-names>Y.Y.</given-names></name>
<name><surname>Li</surname><given-names>Y.D.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Liang</surname><given-names>X.L.</given-names></name>
</person-group><article-title>Genome shuffling of <italic toggle="yes">Streptomyces viridochromogenes</italic> for improved production of avilamycin</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2013</year><volume>97</volume><fpage>641</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1007/s00253-012-4322-7</pub-id><pub-id pub-id-type="pmid">22911092</pub-id></element-citation></ref><ref id="B167-molecules-28-02761"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Payne</surname><given-names>D.J.</given-names></name>
<name><surname>Warren</surname><given-names>P.V.</given-names></name>
<name><surname>Holmes</surname><given-names>D.J.</given-names></name>
<name><surname>Ji</surname><given-names>Y.</given-names></name>
<name><surname>Lonsdale</surname><given-names>J.T.</given-names></name>
</person-group><article-title>Bacterial fatty-acid biosynthesis: A genomics-driven target for antibacterial drug discovery</article-title><source>Drug Discov. Today</source><year>2001</year><volume>6</volume><fpage>537</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/S1359-6446(01)01774-3</pub-id><pub-id pub-id-type="pmid">11369293</pub-id></element-citation></ref><ref id="B168-molecules-28-02761"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Craney</surname><given-names>A.</given-names></name>
<name><surname>Ozimok</surname><given-names>C.</given-names></name>
<name><surname>Pimentel-Elardo</surname><given-names>S.M.</given-names></name>
<name><surname>Capretta</surname><given-names>A.</given-names></name>
<name><surname>Nodwell</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism</article-title><source>Chem. Biol.</source><year>2012</year><volume>19</volume><fpage>1020</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2012.06.013</pub-id><pub-id pub-id-type="pmid">22921069</pub-id></element-citation></ref><ref id="B169-molecules-28-02761"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lomovskaya</surname><given-names>N.</given-names></name>
<name><surname>Otten</surname><given-names>S.L.</given-names></name>
<name><surname>Doi-Katayama</surname><given-names>Y.</given-names></name>
<name><surname>Fonstein</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>X.C.</given-names></name>
<name><surname>Takatsu</surname><given-names>T.</given-names></name>
<name><surname>Inventi-Solari</surname><given-names>A.</given-names></name>
<name><surname>Filippini</surname><given-names>S.</given-names></name>
<name><surname>Torti</surname><given-names>F.</given-names></name>
<name><surname>Colombo</surname><given-names>A.L.</given-names></name>
<etal/>
</person-group><article-title>Doxorubicin overproduction in <italic toggle="yes">Streptomyces peucetius</italic>: Cloning and characterization of the <italic toggle="yes">dnrU</italic> ketoreductase and <italic toggle="yes">dnrV</italic> genes and the <italic toggle="yes">doxA</italic> cytochrome P-450 hydroxylase gene</article-title><source>J. Bacteriol.</source><year>1999</year><volume>181</volume><fpage>305</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1128/JB.181.1.305-318.1999</pub-id><pub-id pub-id-type="pmid">9864344</pub-id></element-citation></ref><ref id="B170-molecules-28-02761"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malla</surname><given-names>S.</given-names></name>
<name><surname>Niraula</surname><given-names>N.P.</given-names></name>
<name><surname>Liou</surname><given-names>K.</given-names></name>
<name><surname>Sohng</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Enhancement of doxorubicin production by expression of structural sugar biosynthesis and glycosyltransferase genes in <italic toggle="yes">Streptomyces peucetius</italic></article-title><source>J. Biosci. Bioeng.</source><year>2009</year><volume>108</volume><fpage>92</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jbiosc.2009.03.002</pub-id><pub-id pub-id-type="pmid">19619853</pub-id></element-citation></ref><ref id="B171-molecules-28-02761"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wong</surname><given-names>M.</given-names></name>
<name><surname>Badri</surname><given-names>A.</given-names></name>
<name><surname>Gasparis</surname><given-names>C.</given-names></name>
<name><surname>Belfort</surname><given-names>G.</given-names></name>
<name><surname>Koffas</surname><given-names>M.</given-names></name>
</person-group><article-title>Modular optimization in metabolic engineering</article-title><source>Crit. Rev. Biochem. Mol. Biol.</source><year>2021</year><volume>56</volume><fpage>587</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1080/10409238.2021.1937928</pub-id><pub-id pub-id-type="pmid">34180323</pub-id></element-citation></ref><ref id="B172-molecules-28-02761"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>M.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.</given-names></name>
<name><surname>Yao</surname><given-names>M.</given-names></name>
<name><surname>Iqbal</surname><given-names>H.</given-names></name>
<name><surname>Hu</surname><given-names>Q.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Qiao</surname><given-names>B.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Skovbjerg</surname><given-names>C.A.S.</given-names></name>
<name><surname>Nielsen</surname><given-names>J.C.</given-names></name>
<etal/>
</person-group><article-title>Pathway engineering in yeast for synthesizing the complex polyketide bikaverin</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>6197</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-19984-3</pub-id><?supplied-pmid 33273470?><pub-id pub-id-type="pmid">33273470</pub-id></element-citation></ref><ref id="B173-molecules-28-02761"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beites</surname><given-names>T.</given-names></name>
<name><surname>Mendes</surname><given-names>M.V.</given-names></name>
</person-group><article-title>Chassis optimization as a cornerstone for the application of synthetic biology based strategies in microbial secondary metabolism</article-title><source>Front. Microbiol.</source><year>2015</year><volume>6</volume><fpage>906</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00906</pub-id><?supplied-pmid 26441855?><pub-id pub-id-type="pmid">26441855</pub-id></element-citation></ref><ref id="B174-molecules-28-02761"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>R.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
<name><surname>Liu</surname><given-names>T.</given-names></name>
</person-group><article-title><italic toggle="yes">Streptomyces</italic> species: Ideal chassis for natural product discovery and overproduction</article-title><source>Metab. Eng.</source><year>2018</year><volume>50</volume><fpage>74</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2018.05.015</pub-id><?supplied-pmid 29852270?><pub-id pub-id-type="pmid">29852270</pub-id></element-citation></ref><ref id="B175-molecules-28-02761"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Engineered biosynthesis of bacterial aromatic polyketides in <italic toggle="yes">Escherichia coli</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>20683</fpage><lpage>20688</lpage><pub-id pub-id-type="doi">10.1073/pnas.0809084105</pub-id><pub-id pub-id-type="pmid">19075227</pub-id></element-citation></ref><ref id="B176-molecules-28-02761"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Hua</surname><given-names>K.</given-names></name>
<name><surname>Liu</surname><given-names>D.</given-names></name>
<name><surname>Wu</surname><given-names>Z.L.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
<name><surname>Pfeifer</surname><given-names>B.A.</given-names></name>
<name><surname>Jiang</surname><given-names>M.</given-names></name>
</person-group><article-title>Heterologous biosynthesis of type ii polyketide products using <italic toggle="yes">E. coli</italic></article-title><source>ACS Chem. Biol.</source><year>2020</year><volume>15</volume><fpage>1177</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1021/acschembio.9b00827</pub-id><pub-id pub-id-type="pmid">31825590</pub-id></element-citation></ref><ref id="B177-molecules-28-02761"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>D.</given-names></name>
<name><surname>Liu</surname><given-names>C.</given-names></name>
<name><surname>Zhu</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>W.</given-names></name>
</person-group><article-title>Connecting metabolic pathways: Sigma factors in <italic toggle="yes">Streptomyces</italic> spp.</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>2546</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.02546</pub-id><pub-id pub-id-type="pmid">29312231</pub-id></element-citation></ref><ref id="B178-molecules-28-02761"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhuo</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Chen</surname><given-names>D.</given-names></name>
<name><surname>Gao</surname><given-names>H.</given-names></name>
<name><surname>Tao</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>M.</given-names></name>
<name><surname>Gou</surname><given-names>Z.</given-names></name>
<name><surname>Zhou</surname><given-names>X.</given-names></name>
<name><surname>Ye</surname><given-names>B.C.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<etal/>
</person-group><article-title>Reverse biological engineering of <italic toggle="yes">hrdB</italic> to enhance the production of avermectins in an industrial strain of <italic toggle="yes">Streptomyces avermitilis</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>11250</fpage><lpage>11254</lpage><pub-id pub-id-type="doi">10.1073/pnas.1006085107</pub-id><pub-id pub-id-type="pmid">20534557</pub-id></element-citation></ref><ref id="B179-molecules-28-02761"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Brempt</surname><given-names>M.</given-names></name>
<name><surname>Clauwaert</surname><given-names>J.</given-names></name>
<name><surname>Mey</surname><given-names>F.</given-names></name>
<name><surname>Stock</surname><given-names>M.</given-names></name>
<name><surname>Maertens</surname><given-names>J.</given-names></name>
<name><surname>Waegeman</surname><given-names>W.</given-names></name>
<name><surname>De Mey</surname><given-names>M.</given-names></name>
</person-group><article-title>Predictive design of sigma factor-specific promoters</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>5822</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-19446-w</pub-id><pub-id pub-id-type="pmid">33199691</pub-id></element-citation></ref><ref id="B180-molecules-28-02761"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>D.</given-names></name>
<name><surname>Arkin</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Sequestration-based bistability enables tuning of the switching boundaries and design of a latch</article-title><source>Mol. Syst. Biol.</source><year>2012</year><volume>8</volume><fpage>620</fpage><pub-id pub-id-type="doi">10.1038/msb.2012.52</pub-id><pub-id pub-id-type="pmid">23089683</pub-id></element-citation></ref><ref id="B181-molecules-28-02761"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Costello</surname><given-names>A.</given-names></name>
<name><surname>Badran</surname><given-names>A.H.</given-names></name>
</person-group><article-title>Synthetic biological circuits within an orthogonal central dogma</article-title><source>Trends Biotechnol.</source><year>2021</year><volume>39</volume><fpage>59</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2020.05.013</pub-id><pub-id pub-id-type="pmid">32586633</pub-id></element-citation></ref><ref id="B182-molecules-28-02761"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Ma</surname><given-names>L.</given-names></name>
<name><surname>Shen</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Feng</surname><given-names>Q.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Zheng</surname><given-names>G.</given-names></name>
<name><surname>Yan</surname><given-names>Y.</given-names></name>
<name><surname>Sun</surname><given-names>X.</given-names></name>
<name><surname>Yuan</surname><given-names>Q.</given-names></name>
</person-group><article-title>Targeting metabolic driving and intermediate influx in lysine catabolism for high-level glutarate production</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>3337</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-11289-4</pub-id><pub-id pub-id-type="pmid">31350399</pub-id></element-citation></ref><ref id="B183-molecules-28-02761"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Lu</surname><given-names>C.</given-names></name>
<name><surname>Bai</surname><given-names>L.</given-names></name>
</person-group><article-title>Conversion of the high-yield salinomycin producer <italic toggle="yes">Streptomyces albus</italic> BK3-25 into a surrogate host for polyketide production</article-title><source>Sci. China Life Sci.</source><year>2017</year><volume>60</volume><fpage>1000</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1007/s11427-017-9122-8</pub-id><?supplied-pmid 28812299?><pub-id pub-id-type="pmid">28812299</pub-id></element-citation></ref><ref id="B184-molecules-28-02761"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Jiang</surname><given-names>M.</given-names></name>
<name><surname>Bai</surname><given-names>L.</given-names></name>
</person-group><article-title>Enhanced salinomycin production by adjusting the supply of polyketide extender units in <italic toggle="yes">Streptomyces albus</italic></article-title><source>Metab. Eng.</source><year>2016</year><volume>35</volume><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2016.02.012</pub-id><?supplied-pmid 26969249?><pub-id pub-id-type="pmid">26969249</pub-id></element-citation></ref><ref id="B185-molecules-28-02761"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ng</surname><given-names>I.S.</given-names></name>
<name><surname>Ye</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Lu</surname><given-names>Y.</given-names></name>
<name><surname>Jing</surname><given-names>K.</given-names></name>
</person-group><article-title>Daptomycin antibiotic production processes in fed-batch fermentation by <italic toggle="yes">Streptomyces roseosporus</italic> NRRL11379 with precursor effect and medium optimization</article-title><source>Bioprocess Biosyst. Eng.</source><year>2014</year><volume>37</volume><fpage>415</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1007/s00449-013-1007-2</pub-id><?supplied-pmid 23828246?><pub-id pub-id-type="pmid">23828246</pub-id></element-citation></ref><ref id="B186-molecules-28-02761"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zabala</surname><given-names>D.</given-names></name>
<name><surname>Brana</surname><given-names>A.F.</given-names></name>
<name><surname>Salas</surname><given-names>J.A.</given-names></name>
<name><surname>Mendez</surname><given-names>C.</given-names></name>
</person-group><article-title>Increasing antibiotic production yields by favoring the biosynthesis of precursor metabolites glucose-1-phosphate and/or malonyl-CoA in <italic toggle="yes">Streptomyces</italic> producer strains</article-title><source>J. Antibiot.</source><year>2016</year><volume>69</volume><fpage>179</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1038/ja.2015.104</pub-id><?supplied-pmid 26464013?><pub-id pub-id-type="pmid">26464013</pub-id></element-citation></ref><ref id="B187-molecules-28-02761"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Myronovskyi</surname><given-names>M.</given-names></name>
<name><surname>Rosenkranzer</surname><given-names>B.</given-names></name>
<name><surname>Nadmid</surname><given-names>S.</given-names></name>
<name><surname>Pujic</surname><given-names>P.</given-names></name>
<name><surname>Normand</surname><given-names>P.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
</person-group><article-title>Generation of a cluster-free <italic toggle="yes">Streptomyces albus</italic> chassis strains for improved heterologous expression of secondary metabolite clusters</article-title><source>Metab. Eng.</source><year>2018</year><volume>49</volume><fpage>316</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2018.09.004</pub-id><pub-id pub-id-type="pmid">30196100</pub-id></element-citation></ref><ref id="B188-molecules-28-02761"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ajikumar</surname><given-names>P.K.</given-names></name>
<name><surname>Xiao</surname><given-names>W.H.</given-names></name>
<name><surname>Tyo</surname><given-names>K.E.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Simeon</surname><given-names>F.</given-names></name>
<name><surname>Leonard</surname><given-names>E.</given-names></name>
<name><surname>Mucha</surname><given-names>O.</given-names></name>
<name><surname>Phon</surname><given-names>T.H.</given-names></name>
<name><surname>Pfeifer</surname><given-names>B.</given-names></name>
<name><surname>Stephanopoulos</surname><given-names>G.</given-names></name>
</person-group><article-title>Isoprenoid pathway optimization for taxol precursor overproduction in <italic toggle="yes">Escherichia coli</italic></article-title><source>Science</source><year>2010</year><volume>330</volume><fpage>70</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1126/science.1191652</pub-id><pub-id pub-id-type="pmid">20929806</pub-id></element-citation></ref><ref id="B189-molecules-28-02761"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dong</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Duan</surname><given-names>J.</given-names></name>
<name><surname>Qin</surname><given-names>Y.</given-names></name>
<name><surname>Yang</surname><given-names>X.</given-names></name>
<name><surname>Ren</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>G.</given-names></name>
</person-group><article-title>Improving the yield of xenocoumacin 1 enabled by in situ product removal</article-title><source>ACS Omega</source><year>2020</year><volume>5</volume><fpage>20391</fpage><lpage>20398</lpage><pub-id pub-id-type="doi">10.1021/acsomega.0c02357</pub-id><pub-id pub-id-type="pmid">32832792</pub-id></element-citation></ref><ref id="B190-molecules-28-02761"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malla</surname><given-names>S.</given-names></name>
<name><surname>Niraula</surname><given-names>N.P.</given-names></name>
<name><surname>Singh</surname><given-names>B.</given-names></name>
<name><surname>Liou</surname><given-names>K.</given-names></name>
<name><surname>Sohng</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Limitations in doxorubicin production from <italic toggle="yes">Streptomyces peucetius</italic></article-title><source>Microbiol. Res.</source><year>2010</year><volume>165</volume><fpage>427</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2009.11.006</pub-id><pub-id pub-id-type="pmid">20116225</pub-id></element-citation></ref><ref id="B191-molecules-28-02761"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>B.</given-names></name>
<name><surname>Sun</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Meng</surname><given-names>W.</given-names></name>
<name><surname>Chen</surname><given-names>T.</given-names></name>
<name><surname>Dyson</surname><given-names>P.</given-names></name>
<name><surname>Liu</surname><given-names>G.</given-names></name>
</person-group><article-title>A new bacterial tRNA enhances antibiotic production in <italic toggle="yes">Streptomyces</italic> by circumventing inefficient wobble base-pairing</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>7084</fpage><lpage>7096</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac502</pub-id><pub-id pub-id-type="pmid">35699212</pub-id></element-citation></ref><ref id="B192-molecules-28-02761"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hwang</surname><given-names>C.K.</given-names></name>
<name><surname>Kim</surname><given-names>H.S.</given-names></name>
<name><surname>Hong</surname><given-names>Y.S.</given-names></name>
<name><surname>Kim</surname><given-names>Y.H.</given-names></name>
<name><surname>Hong</surname><given-names>S.K.</given-names></name>
<name><surname>Kim</surname><given-names>S.J.</given-names></name>
<name><surname>Lee</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Expression of <italic toggle="yes">Streptomyces peucetius</italic> genes for doxorubicin resistance and aklavinone 11-hydroxylase in <italic toggle="yes">Streptomyces galilaeus</italic> ATCC 31133 and production of a hybrid aclacinomycin</article-title><source>Antimicrob. Agents Chemother.</source><year>1995</year><volume>39</volume><fpage>1616</fpage><lpage>1620</lpage><pub-id pub-id-type="doi">10.1128/AAC.39.7.1616</pub-id><pub-id pub-id-type="pmid">7492117</pub-id></element-citation></ref><ref id="B193-molecules-28-02761"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Yin</surname><given-names>Y.</given-names></name>
<name><surname>Tang</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Directed biosynthesis of iso-aclacinomycins with improved anticancer activity</article-title><source>Org. Lett.</source><year>2020</year><volume>22</volume><fpage>150</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.9b04069</pub-id><pub-id pub-id-type="pmid">31829601</pub-id></element-citation></ref><ref id="B194-molecules-28-02761"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hadicke</surname><given-names>O.</given-names></name>
<name><surname>von Kamp</surname><given-names>A.</given-names></name>
<name><surname>Aydogan</surname><given-names>T.</given-names></name>
<name><surname>Klamt</surname><given-names>S.</given-names></name>
</person-group><article-title>OptMDFpathway: Identification of metabolic pathways with maximal thermodynamic driving force and its application for analyzing the endogenous CO<sub>2</sub> fixation potential of <italic toggle="yes">Escherichia coli</italic></article-title><source>PLoS Comput. Biol.</source><year>2018</year><volume>14</volume><elocation-id>e1006492</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006492</pub-id><?supplied-pmid 30248096?><pub-id pub-id-type="pmid">30248096</pub-id></element-citation></ref><ref id="B195-molecules-28-02761"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Zheng</surname><given-names>G.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Ge</surname><given-names>M.</given-names></name>
<name><surname>Jiang</surname><given-names>W.</given-names></name>
<name><surname>Lu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Multiplexed site-specific genome engineering for overproducing bioactive secondary metabolites in actinomycetes</article-title><source>Metab. Eng.</source><year>2017</year><volume>40</volume><fpage>80</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2017.01.004</pub-id><pub-id pub-id-type="pmid">28088540</pub-id></element-citation></ref><ref id="B196-molecules-28-02761"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.H.</given-names></name>
<name><surname>Kim</surname><given-names>H.</given-names></name>
<name><surname>Cong</surname><given-names>L.</given-names></name>
<name><surname>Jeong</surname><given-names>J.</given-names></name>
<name><surname>Bang</surname><given-names>D.</given-names></name>
<name><surname>Church</surname><given-names>G.M.</given-names></name>
</person-group><article-title>Genome-scale promoter engineering by coselection MAGE</article-title><source>Nat. Methods</source><year>2012</year><volume>9</volume><fpage>591</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1971</pub-id><?supplied-pmid 22484848?><pub-id pub-id-type="pmid">22484848</pub-id></element-citation></ref><ref id="B197-molecules-28-02761"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gaudelli</surname><given-names>N.M.</given-names></name>
<name><surname>Komor</surname><given-names>A.C.</given-names></name>
<name><surname>Rees</surname><given-names>H.A.</given-names></name>
<name><surname>Packer</surname><given-names>M.S.</given-names></name>
<name><surname>Badran</surname><given-names>A.H.</given-names></name>
<name><surname>Bryson</surname><given-names>D.I.</given-names></name>
<name><surname>Liu</surname><given-names>D.R.</given-names></name>
</person-group><article-title>Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage</article-title><source>Nature</source><year>2017</year><volume>551</volume><fpage>464</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1038/nature24644</pub-id><?supplied-pmid 29160308?><pub-id pub-id-type="pmid">29160308</pub-id></element-citation></ref><ref id="B198-molecules-28-02761"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grunewald</surname><given-names>J.</given-names></name>
<name><surname>Zhou</surname><given-names>R.</given-names></name>
<name><surname>Lareau</surname><given-names>C.A.</given-names></name>
<name><surname>Garcia</surname><given-names>S.P.</given-names></name>
<name><surname>Iyer</surname><given-names>S.</given-names></name>
<name><surname>Miller</surname><given-names>B.R.</given-names></name>
<name><surname>Langner</surname><given-names>L.M.</given-names></name>
<name><surname>Hsu</surname><given-names>J.Y.</given-names></name>
<name><surname>Aryee</surname><given-names>M.J.</given-names></name>
<name><surname>Joung</surname><given-names>J.K.</given-names></name>
</person-group><article-title>A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing</article-title><source>Nat. Biotechnol.</source><year>2020</year><volume>38</volume><fpage>861</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0535-y</pub-id><pub-id pub-id-type="pmid">32483364</pub-id></element-citation></ref><ref id="B199-molecules-28-02761"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anzalone</surname><given-names>A.V.</given-names></name>
<name><surname>Koblan</surname><given-names>L.W.</given-names></name>
<name><surname>Liu</surname><given-names>D.R.</given-names></name>
</person-group><article-title>Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors</article-title><source>Nat. Biotechnol.</source><year>2020</year><volume>38</volume><fpage>824</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0561-9</pub-id><pub-id pub-id-type="pmid">32572269</pub-id></element-citation></ref><ref id="B200-molecules-28-02761"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tong</surname><given-names>Y.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Lee</surname><given-names>S.Y.</given-names></name>
</person-group><article-title>CRISPR/Cas-based genome engineering in natural product discovery</article-title><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>1262</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1039/C8NP00089A</pub-id><pub-id pub-id-type="pmid">30548045</pub-id></element-citation></ref><ref id="B201-molecules-28-02761"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rogers</surname><given-names>J.K.</given-names></name>
<name><surname>Taylor</surname><given-names>N.D.</given-names></name>
<name><surname>Church</surname><given-names>G.M.</given-names></name>
</person-group><article-title>Biosensor-based engineering of biosynthetic pathways</article-title><source>Curr. Opin. Biotechnol.</source><year>2016</year><volume>42</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2016.03.005</pub-id><pub-id pub-id-type="pmid">26998575</pub-id></element-citation></ref><ref id="B202-molecules-28-02761"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kannan</surname><given-names>S.</given-names></name>
<name><surname>Altae-Tran</surname><given-names>H.</given-names></name>
<name><surname>Jin</surname><given-names>X.</given-names></name>
<name><surname>Madigan</surname><given-names>V.J.</given-names></name>
<name><surname>Oshiro</surname><given-names>R.</given-names></name>
<name><surname>Makarova</surname><given-names>K.S.</given-names></name>
<name><surname>Koonin</surname><given-names>E.V.</given-names></name>
<name><surname>Zhang</surname><given-names>F.</given-names></name>
</person-group><article-title>Compact RNA editors with small Cas13 proteins</article-title><source>Nat. Biotechnol.</source><year>2022</year><volume>40</volume><fpage>194</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/s41587-021-01030-2</pub-id><?supplied-pmid 34462587?><pub-id pub-id-type="pmid">34462587</pub-id></element-citation></ref><ref id="B203-molecules-28-02761"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vojta</surname><given-names>A.</given-names></name>
<name><surname>Dobrini&#x00107;</surname><given-names>P.</given-names></name>
<name><surname>Tadi&#x00107;</surname><given-names>V.</given-names></name>
<name><surname>Bo&#x0010d;kor</surname><given-names>L.</given-names></name>
<name><surname>Kora&#x00107;</surname><given-names>P.</given-names></name>
<name><surname>Julg</surname><given-names>B.</given-names></name>
<name><surname>Klasi&#x00107;</surname><given-names>M.</given-names></name>
<name><surname>Zoldo&#x00161;</surname><given-names>V.</given-names></name>
</person-group><article-title>Repurposing the CRISPR-Cas9 system for targeted DNA methylation</article-title><source>Nucleic Acids Res.</source><year>2016</year><volume>44</volume><fpage>5615</fpage><lpage>5628</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw159</pub-id><?supplied-pmid 26969735?><pub-id pub-id-type="pmid">26969735</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="molecules-28-02761-f001"><label>Figure 1</label><caption><p>The crystal structure of DNA&#x02013;daunomycin complex (PDB 1DA0).</p></caption><graphic xlink:href="molecules-28-02761-g001" position="float"/></fig><fig position="float" id="molecules-28-02761-f002"><label>Figure 2</label><caption><p>Organization of the aclacinomycins biosynthesis gene cluster. Arrows indicate the directions of gene transcription. GT, glycosyltransferase; PKS, polyketide synthase.</p></caption><graphic xlink:href="molecules-28-02761-g002" position="float"/></fig><fig position="float" id="molecules-28-02761-f003"><label>Figure 3</label><caption><p>Biosynthesis pathway of aclacinomycin A. (<bold>A</bold>) Biosynthesis of TDP-sugars; (<bold>B</bold>) Type II PKS pathway and post-PKS tailoring modifications.</p></caption><graphic xlink:href="molecules-28-02761-g003" position="float"/></fig><fig position="float" id="molecules-28-02761-f004"><label>Figure 4</label><caption><p>Structure information of AknH. (<bold>A</bold>) Structure of AknH; (<bold>B</bold>) Superimposition built by Pymol. AknH and SnoaL are shown in green and yellow, respectively.</p></caption><graphic xlink:href="molecules-28-02761-g004" position="float"/></fig><fig position="float" id="molecules-28-02761-f005"><label>Figure 5</label><caption><p>Catalytic mechanisms of glycosyltransferases. (<bold>A</bold>) Reaction mechanism of inverting and retaining glycosyltransferases; (<bold>B</bold>) Inverting glycosyltransferase by a direct-displacement S<sub>N</sub>2-like reaction mechanism.</p></caption><graphic xlink:href="molecules-28-02761-g005" position="float"/></fig><fig position="float" id="molecules-28-02761-f006"><label>Figure 6</label><caption><p>Predicted structure module of AknS. (<bold>A</bold>) AknS monomer prediction carried by AlphaFold Monomer v2.0; (<bold>B</bold>) The three-helix motif in AknS with labels of highly conserved residues.</p></caption><graphic xlink:href="molecules-28-02761-g006" position="float"/></fig><fig position="float" id="molecules-28-02761-f007"><label>Figure 7</label><caption><p>Structure information of AknT. (<bold>A</bold>) Predicted structure model of AknT; (<bold>B</bold>) The cartoon image of ErycIII in complex of EryCII.</p></caption><graphic xlink:href="molecules-28-02761-g007" position="float"/></fig><fig position="float" id="molecules-28-02761-f008"><label>Figure 8</label><caption><p>Homology model of AknK and docking analysis. (<bold>A</bold>) Homology model of AknK; the close-up view of the profile maps showing the active site binding as well as enlarged views of molecular docking of AknK with (<bold>B</bold>,<bold>C</bold>) dTDP-2-deoxyfucose; and (<bold>D</bold>,<bold>E</bold>) dTDP-rhodinose, respectively.</p></caption><graphic xlink:href="molecules-28-02761-g008" position="float"/></fig><fig position="float" id="molecules-28-02761-f009"><label>Figure 9</label><caption><p>Structure information of AknOx. (<bold>A</bold>) Structure of AknOx; (<bold>B</bold>) The S domain and F domain are shown in yellow and light green, respectively; (<bold>C</bold>) FAD-binding pocket of AknOx and Dbv29.</p></caption><graphic xlink:href="molecules-28-02761-g009" position="float"/></fig><table-wrap position="float" id="molecules-28-02761-t001"><object-id pub-id-type="pii">molecules-28-02761-t001_Table 1</object-id><label>Table 1</label><caption><p>The identified and putative functions of the <italic toggle="yes">akn</italic> genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene Product</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Amino Acid Residues</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Uniprot</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Functions</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknA</td><td align="center" valign="middle" rowspan="1" colspan="1">261</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L553</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-ketoreductase</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknB</td><td align="center" valign="middle" rowspan="1" colspan="1">423</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L551</td><td align="center" valign="middle" rowspan="1" colspan="1">KS<sub>&#x003b1;</sub></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknC</td><td align="center" valign="middle" rowspan="1" colspan="1">407</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L550</td><td align="center" valign="middle" rowspan="1" colspan="1">KS<sub>&#x003b2;</sub></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknD</td><td align="center" valign="middle" rowspan="1" colspan="1">91</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L549</td><td align="center" valign="middle" rowspan="1" colspan="1">Acyl carrier protein (ACP)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknE1</td><td align="center" valign="middle" rowspan="1" colspan="1">450</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L554</td><td align="center" valign="middle" rowspan="1" colspan="1">Aromatase (ARO)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknE2</td><td align="center" valign="middle" rowspan="1" colspan="1">368</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L548</td><td align="center" valign="middle" rowspan="1" colspan="1">Determines the starter unit</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknF</td><td align="center" valign="middle" rowspan="1" colspan="1">347</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L547</td><td align="center" valign="middle" rowspan="1" colspan="1">Malonyl-CoA: ACP transacylase (MAT)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknW</td><td align="center" valign="middle" rowspan="1" colspan="1">259</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L4U2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cyclase</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknX</td><td align="center" valign="middle" rowspan="1" colspan="1">122</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L552</td><td align="center" valign="middle" rowspan="1" colspan="1">Mono-oxygenase (OXY)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknG</td><td align="center" valign="middle" rowspan="1" colspan="1">286</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L546</td><td align="center" valign="middle" rowspan="1" colspan="1">Methyl transferase (MET)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknH</td><td align="center" valign="middle" rowspan="1" colspan="1">144</td><td align="center" valign="middle" rowspan="1" colspan="1">O52646</td><td align="center" valign="middle" rowspan="1" colspan="1">Aklanonic acid methyl ester cyclase (AAME-cyclase)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AknU</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">267</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Q9L4U4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aklaviketone reductase (KRII)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-28-02761-t002"><object-id pub-id-type="pii">molecules-28-02761-t002_Table 2</object-id><label>Table 2</label><caption><p>The identified and putative functions of akn enzymes and isozymes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene Product</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Amino Acid Residues</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Uniprot</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Functions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Isozyme</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknY</td><td align="center" valign="middle" rowspan="1" colspan="1">291</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L4U0</td><td align="center" valign="middle" rowspan="1" colspan="1">Glucose-1-phosphate thymidylyltransferase</td><td align="center" valign="middle" rowspan="1" colspan="1">DnmL</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknR</td><td align="center" valign="middle" rowspan="1" colspan="1">323</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L4U7</td><td align="center" valign="middle" rowspan="1" colspan="1">dTDP-Glucose<break/>4,6-dehydratase</td><td align="center" valign="middle" rowspan="1" colspan="1">DnmM</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknN</td><td align="center" valign="middle" rowspan="1" colspan="1">662</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L4V1</td><td align="center" valign="middle" rowspan="1" colspan="1">2,3-Dehydratase</td><td align="center" valign="middle" rowspan="1" colspan="1">DnmT, </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknQ</td><td align="center" valign="middle" rowspan="1" colspan="1">329</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L4U8</td><td align="center" valign="middle" rowspan="1" colspan="1">3-Ketoreductase</td><td align="center" valign="middle" rowspan="1" colspan="1">SpnN</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknP</td><td align="center" valign="middle" rowspan="1" colspan="1">434</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L4U9</td><td align="center" valign="middle" rowspan="1" colspan="1">3-Dehydratase</td><td align="center" valign="middle" rowspan="1" colspan="1">SpnQ</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknZ</td><td align="center" valign="middle" rowspan="1" colspan="1">341</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L4T9</td><td align="center" valign="middle" rowspan="1" colspan="1">Aminotransferase</td><td align="center" valign="middle" rowspan="1" colspan="1">DnmJ, </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknL</td><td align="center" valign="middle" rowspan="1" colspan="1">201</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L556</td><td align="center" valign="middle" rowspan="1" colspan="1">3,5-Epimerase</td><td align="center" valign="middle" rowspan="1" colspan="1">DnmU,</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AknM</td><td align="center" valign="middle" rowspan="1" colspan="1">206</td><td align="center" valign="middle" rowspan="1" colspan="1">Q9L557</td><td align="center" valign="middle" rowspan="1" colspan="1">Reductase</td><td align="center" valign="middle" rowspan="1" colspan="1">DnmV</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AknX2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">238</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Q9L4U1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-methyltransferase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-28-02761-t003"><object-id pub-id-type="pii">molecules-28-02761-t003_Table 3</object-id><label>Table 3</label><caption><p>Strategies for improving the desired metabolites in <italic toggle="yes">Streptomyces</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Organism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Secondary Metabolite</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Strategy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Production Improved</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. lavendofoliae</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">ACM-A</td><td align="center" valign="middle" rowspan="1" colspan="1">NTG mutagenesis</td><td align="center" valign="middle" rowspan="1" colspan="1">300%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B127-molecules-28-02761" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">aklavinone</td><td align="center" valign="middle" rowspan="1" colspan="1">optimization of promoters, vectors, and chassis strains</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;100%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B131-molecules-28-02761" ref-type="bibr">131</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. galilaeus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">ACM-A</td><td align="center" valign="middle" rowspan="1" colspan="1">adjusting broth pH</td><td align="center" valign="middle" rowspan="1" colspan="1">Data not shown</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B128-molecules-28-02761" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. galilaeus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">ACM-A</td><td align="center" valign="middle" rowspan="1" colspan="1">NTG mutagenesis</td><td align="center" valign="middle" rowspan="1" colspan="1">Data not shown</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B129-molecules-28-02761" ref-type="bibr">129</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">DXR/DNR/akavinone</td><td align="center" valign="middle" rowspan="1" colspan="1">disruption of global downregulator gene</td><td align="center" valign="middle" rowspan="1" colspan="1">30% </td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B144-molecules-28-02761" ref-type="bibr">144</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. peucetius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">daunorubicin</td><td align="center" valign="middle" rowspan="1" colspan="1">overexpression of resistance genes</td><td align="center" valign="middle" rowspan="1" colspan="1">410%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B157-molecules-28-02761" ref-type="bibr">157</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. peucetius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">daunorubicin</td><td align="center" valign="middle" rowspan="1" colspan="1">overexpression of global regulator</td><td align="center" valign="middle" rowspan="1" colspan="1">45.7%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B140-molecules-28-02761" ref-type="bibr">140</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. peucetius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">doxorubicin</td><td align="center" valign="middle" rowspan="1" colspan="1">overexpression of rate-limiting enzymes</td><td align="center" valign="middle" rowspan="1" colspan="1">86%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B169-molecules-28-02761" ref-type="bibr">169</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. peucetius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">doxorubicin</td><td align="center" valign="middle" rowspan="1" colspan="1">expression of structural sugar biosynthesis and glycosyltransferase genes</td><td align="center" valign="middle" rowspan="1" colspan="1">460%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B170-molecules-28-02761" ref-type="bibr">170</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. avermitilis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">avermectin</td><td align="center" valign="middle" rowspan="1" colspan="1">ribosomal engineering</td><td align="center" valign="middle" rowspan="1" colspan="1">50%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B178-molecules-28-02761" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. rochei</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Lankacidin/lankamycin</td><td align="center" valign="middle" rowspan="1" colspan="1">deletion of GBL receptors</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;300%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B138-molecules-28-02761" ref-type="bibr">138</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. hygroscopicus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">validamycin</td><td align="center" valign="middle" rowspan="1" colspan="1">exogenous addition of A-Factor analogues</td><td align="center" valign="middle" rowspan="1" colspan="1">30%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B137-molecules-28-02761" ref-type="bibr">137</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. tsukubaensis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">tacrolimus</td><td align="center" valign="middle" rowspan="1" colspan="1">expression of GBL synthetase</td><td align="center" valign="middle" rowspan="1" colspan="1">36%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B139-molecules-28-02761" ref-type="bibr">139</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. rimosus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">oxytetracycline</td><td align="center" valign="middle" rowspan="1" colspan="1">overexpression of transporters</td><td align="center" valign="middle" rowspan="1" colspan="1">60%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B159-molecules-28-02761" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S.</italic> coelicolor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">germicidins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">exogenous addition of ARC2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Data not shown</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B167-molecules-28-02761" ref-type="bibr">167</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>